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ABSTRACT
Medication errors and adverse drug events (ADEs) are a significant public health concern
in the United States as they pose a threat to patient safety. The medication management process is
a complicated process in U.S. acute care hospitals, consisting of a series of steps such as ordering,
transcribing, dispensing and administration and each step is prone to medication errors. The use
of technology is considered to be an important intervention in improving the medication
management process and thereby reducing medication errors and ADEs and further improve
patient safety. The Health Information Technology for Economic and Clinical Health (HITECH)
Act, implemented in the year 2011, is the most important regulation in recent years focused on
enhancing the use of IT in the health care system. This study examined the organizational and
environmental correlates of the adoption of Medication Management Technologies (MMTs) by
U.S. acute care hospitals after the HITECH Act.
The rational adaptation perspective of the resource dependence theory is utilized in this
study, using panel data from 2009 to 2013 with a one-year lag for independent variables and
mixed-effects regression models for analyses. The study operationalized adoption of MMTs
through seven measures: global adoption of MMTs, adoption of closed loop medication
management, adoption of meaningful use MMTs and adoption-levels for the four steps of the
medication management process: ordering, transcribing, dispensing and administration. Hospitals
were more likely to adopt MMTs in the time after the implementation of the HITECH Act (2012,
2013) and were less likely to adopt MMTs before the implementation of the HITECH Act (2009,

2010) as compared to the HITECH Act implementation period (2011). The study further found
that the resource dependence construct of munificence, operationalized through organizational
size, and the construct of interdependence, operationalized through private payer mix was
significantly associated with the adoption of MMTs.

vi
TABLE OF CONTENTS
ACKNOWLEDGEMENTS ...................................................................................................... ii
ABSTRACT ............................................................................................................................. iv
LIST OF TABLES .................................................................................................................. xii
LIST OF FIGURES ................................................................................................................ 14
CHAPTER ONE: INTRODUCTION .................................................................................... 15
Statement of the Problem and Rationale ................................................................................ 15
Purpose of the Study ............................................................................................................. 19
Scope of the Study ................................................................................................................ 19
Research Questions ............................................................................................................... 20
Overview of the Conceptual Framework................................................................................ 20
Research Hypotheses............................................................................................................. 22
Significance and Relevance ................................................................................................... 23
Research Plan and Unit of Analysis ....................................................................................... 23
Outline of Ensuing Chapters .................................................................................................. 24
CHAPTER TWO: LITERATURE REVIEW ........................................................................ 25
Section One: The Medication Management Process ............................................................... 26
Overview of Medication Safety ......................................................................................... 26
Steps of the Medication Management Process ................................................................... 28
Ordering. ....................................................................................................................... 29
Transcribing. ................................................................................................................. 29

vii
Dispensing. ................................................................................................................... 29
Administration. ............................................................................................................. 30
Automation of the Medication Management Process ......................................................... 30
1. Electronic Health Record (EHR). ............................................................................... 33
2. Computerized Physician Order Entry (CPOE) and Clinical Decision Support Systems
(CDSS). ........................................................................................................................ 34
3. Transcription Software. ............................................................................................. 37
4. Electronic Medication Administration Record (eMAR). ............................................. 37
5. Robot-filling. ............................................................................................................. 38
6. Automated Dispensing Machine (ADM). ................................................................... 38
7. Bar-coding. ................................................................................................................ 40
8. Radio Frequency Identification (RFID). ..................................................................... 42
9. Pharmacy Management System. ................................................................................ 43
10. Intravenous Smart Pumps. ....................................................................................... 43
11. Closed Loop Medication Management System (CLMM). ......................................... 44
Section Two: The Regulatory Environment ........................................................................... 45
Institute of Medicine, 1991 ................................................................................................ 45
Institute of Medicine, 2000 ................................................................................................ 46
Institute of Medicine, 2001 ................................................................................................ 46
President’s Health Information Technology Plan, 2004...................................................... 47
Institute of Medicine, 2006 ................................................................................................ 48
Health Information Technology for Economic and Clinical Health (HITECH) Act, 2009 ... 49

viii
Patient Protection and Affordable Care Act, 2010 .............................................................. 51
National Action Plan for Adverse Drug Event Prevention, 2013 ........................................ 51
National Patient Safety Goals, 2016 .................................................................................. 52
Section Three: Adoption of Medication Management Technology ......................................... 52
Adoption of EHRs ............................................................................................................. 53
Achievement of MU .......................................................................................................... 54
Adoption of MMTs ........................................................................................................... 55
Summary of Gaps in the Literature ........................................................................................ 57
Summary of the Chapter ........................................................................................................ 57
CHAPTER THREE: THEORETICAL BACKGROUND .................................................... 59
Section One: Competing Perspectives for Organizational Strategic Behavior ......................... 60
Organizational Strategic Behavior ..................................................................................... 60
Organizational Innovation ................................................................................................. 63
Adoption of Innovation ..................................................................................................... 65
Section Two: Theoretical Framework of the Study ................................................................ 67
Overview of Resource Dependence Theory ....................................................................... 67
Development of the Conceptual Model .............................................................................. 70
Key Constructs .................................................................................................................. 72
Research Hypotheses......................................................................................................... 72
Uncertainty.................................................................................................................... 72
Munificence. ................................................................................................................. 74

ix
Interdependence. ........................................................................................................... 76
Summary of the Chapter ........................................................................................................ 78
CHAPTER FOUR: METHODOLOGY ................................................................................. 79
Research Design.................................................................................................................... 79
Data Sources ......................................................................................................................... 82
Study Universe, Population and Sample ................................................................................ 83
Key Measures ....................................................................................................................... 85
Dependent Variables ......................................................................................................... 89
Measurement of Dependent Variables ............................................................................... 91
Independent Variables ....................................................................................................... 92
Operationalizing Uncertainty ......................................................................................... 92
Operationalizing Munificence........................................................................................ 93
Operationalizing Interdependence .................................................................................. 94
Control Variables .............................................................................................................. 95
Data Analysis Approach ........................................................................................................ 96
Descriptive Analyses ......................................................................................................... 97
Multivariate Analyses ....................................................................................................... 97
Methodological Limitations................................................................................................. 101
Ethical Considerations ......................................................................................................... 102
Summary of the Chapter ...................................................................................................... 102
CHAPTER FIVE: RESULTS............................................................................................... 103

x
Descriptive Analyses Results............................................................................................... 104
Comparison of Study Population and Sample .................................................................. 107
Sample Descriptive Characteristics .................................................................................. 108
Changes in the Dependent Variable Measures from the Pre-HITECH period to the PostHITECH Period .............................................................................................................. 113
Correlation Analysis........................................................................................................ 116
Multivariate Regression Analyses Results ........................................................................... 118
Specification Tests of Consistency .................................................................................. 118
Model 1: Global Adoption of MMTs ............................................................................... 119
Model 2: Adoption of MU MMTs ................................................................................... 121
Model 3: Adoption of CLMM ......................................................................................... 122
Model 4: Adoption of Ordering Technologies .................................................................. 123
Model 5: Adoption of Transcribing Technologies ............................................................ 125
Model 6: Adoption of Dispensing Technologies .............................................................. 127
Model 7: Adoption of Administration Technologies ........................................................ 129
Sensitivity Analysis ......................................................................................................... 131
Summary of Chapter ........................................................................................................... 132
CHAPTER SIX: DISCUSSION ........................................................................................... 134
Introduction ........................................................................................................................ 134
Summary and Interpretation of Descriptive Analyses ........................................................... 136
Summary and Interpretation of Hypotheses Testing ............................................................. 136
Implications for Theory-based Research .............................................................................. 147

xi
Implications for Methodology ............................................................................................. 148
Implications for Policy and Practice .................................................................................... 148
Limitations of the Study ...................................................................................................... 149
Suggestions for Future Research.......................................................................................... 150
Conclusions ........................................................................................................................ 151
REFERENCES ..................................................................................................................... 152

xii

LIST OF TABLES
Table 1: Constructs, Variables and Measurements and Data Sources ......................................... 86
Table 2: MMTs used in the Medication Management Process and their Adoption Definitions.... 91
Table 3: Creation of Study Sample .......................................................................................... 106
Table 4: Comparison of Non-CAH, Non-federal, Acute Care Hospitals in Study Population and
Sample.................................................................................................................................... 108
Table 5: Descriptive Statistics for Study Variables for all Years (n=13,690) ............................ 111
Table 6: Changes in the Dependent Variable Measures from the pre-HITECH period to the postHITECH period ...................................................................................................................... 114
Table 7: Correlation Analysis for Pooled Analytic Sample (n=13,690) .................................... 117
Table 8: Hausman Specification Test ...................................................................................... 119
Table 9: Parameter Estimates: Global Adoption of MMTs....................................................... 120
Table 10: Parameter Estimates: Adoption of Meaningful Use MMTs ...................................... 122
Table 11: Parameter Estimates: Adoption of CLMM ............................................................... 123
Table 12: Parameter Estimates: Adoption of Ordering Technologies ....................................... 125
Table 13: Parameter Estimates: Adoption of Transcribing Technologies .................................. 127
Table 14: Parameter Estimates: Adoption of Dispensing Technologies .................................... 129
Table 15: Parameter Estimates: Adoption of Administration Technologies .............................. 131
Table 16: Confirmation of Hypothesis 1 and Direction of Coefficients .................................... 138
Table 17: Confirmation of Hypothesis 2 and Direction of Coefficients .................................... 139
Table 18: Confirmation of Hypothesis 3 and Direction of Coefficients .................................... 140
Table 19: Confirmation of Hypothesis 4 and Direction of Coefficients .................................... 141
Table 20: Confirmation of Hypothesis 5 and Direction of Coefficients .................................... 143
Table 21: Confirmation of Hypothesis 6 and Direction of Coefficients .................................... 144
Table 22: Confirmation of Hypothesis 7 and Direction of Coefficients .................................... 145

xiii
Table 23: Confirmation of Hypothesis 8 and Direction of Coefficients .................................... 147

14

LIST OF FIGURES
Figure 1: Steps and Automation of the Medication Management Process ................................... 32
Figure 2: Conceptual Model of the Study .................................................................................. 71
Figure 3: Research Design: Interrupted Time Series .................................................................. 79
Figure 4: Changes in Dependent Variable Measures from Pre-HITECH period to Post-HITECH
period. .................................................................................................................................... 115

15

CHAPTER ONE: INTRODUCTION
Statement of the Problem and Rationale
Medical errors are a significant public health concern in the United States (U.S.) as they
pose a significant threat to patient safety (La Pietra, Calligaris, Molendini, Quattrin, &
Brusaferro, 2005). Further, medication errors are the most common cause of medical errors
(Leape et al., 1991). Around 1.5 million Americans suffer from injuries due to medication-related
errors annually in hospitals, nursing homes and physician offices (Institute of Medicine, 2006).
This number does not include those injuries arising out of the patients’ mix-up of medications at
home and other settings and thus represents only a fraction of the total population that could be
facing medication errors and injuries associated with medication errors (Kohn, Corrigan, &
Donaldson, 1999). An Adverse Drug Event (ADE) could potentially be a consequence of
medication error. An ADE is a direct measure of patient harm and is defined as “injuries related
to medical interventions related to a drug” (Bates et al., 1995). Further, 28% of the ADEs are
found to be associated with medication errors, which may be potentially preventable (Bates et al.,
1995). Thus, medication errors are directly related to patient safety. Another growing concern is
that medication errors and ADEs are costly. One ADE accounts for $2,000 in additional costs
excluding the malpractice costs (Bates et al., 1995). In a large tertiary care hospital, ADEs were
responsible for $5.6 million annual health care costs and preventable ADEs were responsible for
$2.8 million annual health care costs (Bates et al., 1997). The estimated national burden
associated with ADEs is $2 billion (Bates et al., 1999).
In U.S. hospitals, the process of medication management is complicated and occurs
through a series of steps, comprising of different hospital personnel working in conjunction to
accomplish each step of the process (Agrawal, 2009; Bates et al., 2001). The major steps of the
medication management process include ordering, transcribing, dispensing and administration
(Agrawal, 2009). Ordering involves ordering of the drug by the health care practitioner,
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transcribing involves transfer of the prescription information into a medication administration
record for the patient, dispensing involves the pharmacist checking the order and providing the
drug as per the medication order and administration involves giving the drug to the patient. There
is a possibility for errors to occur at each step of this process (Bates et al., 1995; Leape et al.,
1995) and hence, the need for interventions to prevent errors at each step of the process, in order
to ensure patient safety. Given the impact of medication errors on patient safety, it is essential to
implement ways of reducing medication errors, so that the five rights of medication
administration (right drug, right patient, right dose, right route and right time) are adhered to
(Agrawal & Glasser, 2009).
There is evidence that technology has the potential to reduce medication errors through
automating the steps of the medication management process and eliminating sources of errors
(Bates, 2000; McKibbon et al., 2012). This further reduces the injuries and ADEs that arise out of
medication errors. Since these injuries and ADEs lead to patient harm, their reduction would lead
to increased patient safety (Institute of Medicine, 2001). Hence, the use of technology has been
touted as an essential tool to improve patient safety (Furukawa, Raghu, Spaulding, & Vinze,
2008). Several organizations in the U.S. such as Leapfrog, the Institute of Medicine (IOM), the
Agency for Healthcare Research and Quality (AHRQ) and the Office of the National Coordinator
for Health Information Technology (ONCHIT) have recommended the use of technology for
improving the medication management process and thereby impacting overall patient safety
(McKibbon et al., 2012). The IOM report titled, ‘Crossing the Quality Chasm: A New Health
System for the Twenty-first Century’ (2001) stresses the need for development of information
technology (IT) and its application in improving patient safety (Institute of Medicine, 2001).
Each step of the medication management process can be automated through the use of
technology (Bates, 2000). Technologies such as computerized physician order entry (CPOE) and
clinical decision support system (CDSS) are used at the ordering step; electronic medication
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administration record (eMAR) and in-house transcription software are used at the transcribing
step; bar-coding, radio frequency identification (RFID), robot-filling for prescriptions, automated
dispensing machines (ADMs) and pharmacy management system are used at the dispensing step;
and bar-coding, RFID, eMAR and smart pumps are used at the administration step (Bates, 2000;
Bates et al., 2001). For the purpose of this dissertation, these technologies will be collectively
referred to as medication management technologies (MMTs). Further, a technology that
automates and coordinates all the steps of the medication management process is the closed loop
medication management (CLMM) system. This CLMM system is “end-to-end electronic
medication management with a seamless flow of information along the process” (Agrawal, 2009).
HIMSS identifies the components of the CLMM system as the technologies which automate
medication ordering, provide decision support, aid with medication packaging, automate
medication dispensing in the hospital units and help with medication administration to provide
the correct medication to the right patient (Healthcare Information and Management Systems
Society, 2010).
The most important regulation around enhancing the use of IT in the health care system
enacted recently has been the Health Information Technology for Economic and Clinical Health
(HITECH) Act, which was passed on February 17, 2009 as part of the American Recovery and
Reinvestment Act under President Barack Obama’s administration (Blumenthal, 2009). Under the
HITECH Act, the Office of the National Coordinator for Health Information Technology
(ONCHIT) within the Department of Health and Human Services (DHHS), was designated as the
main federal organization to promote the adoption of health IT and electronic health information
exchange (Blumenthal, 2009). Additionally, the CMS was allocated around $30 billion
incentivize providers and hospitals for demonstrating meaningful use of Electronic Health
Records (EHRs) through the Medicare and Medicaid EHR Incentive Programs (Centers for
Medicare and Medicaid Services, 2014d). The EHR Incentive Programs were designed to
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promote the adoption, implementation and upgradation of certified EHR technology and its
various functionalities as well as demonstration of meaningful use of that certified EHR
technology by eligible providers and eligible hospitals through three stages (Centers for Medicare
and Medicaid Services, 2016d). The first stage of this Act came into effect in 2011 with eligible
hospitals and providers that meet the objectives set forth in Stage 1 becoming entitled for
financial incentives (Centers for Medicare and Medicaid Services, 2016d). The EHR Incentive
Programs offered incentives to eligible hospitals and providers who met certain defined
objectives known as the meaningful use (MU) objectives (Centers for Medicare and Medicaid
Services, 2016d). These objectives and the attached incentives were rolled out in stages, with
each stage involving defined measures that needed to be met (Centers for Medicare and Medicaid
Services, 2016d). Certain objectives were specific to adoption and use of MMTs in order to gain
incentives. These MMTs that were included in the MU objectives at various stages were CPOE,
CDSS and eMAR (Centers for Medicare and Medicaid Services, 2014b).
Research on the adoption of MMTs is of interest given the benefits of technology in
reducing medication errors and thereby improving patient safety (McKibbon et al., 2012).
Further, the enactment of the HITECH Act and the implementation of the stage 1 of the Act
created an uncertain regulatory environment for hospitals. Policymakers and legislators would
also be interested in the response of the hospitals to the implementation of the HITECH Act, as
they would like to know whether the Act enhanced the adoption of technology for medication
management in the hospitals. Also, examining the contextual factors of adoption of MMTs at
each step of the medication management process is essential to understand the factors associated
with this strategic behavior of the hospitals. Previous studies have examined the adoption of
selected MMTs individually, but there is a no empirical study that has examined the adoption of
the technologies in context of their use in the medication management process. This study is
expected to contribute towards the theoretical and empirical literature on organizational responses
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of acute care hospitals to the HITECH Act and the strategic behavior of the automation of the
medication management process.

Purpose of the Study
The objectives of this study were to:
a. Examine the impact of the implementation of the HITECH Act on the adoption of MMTs by
U.S. acute care hospitals.
b. Examine the organizational and environmental correlates of adoption of MMTs by U.S. acute
care hospitals.
The variable of adoption of MMTs was measured as: (1) the global adoption of all
MMTs, (2) adoption of MU MMTs (CDSS, CPOE and eMAR), (3) adoption of CLMM and (4)
the adoption of technologies for each of the four steps of the medication management process i.e.,
ordering, transcribing, dispensing and administration.

Scope of the Study
This study examined the impact of the implementation of the HITECH Act on the
adoption of MMTs as well as the organizational and environmental correlates of the adoption of
MMTs by U.S. acute care hospitals. The study examined global adoption of all MMTs, adoption
of MU MMTs (CPOE, CDSS and eMAR) and adoption of CLMM and as well as adoption of the
technologies used at each step of the medication management process (ordering, transcribing,
dispensing and administration of medications).
The scope of this study was limited to the assessment of adoption of MMTs and did not
attempt to examine the extent of utilization of these technologies due to the lack of data. Further,
this study was also limited to examining the contextual factors of adoption of a strategic behavior
and did not attempt to examine the impact of this adoption. The study examined the adoption of
MMTs by non-Critical Access Hospitals (CAH), non-federal, acute care hospitals located in the
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50 U.S. states and the District of Columbia that had responses recorded in the Healthcare
Information and Management Systems Society (HIMSS) Analytics Database. This study was
limited to non-CAH, non-federal, acute care hospitals and excluded specialty hospitals such as
orthopedic, psychiatric and children’s hospitals and excluded federally-owned hospitals such as
the Veteran’s Affairs Hospitals, Military Hospitals and Public Health Indian Service Hospitals.

Research Questions
This study attempts to answer the following research questions:
1) How did the implementation of the HITECH Act affect the adoption of MMTs in U.S. acute
care hospitals?
2) What are the organizational and environmental factors that are associated with the adoption
of MMTs in U.S. acute care hospitals?

Overview of the Conceptual Framework
The conceptual framework for examining the research questions of this study was derived
from the theoretical framework of resource dependence theory (RDT). RDT is rooted in the
premise that organizations and their environment interact with each other and are influenced by
each other (Pfeffer & Salancik, 1978). RDT was posited by Pfeffer & Salancik in 1978 and they
proposed that organizational survival is dependent on the management of dependencies in the
external environment to secure the necessary resources for survival (Pfeffer & Salancik, 1978).
RDT is an open systems theory that is based on the premise that organizations are not
self-sufficient and do not have complete control over the resources that are necessary for their
survival (Pfeffer & Salancik, 1978). Thus, organizations engage in various strategic behaviors to
maintain their dependencies on the external environment and maintain a flow of essential
resources (Hatch & Cunliffe, 2013). These resources include financial, human, social or physical
resources. These resources are usually scarce and are shared by the organizations in the same
market (Pfeffer & Salancik, 1978). Hence, in order to survive in such an environment,
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organizations depend on other external entities in the environment. Organizations attempt to
acquire resources from their dependent relationships, while still trying to remain autonomous
(Pfeffer & Salancik, 1978).
RDT is represented by the three constructs of uncertainty, munificence and
interdependence (Pfeffer & Salancik, 1978). Uncertainty refers to the unstable nature of the
environment that impacts the availability of resources for the organizations (Pfeffer & Salancik,
1978). In times of uncertainty, organizations make strategic decisions to ensure the flow of
resources in the organizations (Hatch & Cunliffe, 2013). The enactment of new regulatory
policies that may impact the availability of scarce resources and the competition in the market
represents the uncertainty in the environment for the organizations. When new regulatory policies
that impact the availability of scarce resources come into effect, organizations may attempt to
conform to the policy in order to reduce uncertainty in the environment and maintain a stable
flow of resources. In markets with high competition, organizations compete for the same pool of
resources (Pfeffer & Salancik, 1978) and survival of the organizations depends on the allocation
of these resources. Munificence refers to the abundance of resources in the environment of the
organization (Pfeffer & Salancik, 1978). In unfavorable conditions of scarce availability of
resources, organizations that are munificent in terms of resources will be more likely to adopt
new innovations (Damanpour, 1991). Interdependence refers to the degree of external
dependence of the organization (Pfeffer & Salancik, 1978). An organization that is dependent on
external entities is likely to have resources through their external dependencies and is also more
likely to comply with the demands of these external entities (Pfeffer & Salancik, 1978).
Guided by the RDT framework and the existing literature on the adoption of innovations,
the following general hypotheses were proposed in this study:
1) After the implementation of the HITECH Act, U.S. acute care hospitals will be more likely to
adopt MMTs.
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2) Organizational factors (organizational size, system membership, financial resources, private
payer mix and ownership control) and environmental factors (market competition and
community wealth in the hospital market) will be associated with the adoption of MMTs by
the U.S. acute care hospitals.

Research Hypotheses
The specific research hypotheses that were empirically tested in this study were:
H1: Hospitals will be more likely to adopt MMTs in the period after the implementation of the
HITECH Act, all things being equal.
H2: Hospitals located in markets with higher competition will be more likely to adopt MMTs, all
things being equal.
H3: Hospitals located in markets with higher community wealth will be more likely to adopt
MMTs, all things being equal.
H4: Larger hospitals will be more likely to adopt MMTs, all things being equal.
H5: Hospitals that are part of a multi-hospital system will be more likely to adopt MMTs, all
things being equal
H6: Hospitals with greater financial resources will be more likely to adopt MMTs, all things
being equal.
H7: Hospitals with a higher proportion of private payer mix will be more likely to adopt MMTs,
all things being equal.
H8: For-profit hospitals will be more likely to adopt MMTs as compared to public hospitals, all
things being equal.
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Significance and Relevance
The implications for patient harm due to medication errors are huge and hence,
interventions to prevent these errors are essential. Although, technologies have been known to
improve the medication management process by automation of the process and reducing errors,
little research has been done to examine the strategic behavior of adoption of technologies
specifically for the medication management process. Further, there is a paucity of literature on the
impact of the environmental uncertainty of the HITECH Act on the adoption of MMTs by U.S
acute care hospitals. Given this background, it is quite relevant from a theoretical and empirical
perspective to examine the strategic adoption of MMTs in the context of the changing
regulations, especially since the use of MMT can improve patient safety (McKibbon et al., 2012).

Research Plan and Unit of Analysis
This study used panel data of organizational and environmental characteristics and
adoption of MMTs. The unit of analysis of this study was the individual non-Critical Access
Hospitals (CAH), non-federal, acute care hospital. The research design that was used in this study
was the interrupted time series design with no comparison group (Cherulnik, 2001). The study
population included all non-CAH, non-federal, acute care hospitals within the 50 U.S. states and
District of Columbia that reported data to the HIMSS Analytics Database. The data for this study
were obtained from three secondary databases: the HIMSS Analytics Database, the Healthcare
Cost Report Information Systems (HCRIS) data and the Area Health Resource File (AHRF). The
study sample included all the non-CAH, non-federal, acute care hospitals in the study population
that merged across the three data sources, had no missing data for any of the key dependent and
independent variables of the study and were observed for all five years of the study period. The
measures of the dependent variable were derived from the HIMSS Analytics Database for the
years 2009 to 2013, while the independent and control variables were lagged by one year and
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were derived from the HIMSS Analytics Database, HCRIS data and AHRF database for the years
2008 to 2012.
This study analyzed the impact of the HITECH Act; organizational factors of size, system
membership, financial resources, private payer mix and ownership control; and environmental
factors of competition and community wealth on the adoption of MMTs by U.S. acute care
hospitals over time. The analytical strategy involved descriptive analyses and regression models
to examine the changes in adoption of MMTs. The regressions included fixed effects, random
effects and mixed effects models, which are suitable for analyzing panel data.

Outline of Ensuing Chapters
Chapter 2 provides a review of the literature on the steps of the medication management
process including the automation of each step of the medication management process through the
use of technology; the changes in the regulatory environment of the hospitals in the late 1990s
and the beginning of the 21st century, with an emphasis on the HITECH Act; and empirical
evidence on the adoption of MMTs by health care organizations in the U.S. Chapter 3 describes
the competing perspectives for strategic behaviors of organizations, with a focus on the decision
to adopt innovations; elaborates the theoretical framework and develops a conceptual model
based on the resource dependence theory and also presents the specific hypotheses that will be
tested in the study. Chapter 4 discusses the research methodology including the research design,
study population and sample, data sources, key variables and their measurements, analytical
strategy, ethical considerations and the methodological limitations of the study. Chapter 5
presents the results of the study. Finally, Chapter 6 provides a discussion of the study results, the
implications of the study findings and the limitations of the study and identifies potential areas for
future research.
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CHAPTER TWO: LITERATURE REVIEW
This chapter summarizes the literature available on the medication management process
in U.S. hospitals, as well as the different MMTs used to automate the medication management
process. It is comprised of three main sections: (1) The Medication Management Process, (2)
Regulatory Environment and (3) Adoption of Medication Management Technologies. The first
section describes the medication management process in U.S. hospitals and describes the steps of
the medication management process and the technologies that can be used to automate these
steps. The second section includes a review of the changing regulatory environment that has had
an impact on medication safety and the use of health IT in U.S. acute care hospitals and it also
describes the HITECH Act and its objectives in depth. The third section presents the existing
empirical literature on the adoption of MMTs in U.S. hospitals.
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Section One: The Medication Management Process
Overview of Medication Safety
The IOM has identified six domains of the quality of health care (Institute of Medicine,
2001). These domains are centered on the need for health care to be safe, effective, patientcentered, timely, efficient and equitable (Institute of Medicine, 2001). The AHRQ defines quality
of health care as “doing the right thing for the right patient, at the right time, in the right way to
achieve the best possible results” (Agency for Healthcare Research and Quality, 2005). Safety of
the patient is thus an important aspect of quality in the health care system. Patient safety is
defined as,
“a discipline in the health care sector that applies safety science methods toward the goal
of achieving a trustworthy system of health care delivery. It is also an attribute of health
care systems; it minimizes the incidence and impact of and maximizes recovery from,
adverse events” (Emanuel et al., 2008).
Given the importance of patient safety in health care, medical errors are a significant
concern for the U.S. health care system (Kaushal & Bates, 2002). Medical errors are found to be
frequent and injuries associated with these errors pose clinical as well as financial ramifications
on the health care system (Kaushal & Bates, 2002). One of the first investigations of accidental
injuries in hospitalized patients was conducted by the Harvard Medical Practice Study in 1984 in
the state of New York. The study found that 3.7% of the hospitalized patients suffered an
iatrogenic injury during their hospital stay (Leape et al., 1991). Medication-related events are the
most common cause of these injuries, with about 20% of the injuries attributed to medication use
(Kaushal & Bates, 2002).
The National Coordinating Council for Medication Error Reporting and Prevention
defines medication error as,
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“any preventable event that may cause or lead to inappropriate medication use or patient
harm while the medication is in the control of the health care professional, patient, or
consumer; where the events may be related to professional practice, health care products,
procedures and systems, including ordering; order communication; product labeling,
packaging and nomenclature, compounding, dispensing, distribution, administration,
education, monitoring and use” (National Coordinating Council for Medication Error
Reporting and Prevention, 2015).
Studies conducted by the Adverse Drug Event Prevention Study Group in 1995 defined
medication error as, “any error in the process of ordering, dispensing, or administering a drug”
(Bates et al., 1995; Leape et al., 1991; Leape et al., 1995). The Agency for Healthcare Research
and Quality defines medication error as, “preventable mistakes in ordering and delivering
medication to patients” (Agency for Healthcare Research and Quality, 2000).
The World Health Organization (WHO) defines Adverse Drug Reaction (ADR) as,
“noxious and unintended and which occurs at doses used in man for prophylaxis, diagnosis or
therapy” (World Health Organization, 1972). This definition of ADR, although widely used as an
outcome of interest in studying medication-related injuries, assumes that these injuries arise only
due to appropriate usage of medications, while the fact is that most of the preventable drugrelated injuries arise due to inappropriate use or errors in the use of medications (Bates et al.,
1995).
An ADE is a direct measure of patient harm and is defined as “injuries related to medical
interventions related to a drug” (Bates et al., 1995). This definition is more comprehensive and is
more clinically significant as compared to ADR, since it covers any injury arising out of
appropriate or inappropriate medication use (Bates et al., 1995). Potential ADEs are the ‘near
misses’ that could have a considerable probability of harming a patient but did not lead to a
harmful event (Kaushal & Bates, 2002). ADEs that are related to a medication error are
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considered preventable ADEs, while those that did not result from a medication error are
considered non-preventable ADEs (Kaushal & Bates, 2002). Those potential ADEs that were
identified and prevented from reaching the patient by a prevention system or intervention are
termed as intercepted potential ADEs, while those that reached the patient but did not result in
any harm are termed as non-intercepted potential ADEs (Kaushal & Bates, 2002).
The burden of medication errors and ADEs in the U.S. is concerning. Around 1.5 million
Americans suffer from injuries due to medication-related errors annually in hospitals, nursing
homes and physician offices (Institute of Medicine, 2006). This number does not include those
injuries arising out of the patients’ mix-up of medications at home and other settings such as
ambulatory care and thus represents only a fraction of the total population that could be facing
medication errors and injuries associated with medication errors (Kohn et al., 1999). In addition,
28% of the ADEs are found to be associated with medication errors, which may be potentially
preventable (Bates et al., 1995). Another growing concern is that medication errors and ADEs are
costly. One ADE accounts for $2,000 in additional costs, excluding the malpractice costs (Bates
et al., 1995). In a large tertiary care hospital, ADEs were responsible for $5.6 million annual
health care costs and preventable ADEs were responsible for $2.8 million annual health care costs
(Bates et al., 1997). The estimated national burden associated with ADEs is $2 billion (Bates et
al., 1999).
Steps of the Medication Management Process
In U.S. hospitals, medication management occurs through a series of steps, comprising of
different hospital personnel working in conjunction to accomplish each step of the process
(Agrawal, 2009; Bates, 2000; Leslie, 2010). Thus, medication management is complicated
(Agrawal, 2009). The steps of the medication management process include prescribing/ordering,
transcribing, dispensing and administration (Agrawal, 2009). The ordering step is a commonly
used terminology in a hospital setting, while it may also be referred to as the prescribing step in
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outpatient settings (Lisby, Nielsen, & Mainz, 2005). Hence, the term ‘ordering step’ will be used
in this dissertation as it focuses on acute care hospitals. The various steps of the medication
management process and the potential for errors at each step is outlined below.
Ordering. The step of ordering involves the clinician, such as a physician, deciding and
ordering the course of drug treatment (Leslie, 2010). This includes identifying the name, dose,
frequency of intake and route of administration of the drug, intended duration of drug treatment,
as well as additional notes essential for safe and efficient drug dispensing and administration
(Leslie, 2010). All the components of the ordering steps are prone to error. Ordering errors can
arise due to ordering a wrong drug or dosage form or route of administration, the wrong
frequency or duration of drug therapy, calculation errors in the dose, overlooking of drug-drug
allergies, overlooking or missing to account for the patient’s other conditions that could impact
the dosage, etc. (Agrawal, 2009; Velo & Minuz, 2009). Most medication errors are reported to
happen at this step (Agrawal, 2009). Bates et al. (1995) reported 49% of any potential ADEs to
occur as a result of errors at the prescribing/ordering step, out of which 56% ADEs were
preventable (Bates et al., 1995).
Transcribing. Transcribing refers to the interpretation and transfer of the prescription
drug information, as ordered by the clinician in the ordering process. The information is
transferred into a medication administration record for the patient to be further used for drug
administration after the drugs are dispensed from the hospital pharmacy (I. C. Wong, Ghaleb,
Franklin, & Barber, 2004). However, the rate of adverse events arising due to transcription errors
is small. A study by Bates et al. (1995) reported that 11% of the ADEs resulted from errors in the
transcribing step, of which 6% of the ADEs could be preventable (Bates et al., 1995).
Dispensing. During the dispensing step, the pharmacist uses the transcribed medication
order to provide the drug which matches the dose requirements defined in the order (Leslie,
2010). An error occurs in the dispensing step when there is a discrepancy between the order given
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by the clinician and the drug that is actually administered to the patient (Cheung, Bouvy, & De
Smet, 2009), or if there is a deviation from the established protocols of the pharmacy (Cina et al.,
2006). These errors could arise due to discrepancies such as dispensing of a drug: to a wrong
patient, or an incorrect medicine, in the wrong strength, quantity or dosage form, or a medicine
that was not compounded correctly, medicine which has incorrect information on the label, or the
complete failure to dispense a medication (Cheung et al., 2009). There is a possibility for
dispensing errors to go unnoticed owing to the large volume of medications that are dispensed in
the hospitals (Agrawal, 2009). Around 11-14% of ADEs arise from errors in the dispensing step
and among these, 4% are potentially preventable ADEs (Bates et al., 1995; Leape et al., 1995).
Administration. Medication administration is the step in which the drug that is ordered
by the clinician and dispensed by the pharmacist is given to the patient (Leslie, 2010). Errors in
the administration step can arise due to discrepancies between the ordered medicine and the
administered medicine, which includes: the wrong patient, or drug, dose, dosage form,
administration route, time, frequency, treatment duration, or administration of a damaged drug or
even the failure to administer the drug (Rodriguez-Gonzalez et al., 2012). Errors in the
administration step are the second-most common cause of ADEs, with about 26%-38% of the
ADEs occurring due to errors in medication administration, out of which 34% are potentially
preventable (Bates et al., 1995; Leape et al., 1995).

Automation of the Medication Management Process
The use of IT has been considered as an essential tool to improve patient safety
(Furukawa et al., 2008). Health IT refers to the application of technology towards improvement in
the medical treatment and health care of a patient (Fuji & Galt, 2008). Several organizations in
the U.S. such as Leapfrog, the IOM, the AHRQ and the ONCHIT have recommended the use of
technology for improving the medication management process and thereby impacting overall
patient safety (McKibbon et al., 2012). Each step of the medication management process can be
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automated through the use of technology (Bates, 2000). Figure 1 was modified from a study
published by Bates (2000) to incorporate newer technologies and the major steps of the
medication management process (Bates, 2000). This figure outlines the steps of the medication
management process as described earlier in this chapter, along with the technologies used to
automate these steps and the ensuing discussion focuses on describing these technologies in
detail.
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Ordering
Computerized Physician Order Entry (CPOE)
Clinical Decision Support System (CDSS)

Transcription
In-house Transcription Software
Electronic Medication Administration Record (eMAR)

Dispensing
Bar-coding at Dispensing
RFID at Dispensing
Robot-filling for Prescriptions
Automated Dispensing Machine (ADM)
Pharmacy Management System

Administration
Bar-coding at Administration
RFID at Administration
Electronic Medication Administration Record (eMAR)
Smart Pumps

Figure 1: Steps and Automation of the Medication Management Process
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1. Electronic Health Record (EHR). Electronic Health Records (EHRs) can incorporate
and integrate certain technological tools pertaining to medication management. The Centers for
Medicare and Medicaid Services (CMS) defines an EHR as,
“an electronic version of a patient’s medical history, that is maintained by the provider
over time and may include all of the key administrative clinical data relevant to that
person’s care under a particular provider, including demographics, progress notes,
problems, medications, vital signs, past medical history, immunizations, laboratory data
and radiology reports” (Centers for Medicare and Medicaid Services, 2012a).
The Healthcare Information and Management Systems Society (HIMSS) defines an EHR
as, “a longitudinal electronic record of patient health information generated by one or more
encounters in any care delivery setting”. An Electronic Health Record (EHR), which is the
electronic version of the patient’s medical history, supports several functions that play a role in
the medication management process. These functions include the CPOE, ancillary clinical
systems for management of results (such as in the laboratory, radiology, pharmacy, etc.), clinical
documentation, clinical decision support and bar-coding (Adler-Milstein, Everson, & Lee, 2014).
These functions are inter-dependent and there is a need for these functions to work together for
the overall improvement in the quality of care (Adler-Milstein et al., 2014). The Meaningful Use
(MU) objectives established by the HITECH Act, which have been described in detail in Section
Two of this Chapter, established various objectives that require the adoption of these EHR
functions. The functions that impact medication management and that are specifically required to
be adopted by the MU objectives are: CPOE, CDSS, e-prescribing, drug-drug and drug-allergy
interaction checks, maintaining active medication list, maintaining active medication allergy list,
implementing drug formulary checks, medication reconciliation and electronic discharge
prescriptions (Centers for Medicare and Medicaid Services, 2012b; Centers for Medicare and
Medicaid Services, 2014a).
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2. Computerized Physician Order Entry (CPOE) and Clinical Decision Support
Systems (CDSS). Computerized Physician Order Entry (CPOE) and Clinical Decision Support
Systems (CDSS) play an important role in the ordering step of the medication management
process (Bates, 2000). Several studies have documented that medication errors and preventable
ADEs arising from them are most common at the drug ordering step (Bates, Leape, & Petrycki,
1993; Bates et al., 1995; Kaushal et al., 2001; Leape et al., 1995). Hence, automation of this step
is a significant intervention in improving patient safety, as it replaces the paper written orders
with electronic ordering (Bubalo et al., 2014; Kaushal & Bates, 2002). CPOE is beneficial in the
ordering step in several effective ways. Computerization of the ordering step through the CPOE
systems improves medication safety by inculcating a structure into the order so that the clinician
must necessarily include the dose, route and frequency of medication administration. Orders
through the CPOE system do not have issues of legibility and can be traced back easily to the
clinician for further clarifications if needed (Bates, 2000). A pre-and post-implementation study
of CPOE at Brigham and Women’s Hospital found a 55% reduction in non-intercepted
medication errors (Bates et al., 1998). As established by Bates et al. (1999), even a simple CPOE
system without any advanced functionalities led to a 64% reduction in medication errors (Bates et
al., 1999). Although there are significant costs associated with implementing a CPOE system in a
hospital, averaging about US $8 million and an additional US $ 1.35 million annually for
maintaining the system for a 500-bed hospital (Bubalo et al., 2014), the cost-benefit analysis of
implementing a CPOE system in a 720-bed, academic, tertiary care medical center found that the
system saved $28.5 million over a period of ten years (Kaushal et al., 2006). A meta-analysis of
the effectiveness of CPOE in reducing ADEs and medication errors in hospitals reported that
CPOE implementation was associated with almost half the risk of preventable ADEs and
medication errors (Nuckols et al., 2014).
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CPOE system can be enhanced further by coupling it with a CDSS (Bates, 2000; Baysari,
Westbrook, Richardson, & Day, 2011; Kaushal & Bates, 2002; Kaushal, Shojania, & Bates,
2003). A CDSS is defined as, “as any electronic or non-electronic system designed to aid directly
in clinical decision making, in which characteristics of individual patients are used to generate
patient-specific assessments or recommendations that are then presented to clinicians for
consideration” (Kawamoto, Houlihan, Balas, & Lobach, 2005). One of the factors that is closely
associated with ordering errors is the deficiency of medical knowledge (Baysari et al., 2011).
Hence, a CDSS system can help eliminate this factor, as it reduces the clinician’s dependence on
memory and provides access to all the relevant medication information through a drug database
system (Baysari et al., 2011; Bubalo et al., 2014). With a CDSS, the medication order can be
checked for drug allergies, drug-drug interactions, rechecking the laboratory results for the
patients to check for potential problems with some medications, updating discontinued
medications etc. (Bates, 2000). The capability of CPOE in combination with CDSS to decrease
medication errors and ADEs has been documented widely (Charles, Cannon, Hall, & Coustasse,
2014). A CPOE system with a decision support tool has shown the highest evidence in terms of
reducing medication errors, with about 55% to 83% decrease in reported error rates (Bates, 2000).
A study at the University Health Network in the Toronto area found that the incremental costeffectiveness of implementing an electronic medication order entry and a medication
administration system was USD $12,700 per ADE prevented (Wu, Laporte, & Ungar, 2007).
Mayo Clinic Hospital in Phoenix, AZ found no significant changes in the rate of medication
errors in surgical patients after the implementation of the CPOE system in its inpatient unit even
after six months and 12 months post-implementation (Stone, Smith, Shaft, Nelson, & Money,
2009). However, this study found that after implementing the CPOE system, the time between the
physician placing an order and the nurse receiving it reduced significantly from 41.2 minutes to
27 seconds per order (Stone et al., 2009). A CDSS was implemented in hospitals that were a part
of a Catholic health system in the U.S. called Trinity Health, while additional technology such as
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CPOE systems along with an advanced CDSS were implemented in a subset of nine hospitals in
the system (Roberts et al., 2010). For these nine hospitals, there was a significant increase in the
frequency of alerts of potential ADEs that were sent to the pharmacist for review as compared to
the hospitals that had only CDSS, out of which 94% were found to be false-positives by
pharmacists (Roberts et al., 2010). Of those alerts that were identified as potentially true
positives, there was an increase in in the number of true-positives per 1,000 admissions (Roberts
et al., 2010). Chertow et al. (2001) found a 13% decrease in the ordering of inappropriate doses
and a 24% reduction in the ordering of an inaccurate frequency of medication of nephrotoxic
drugs in patients with renal insufficiency after the implementation of a CPOE and CDSS
combination (Chertow et al., 2001). Implementation of a CPOE system with decision support at
Brigham and Women’s Hospital led to an 83% decrease in the occurrence of medication errors
(Bates et al., 1999).
Although there are several advantages associated with the use of CPOE, with or without
the CDSS functionality, there are also some disadvantages. The increased number of medication
alerts due to the CDSS and CPOE system may introduce alert fatigue among the clinician if the
threshold for alerting is set too low (Bubalo et al., 2014). A multi-center study of primary care
practices found that physicians overrode 94% of the alerts for drug allergy and 89.4% of the alerts
for drug interaction alerts that were of high severity (Weingart et al., 2003). Additionally, the
transition from paper-based ordering to CPOE systems could be a learning curve for clinician,
leading to an increase in the time spent in ordering (Bubalo et al., 2014). Villamañán et al. (2013)
reported that that the errors that still occur despite the implementation of CPOE are mainly due to
the CPOE technology itself (Villamañán et al., 2013). These include wrong selection of drugs
from the drop-down list in the CPOE system, inflexibility with the CPOE structure that leads to
the clinician to overuse the free-text section of the CPOE, which causes a discrepancy in the
selected medication through the structured format and the free text comments (Villamañán et al.,
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2013). Sometimes, the medications selected from the CPOE system are not stocked in the hospital
and the CPOE system fails to provide this information to the clinician (Villamañán et al., 2013).
3. Transcription Software. Transcription software is used in the transcribing step of the
medication management process (Bates, 2000). Transcribing refers to the interpretation of the
dictations given by physicians into a text format (TechTarget SearchHealthIT, 2016a). Earlier,
medical transcriptionists were hired to convert these dictations into text (Access Transcription,
2012). However, with the advent of technology, transcription software is now available that can
use voice recognition to convert dictations into texts. This software has a database of medical
terminologies and has a specialized speech recognition program to aid this process (TechTarget
SearchHealthIT, 2016b). The literature on this software is minimal and studies on the use of this
software, as well as its impact have not been conducted.
4. Electronic Medication Administration Record (eMAR). The Electronic Medication
Administration Record (eMAR) is a software program which is a part of the CPOE system that
includes a record of the medications that are transcribed from the orders before medication
administration (Hidle, 2007). Hence, it is useful in both the transcribing step and the
administration step of the medication management process. It is an electronic documentation of
all the medications that the patient has been prescribed along with the medication information
such as the appropriate dose, route, frequency, formulation, infusion rate, etc. (Bubalo et al.,
2014). The system also allows nurses to document medication administrations and record the
reasons for medications that were not given or changed (Bubalo et al., 2014).
Appari and colleagues examined the association between adoption of eMAR and CPOE
and medication process quality (Appari, Carian, Johnson, & Anthony, 2012). Medication process
quality was measured through 11 evidence-based process measures of adhering to medication
guidelines for conditions such as myocardial infarction (AMI), heart failure (HF), pneumonia
(PN) and surgical care infection prevention (SCIP) as defined in the CMS Hospital Compare
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Database (Appari et al., 2012).The hospitals that adopted eMAR had 14 to 29% higher odds of
adhering to ten of the 11 evidence-based process measures for medication process quality, while
those that adopted eMAR in conjunction with the CPOE system had a 13 to 38% higher odds of
adhering to ten of the 11 evidence-based process measures for medication process quality (Appari
et al., 2012). Thus, the combination of CPOE and eMAR led to higher odds of adherence to
medication process quality guidelines. Adherence to the guidelines is indicative of higher
medication process quality. Association between improved process quality and patient outcomes
is well established and thus, improved medication process quality can thereby improve the
outcomes of patients and lead to an improvement in patient safety ((Chassin, Loeb, Schmaltz, &
Wachter, 2010).
Despite the provision of a real-time medication record, eMAR systems pose certain
limitations. Some systems do not allow documentation of medications too far ahead of time or
those that were administered too far into the past but were not entered on the eMAR (Bubalo et
al., 2014). Additionally, some eMAR systems also do not allow documenting free texts as notes,
which was frequently done with the paper administration records where the nurse documented
information critical to the medication that was administered (Bubalo et al., 2014).
5. Robot-filling. Robot-filling is used to automate the dispensing of drugs through the
use of robots, which increases the precision in filling medication orders (Bates, 2000). The
evidence of the use of robots for preventing medication errors is limited, but one study reported a
reduction in the dispensing error rate from 2.9% to 0.6% post-implementation of a robot (Weaver,
1998). After installation of a robotic prescription filling system in an independent pharmacy,
there was a significant decrease in the filling time for medication orders (Lin, Huang, Punches, &
Chen, 2007).
6. Automated Dispensing Machine (ADM). Automated dispensing machines (ADMs)
are used in the dispensing step of the medication management process (Bates, 2000). ADMs have
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also been identified in the literature as unit-based cabinets (UBCs), automated dispensing devices
(ADDs), automated distribution cabinets or automated dispensing cabinets (ADCs) (Institute for
Safe Medication Practices (ISMP), 2008). ADMs are decentralized machines used for dispensing
medications, storing medications until administration and tracking medication distribution at the
point of care (Uy, Kury, & Fontelo, 2015). ADMs allow reducing the pharmacists’ work of
dispensing medications by permitting the nurses to dispense the drug at the point of care. The
medication ordered for the patient is sent to the central server in the pharmacy for review by the
pharmacists. Once it is reviewed and approved, the medication appears in the patient’s records for
the nurses to administer (Chung, Choi, & Moon, 2003). In emergent cases, the pharmacist review
can be bypassed through an override (Harolds & Harolds, 2016). The ADM hardware consists of
cabinets and drawers that store medications and allow the nurses to withdraw the medications for
the patient and the withdrawal is recorded in the pharmacy system servers. Moreover, the server
also generates refill requests when any medication in the cabinet falls below a specified threshold
and automatically bills the medications to the patient’s billing record (Chung et al., 2003). Some
systems also provide alerts if a drug has been administered but failed to record on the medication
administration record and another nurse tried to give the dose again (Harolds & Harolds, 2016).
Thus, an ADM leads to automation of the dispensing step and eliminates the manual actions to
fill and pack medications (Baril, Gascon, & Brouillette, 2014). ADMs are beneficial in
safeguarding the use of medications and securing the controlled drugs to certain cabinets which
cannot be accessed unless it has been reviewed and approved for the patient (Harolds & Harolds,
2016). ADM drawers can also be pre-set to dispense only one medication at a time, which is a
needed security measure for controlled and dangerous drugs (Harolds & Harolds, 2016). ADMs
can also be linked with a bar-coded system for medication and patient identification (Bates, 2000)
and they can also be linked with the CPOE system so that the ordered medication through CPOE
is directly sent to the ADM servers (Chung et al., 2003).
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A systematic review by Tsao et al. (2014) found evidence that the use of ADMs was
responsible for a decrease in medication errors (Tsao, Lo, Babich, Shah, & Bansback, 2014). A
study by Chapuis et al. (2012) examined the impact of an ADM in an intensive care setting with
an intervention unit and a control unit in the same department of a hospital and found a decrease
in the proportion of total error opportunities in the intervention unit and s significantly reduced
proportion of total error opportunities after the implementation of ADM as compared to before
implementation in the same unit (Chapuis et al., 2010).
7. Bar-coding. Bar-coding helps in identification and can be used in the dispensing
process to identify the right drug for the right patient and can also be used in the administration
process to make sure the drug that is dispensed is given to the correct patient. Bar-coded systems
ensure the five ‘rights’ of the medication administration process: right patient, right drug, right
dose, right route and right time (Agrawal & Glasser, 2009). Bar-coded systems used at the
administration step are referred to as bar-coded medication administration (BCMA) system.
During medication administration at the point of care, the nurse can scan the patient’s
identification bracelet and the bar-code on the unit dose of the medication and can detect any
discrepancies so that the appropriate drug is given to the right patient (Agrawal, 2009). The barcode systems can be linked with various other systems in the hospital such as the EMR, eMAR
and CPOE (Bubalo et al., 2014; Chung et al., 2003). When a bar-code scanner linked to an EMR
is used to scan a patient’s identification, the nurse can identify the appropriateness of the
medication for the patient (Bubalo et al., 2014). When the unit dose medications are scanned, the
nurse can ensure that there are no discrepancies between the medication that has been dispensed
and those that are listed on the patient’s administration record through a linkage with the eMAR
system (Bowers et al., 2015; Bubalo et al., 2014). Interfacing with the CPOE system can help
identify if the scanned medication matches with the physician order as entered into the CPOE
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(Chung et al., 2003). The use of a bar-coded system permits tracking of medication use, nearmisses, as well as medication errors through the link with the EHR system (Bubalo et al., 2014).
Previous studies have reported several advantages of the bar-coded system. The barcoded system has been shown to reduce 54-87% of errors in the administration of medications
(Agrawal, 2009). There was a 68% reduction in the total error rate after the implementation of a
bar-coded medication administration (BCMA) system, integrated into the EMR, in an academic
inpatient solid organ transplant unit (Bonkowski et al., 2014). A 56% reduction in the medication
error rate was reported after the implementation of a BCMA in a community teaching hospital
medical intensive care unit with the reported error reductions arising due to the reduction of
wrong administration times (DeYoung, Vanderkooi, & Barletta, 2009). In a 36-bed medical
surgical unit, there was a 54% reduction in medication administration errors after the
implementation of a BCMA and an eMAR system, as compared to the paper MAR system before
the intervention (Paoletti et al., 2007). Post-implementation of a bar-code and eMAR system in
35 adult medical, surgical and intensive care units in a 735-bed tertiary academic medical center,
there was a 50.8% reduction in the rate of potential ADEs, although this reduction rate was
obtained by excluding those ADEs arising due to errors in the timing of medication
administration and a complete elimination of transcription errors (Poon et al., 2010). Although
this study also reported a 27.3% reduction in the errors in the timing of medication
administration, it did not report any significant changes in the rate of potential ADEs arising due
to these timing errors, after the implementation of a bar-code and an eMAR (Poon et al., 2010).
The cost of implementing and maintaining a BCMA system along with medication dose
repackaging and the electronic management systems in the pharmacy was approximately $40,000
per BCMA-enabled bed over a period of five years in a community hospital (Sakowski &
Ketchel, 2013). The BCMA system has demonstrated cost-effectiveness, since the cost of
implementing the system and operating it over a five-year period are $2,000 per harmful
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medication error, which is much lower than the estimated costs if such errors are not averted
($3,100 to $7,400) (Sakowski & Ketchel, 2013).
Even with the implementation of a bar-coding system either in the dispensing or
administering step, there are certain medication errors that cannot be completely eliminated and
are mostly related to the logistical problems of technology such as mislabeling of medication with
the wrong bar-code leading to administration of the wrong medication or the wrong dosage of the
right medication, lack of bar-codes on the drugs, bar-codes that could not be scanned, overrides of
warnings, circumventing the safeguards of the system, medication administration to wrong
patients especially in emergent situations where the medication was scanned after being
administered and temporary downtime of the system (Cochran, Jones, Brockman, Skinner, &
Hicks, 2007). Specifically, overridden bar-codes led to a substantial number of potential
medication errors (Early, Riha, Martin, Lowdon, & Harvey, 2011). Preventing such logistical
errors requires attention to the implementation of the system such as protocols to prevent missing
labels, scanning authentication, documentation and database maintenance (Bubalo et al., 2014).
Certain other disadvantages include increased workload for the nurses during the medication
administration step (Bubalo et al., 2014). A case study in an inpatient unit showed a two-fold
increase in the number of steps for medication administration one year post-implementation of
the BCMA system (Bargren & Lu, 2009).
8. Radio Frequency Identification (RFID). Radio frequency identification (RFID) is
another technology that aids with identification and hence, can be used in both the dispensing and
administration step. It refers to wireless technology which uses radio waves for identification
through microelectronic tags (Ajami & Rajabzadeh, 2013; Zare Mehrjerdi, 2011). The RFID
system consists of an antenna that scans for radio waves, a transceiver for data interpretation, a
receiver for transmission and receipt of the radio wave frequencies and a transponder, which is
the RFID tag attached to the object (Zare Mehrjerdi, 2011). RFID can be used for retrieving
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patient information and to identify patients to their corresponding medicines (Ajami &
Rajabzadeh, 2013). RFID holds high potential in the medication administration process as each
RFID tag is unique to the specific medication that it is attached to and contains information such
as the product identification number, cost, date of manufacture, location and inventory, which can
be read through a wireless scanner (Zare Mehrjerdi, 2011). Although the function of both barcodes and RFID is identification, the RFID has certain advantages over the use of bar-codes (Zare
Mehrjerdi, 2011). An RFID tag can hold extensive information about the object it is tagged to, as
opposed to the limited information on bar-codes (Zare Mehrjerdi, 2011). Also, RFID tags are
durable, can withstand x-rays and heat sterilization and are much faster to scan at the rate of 1001,000 tags per second as opposed to the manual scanning of bar-codes (Zare Mehrjerdi, 2011).
9. Pharmacy Management System. A Pharmacy Management System is an application
that provides automation and coordination between all aspects of the pharmacy department and
hence plays an important component of automating and coordinating the medication dispensing
process (Healthcare Information and Management Systems Society, 2010). It allows the
pharmacist to enter and fill the medication order and it also performs all related functions such as
billing the patient, re-supply scheduling, inventory management, etc. (Healthcare Information and
Management Systems Society, 2010).
10. Intravenous Smart Pumps. Infusion pump systems are used in the medication
administration step to administer medications to the patients intravenously (Rothschild, Keohane,
Thompson, & Bates, 2003). These pumps have now become highly sophisticated and have a dose
error reduction software for the safety of medication administration and have been given the
name ‘smart pumps’ (Blandford et al., 2016). This software comprises of a programmable drug
library that alerts the nurse if the infusion rates are set as too high or too low as compared to the
preset limits for the specific drug (Blandford et al., 2016; Bubalo et al., 2014; Husch et al., 2005).
There are usually two types of limits on these smart pumps- soft limit or hard limit (Blandford et
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al., 2016; Bubalo et al., 2014). The soft limit provides an alert to the nurse that the programmed
infusion rate is beyond the range of the preset, but allows the nurse to continue through an
override if confirmed by the clinician (Blandford et al., 2016). However, the hard limit does not
permit the nurse to continue the administration of the intravenous medication if the programmed
infusion rate is far off from the specified safe range (Bubalo et al., 2014). These preset limits can
be modified as per the specific needs of the hospital or the hospital unit (Bubalo et al., 2014). The
safety feature helps in preventing dangerous doses of medications and helps in preventing
medication errors and ADEs (Bubalo et al., 2014).
11. Closed Loop Medication Management System (CLMM). The technology that
automates and coordinates all the steps of the medication management process comprise the
CLMM system (Healthcare Information and Management Systems Society, 2010). This CLMM
system is “end-to-end electronic medication management with a seamless flow of information
along the process” (Agrawal, 2009). HIMSS identifies the components of the CLMM system as
the technologies which automate medication ordering (EHR, CPOE), provide decision support
(CDSS), aid with medication packaging (robot-filling), automate medication dispensing in the
hospital units (ADMs, intravenous smart pumps, bar-code, RFID) and help with medication
administration to provide the correct medication to the right patient (eMAR, bar-code, RFID)
(Healthcare Information and Management Systems Society, 2010).
Studies evaluating the implementation of a CLMM system have seen limited attempts in
the U.S., however, implementation of a closed-loop system consisting of electronic prescribing
with basic decision support, automated dispensing in the hospital ward, bar-code for patient
identification and eMARs in a teaching hospital in London found evidence that there was a
significant decrease in prescribing/ordering errors, decrease in the failure to check patient
identity and decrease in medication administration errors (Franklin, O'Grady, Donyai, Jacklin, &
Barber, 2007). Additionally, the study also reported a significant increase in the time required to
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order a regular inpatient drug and in the time spent in providing a hospital ward with pharmacy
services (Franklin et al., 2007). Although the time spent per drug administration round decreased,
nursing time on medication tasks apart from the drug rounds increased significantly (Franklin et
al., 2007).

Section Two: The Regulatory Environment
Since the establishment of Medicare in 1965, a retrospective cost-based reimbursement
system of the private health insurance sector was adopted by Congress for the payment of
hospital services provided to Medicare patients (DHHS Office of Inspector General (Office of
Evaluation and Inspections), 2001). Under this payment system, the hospital costs for Medicare
increased exponentially from $3 billion to $37 billion annually between 1967 and 1983 since the
payment systems incentivized the providers to provide more services (DHHS Office of Inspector
General (Office of Evaluation and Inspections), 2001). In order to control the costs, a prospective
payment system (PPS) was created in 1982, which was a fixed-cost structure per case for
inpatient hospital care (DHHS Office of Inspector General (Office of Evaluation and
Inspections), 2001). This shift warranted a changing focus towards the quality of care, effective
medical decisions and outcomes and cost-containment (DHHS Office of Inspector General
(Office of Evaluation and Inspections), 2001).

Institute of Medicine, 1991
In 1991, the IOM called for the need for a computerized patient record (CPR) to provide
health care professionals with better access to patient information and lead to an improvement in
the delivery of health care (Dick, Steen, & Detmer, 1997). The IOM recommended that the CPR
should be a longitudinal record of events related to the person’s health (Dick et al., 1997).
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Institute of Medicine, 2000
In 2000, the IOM published a reported titled ‘To Err is Human: Building a Safer Health
System’ (Institute of Medicine, 2000). This report shed light on the extent of medical errors in the
U.S. health care system (Institute of Medicine, 2000). Through an extrapolation of the analysis of
two studies on adverse events- one examining Colorado and Utah hospitals and the other
examining hospitals in New York, the report highlighted that at least 44,000 and as many as
96,000 Americans died in hospitals each year due to medical errors (Institute of Medicine, 2000).
These numbers were higher than the deaths due to motor vehicle accidents, breast cancer, or even
AIDS (Institute of Medicine, 2000). Additionally, over 7,000 deaths were attributed to medication
errors annually, which is higher than the number of fatalities caused by workplace injuries
(Institute of Medicine, 2000). These numbers shocked the entire nation and drew widespread
attention towards this issue of medical errors among the public, media, politicians, as well as the
health care professionals (D. A. Wong et al., 2009). The report also contended that preventable
ADEs occurred in about two to seven of every 100 hospital admissions (Institute of Medicine,
2000). These events may lead to increased costs. For example, ADEs that could have been
potentially preventable were responsible for a $4,700 increase in hospital costs per admission,
accounting to $2.8 million in a year for a 700-bed teaching hospital (Bates et al., 1997). The
report stressed the importance of addressing patient safety and recommended comprehensive
strategic measures that would be needed to be made in the hospitals, as well as the medical
processes to reduce medical errors and the injuries resulting from them (Institute of Medicine,
2000). This report also established that at least 50% of the medical errors should be reduced in the
next five years (Institute of Medicine, 2000).

Institute of Medicine, 2001
In 2001, an IOM report titled ‘Crossing the Quality Chasm: A New Health System for the
21st Century’ reported that the use of IT has the potential to transform the health care system in
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the country and recommended the use of automated systems for communication of patient
information, ordering medications and computerized reminders (Institute of Medicine, 2001). The
report called for a nationwide commitment of stakeholders to eliminate majority of the
handwritten clinical information by the end of the decade (Institute of Medicine, 2001). In July
2001, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) adopted new
standards for an integrated, organization-specific patient safety program which emphasized the
identification of potential errors and highlighted the steps needed to reduce the occurrence of
these errors (Cavanaugh, 2001). The Consolidated Appropriations Act of 2001, which includes
the Patient Safety Errors Reduction Act calls for implementing error reduction systems and
examining safe practices for health care delivery and it also provides legal protection to the
organization in order to encourage reporting and collection of errors (Cavanaugh, 2001). This Act
led to the establishment of the National Patient Safety Database of reported medical events by the
AHRQ, which could be used for research aimed towards improvement in the quality of health
care (Cavanaugh, 2001).
President’s Health Information Technology Plan, 2004
In July 2004, President George W. Bush announced the President’s Health Information
Technology Plan, which intended to promote the use of EHRs in the U.S. health care system in
the next ten years (The White House, 2009). This plan called for the adoption of health
information standards so that medical information could be saved and shared in an electronic
system while still assuring privacy and security, doubling of the funding for Health IT
demonstration projects, tapping into the Federal Government as the largest buyers of health care
to create incentives for the use of EHRs and the creation of a new sub-Cabinet level position of
the National Health Information Technology Coordinator who would report directly to the
Secretary of Health and Human Services and guide the ongoing efforts for adoption of health IT
(The White House, 2009). This led to the establishment of ONCHIT and the American Health
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Information Community (AHIC) by the DHHS (Simborg, 2008), which set the foundation for
future efforts for promoting Health IT by President Barack Obama (Sheridan et al., 2012).

Institute of Medicine, 2006
In 2006, another report by the IOM titled ‘Preventing Medication Errors: Quality Chasm
Series’ stressed the unacceptable levels of medication errors in the U.S. health care system and
outlined a comprehensive approach targeted at decreasing these medication errors (Institute of
Medicine, 2006). The report contended that an ADE that arises due to an error is potentially
preventable and at least as many as 1.5 million preventable ADEs occur annually in the U.S.
(Institute of Medicine, 2006). Even conservative estimates led to annual costs of $3.5 billion due
to ADEs (Institute of Medicine, 2006). This report pointed out that the striking aspect of these
harmful events was that most of them were preventable through various strategies to reduce
medication errors (Institute of Medicine, 2006). To reduce these medication errors, the IOM
recommended a series of steps that needed to be taken (Institute of Medicine, 2006). The first step
called out for a more patient-centric approach allowing the patient to take on an active role in
their medical care, as opposed to a provider-centric approach (Institute of Medicine, 2006). In this
approach, the provider would educate, consult and listen to their patients and make way for open
communication (Institute of Medicine, 2006). Due to this approach, patients would understand
their medications better and take responsibility in managing and monitoring their medications
(Institute of Medicine, 2006). The second step placed emphasis on increasing the use of ITs in the
ordering and the dispensing steps of the medication administration process, as well as an effective
internal monitoring system to detect ADEs more accurately (Institute of Medicine, 2006). The
third step was clear and effective communication of drug information through improvement in
nomenclature, as well as labeling and packaging of medications (Institute of Medicine, 2006).
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Health Information Technology for Economic and Clinical Health (HITECH) Act, 2009
One of the major legislations passed in the recent years that built upon President George
W. Bush’s President’s Health Information Technology Plan was the HITECH Act, which was
passed on February 17, 2009, as part of the American Recovery and Reinvestment Act under
President Barack Obama’s administration. Under the HITECH Act, the ONCHIT within the
DHHS, was designated as the primary federal organization to promote the adoption of health IT
and electronic health information exchange. Additionally, the CMS was allocated around $30
billion to incentivize providers and hospitals for demonstrating meaningful use of EHRs through
the Medicare and Medicaid EHR Incentive Programs (Centers for Medicare and Medicaid
Services, 2014d; DesRoches, Audet, Painter, & Donelan, 2013). Starting in 2011, the EHR
Incentive Programs were designed to promote the adoption, implementation and upgradation of
certified EHR technology, as well as demonstration of meaningful use of that certified EHR
technology by eligible providers and eligible hospitals (Centers for Medicare and Medicaid
Services, 2016d). The hospitals eligible for the Medicare EHR Incentive Program included those
hospitals that are paid under the Inpatient Prospective Payment System, Critical Access Hospitals
(CAHs) and Medicare Advantage (MA-Affiliated) hospitals. The hospitals eligible for the
Medicaid EHR Incentive Program included those acute care hospitals that had at least 10%
Medicaid patient volume and all Children’s hospitals (Centers for Medicare and Medicaid
Services, 2013).
‘Meaningful use’ (MU) was measured by a set of core and menu objectives established
by the CMS and achievement of these objectives was expected to occur in three stages (Appari,
Eric Johnson, & Anthony, 2013). The objectives and requirements were modified and updated
through the years of implementation beginning in 2011 (Centers for Medicare and Medicaid
Services, 2016d). Stage 1 of MU laid the foundation by establishing standards for electronic data
collection of clinical information (Centers for Medicare and Medicaid Services, 2016a). The
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Stage 1 objectives (2010 definition) for hospitals to be eligible for the EHR Incentive Programs
involved meeting 14 core objectives and five selected menu objectives from a list of ten (Centers
for Medicare and Medicaid Services, 2010). The requirements of Stage 1 MU (2013 definition)
for hospitals to be eligible for an incentive payment was to meet 13 required core objectives and
five selected menu objectives from a list of ten (Centers for Medicare and Medicaid Services,
2014a). The requirements of Stage 1 MU (2014 definition) for hospitals to be eligible for an
incentive payment was to meet 11 required core objectives and five selected menu objectives
from a list of ten (Centers for Medicare and Medicaid Services, 2014b).
Stage 2 expanded the Stage 1 criteria by requiring the use of health IT for continuous
improvement in quality at the point of care and for structured data exchanges. The requirements
of Stage 2 MU for hospitals to be eligible for an incentive payment were established in 2014 and
the requirements were to meet 16 core objectives and three selected menu objectives from a list of
six (Centers for Medicare and Medicaid Services, 2014d). Modified Stage 2 requirements were
released by CMS in October 2015 which further specifies the criteria for eligible hospitals to
participate in the EHR Incentive Programs in 2015 through 2017 (Centers for Medicare and
Medicaid Services, 2016a). Modified Stage 2 criteria established a single set of objectives and
measures, by eliminating the menu and core structures, leading to nine objectives for all eligible
hospitals (Centers for Medicare and Medicaid Services, 2016b). Setting the objectives for Stage 3
is still underway (Centers for Medicare and Medicaid Services, 2016a). Eligible hospitals
received incentive payments from the Medicare Program from fiscal year (FY) 2011 to FY 2015,
with decreasing incentives for those hospitals that started receiving payments in 2014 and
penalties for those who did not demonstrate meaningful use of EHRs (Centers for Medicare and
Medicaid Services, 2016d). Eligible hospitals received incentive payments from the Medicaid
Program from FY 2011 to FY 2016, but there were no subsequent penalties (Centers for Medicare
and Medicaid Services, 2016d). Hospitals can receive payments from both the Medicare and
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Medicaid EHR Incentive Programs if they are eligible (Centers for Medicare and Medicaid
Services, 2013).

Patient Protection and Affordable Care Act, 2010
On March 23rd 2010, President Obama signed the Patient Protection and Affordable Care
Act (ACA) into law (U.S. Congress, 2010). The ACA was intended to improve the quality and
affordability of health insurance through mandates, subsidies and insurance exchanges (U.S.
Congress, 2010). One of the important aspects of the ACA was the establishment of accountable
care organizations (ACOs) that required physicians, hospitals and other health care providers to
provide coordinated care to Medicare beneficiaries and made them jointly responsible for the
quality and the cost of care provided (U.S. Congress, 2010). Thus, Health IT has an important
place in this initiative of improving health care quality in the U.S., even though the ACA did not
specifically impact health IT adoption (U.S. Congress, 2010).

National Action Plan for Adverse Drug Event Prevention, 2013
In 2013, the U.S. DHHS released the National Action Plan for Adverse Drug Event
Prevention with the intent to “identify common, preventable and measurable ADEs that may
result in significant patient harm and align the efforts of federal health agencies to reduce patient
harms from these specific ADEs nationally” (US Department of Health and Human Services,
Office of Disease Prevention and Health Promotion, 2014). The ADE action plan identified three
initial targets of anticoagulants, diabetes agents and opioids and suggested an approach of
surveilling data sources to assess the burden and rates of ADEs, sharing evidence-based
prevention tools to prevent ADEs, exploring financial incentives to promote ADE prevention and
identifying the gaps in knowledge and future research opportunities for ADE prevention (US
Department of Health and Human Services, Office of Disease Prevention and Health Promotion,
2014). This plan intended to promote the implementation of evidence-based guidelines by federal,
state and local leaders. The ADE action plan identifies health IT as a helpful tool in supporting its
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goals of surveillance, prevention, incentives and research (US Department of Health and Human
Services, Office of Disease Prevention and Health Promotion, 2014).

National Patient Safety Goals, 2016
The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) revised its
accreditation standards effective from January 1, 2016, through the 2016 National Patient Safety
Goals (NPSGs) (The Joint Commission, 2015). The new standards established a few standards
specific to medication management such as correct identification of patients through the use of at
least two identifiers and safe use of medications through labeling (The Joint Commission, 2015).
Thus, medication management has been a priority of several changing regulations over the
decade, with the HITECH Act and its MU objectives specifically focused on the use of IT to
improve the medication management process.

Section Three: Adoption of Medication Management Technology
The adoption of health IT in health care settings is a complex process. It requires the
initial capital to invest into purchasing the technology, transition of the current system and
processes into the new technology in different units of the hospital and requires an investment in
training the hospital personnel to use the technology in the appropriate manner. Thus, adoption of
health IT is not just completed in a short period, it requires a substantial investment of time to
achieve the optimal benefits. Further, the benefits of health IT can reach a maximum potential
only through the interoperability between different health IT systems, which brings in additional
complexity. There is limited research on the adoption of MMTs that automate all the steps of the
medication management process. Most studies have focused on the adoption of one specific type
of technology, or on the adoption of few similar technologies that may be interfaced with each
other.
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Adoption of EHRs
The adoption of EHR and its functionalities to achieve the MU objectives and thereby
receive incentives has been extensively studied, owing to the focus on the topic after the
enactment of the HITECH Act in 2009 and implementation of the MU Stages since 2011. Early
studies showed limited adoption of EHRs by hospitals (Jha et al., 2009; Jha, DesRoches,
Kralovec, & Joshi, 2010). Data from the American Hospital Association (AHA) IT supplement
survey was used widely to assess the adoption of EHRs (Jha et al., 2009; Jha et al., 2010; Jha et
al., 2011). The AHA IT supplement survey defined two levels of adoption- comprehensive EHR
system as having 24 EHR functions present in all units and a basic EHR system as having ten
functions in at least one unit (Jha et al., 2009).
Jha et al. (2009) reported that in 2008, only 1.5% of the U.S. hospitals had a
comprehensive EHR system, while 7.6% had a basic system (Jha et al., 2009). These numbers
changed modestly in 2009, with 2.5% of the U.S. hospitals having a comprehensive system and
9.2% having a basic system (Jha et al., 2010). Blavin et al. (2010) identified four factors of
adoption categories among the 24 functions- electronic clinical documentation, results viewing,
CPOE and CDSS (Blavin, Buntin, & Friedman, 2010). Adler et al. (2014) examined if there is a
sequence in which a hospital adopts various EHR functions and concluded that hospital
characteristics have an impact in the adoption sequence of EHR functionalities. Furthermore, the
functionalities of EHR that are usually adopted later in the sequence are CPOE and CDSS, which
are integral to MU Stage 1 objectives (Adler-Milstein et al., 2014).
Kazley et al. (2007) examined the organizational and environmental characteristics
associated with the adoption of EMRs. This study found that small hospitals, hospitals in an
uncertain environment as well as those located in rural areas were less likely to adopt EMRs
(Kazley & Ozcan, 2007). The authors of this study contend that the significant characteristics
associated with EMR adoption in hospitals represented the barriers that certain hospitals may face
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when adopting EMRs (Kazley & Ozcan, 2007). Elnahal et al. (2011) examined the adoption of
specific EHR functionalities such as clinical documentation, results viewing, CPOE and CDSS
and the impact of hospital quality, based on summary scores for hospital performance in caring
for patient with acute myocardial infarction, congestive heart failure, pneumonia and prevention
of surgical complications on this adoption (Elnahal, Joynt, Bristol, & Jha, 2011). The study found
that hospitals with higher quality are more likely to adopt all EHR functions and most of the lowquality hospitals without EHR functionalities reported no future plans of implementing them
(Elnahal et al., 2011).

Achievement of MU
With the enactment of the HITECH Act, there also has been increased focus on research
related to the achievement of MU objectives. In 2010, the MU criteria for Stage 1 were much
clearer (DesRoches et al., 2010). Among the eligible hospitals, 4.4% met the definition for MU
Stage 1 in 2010 (Jha et al., 2011), while 18.4% satisfied the definition in 2011 (DesRoches,
Worzala, Joshi, Kralovec, & Jha, 2012). Since then, these numbers have been increasing steadily
as the MU Stages rolled out and payments were made by the EHR incentive program. In 2012,
38% of the eligible U.S. hospitals received Medicare MU incentive payments (Diana, Harle,
Huerta, Ford, & Menachemi, 2014). Diana et al. (2012) attempted to examine the intent of the
hospitals to apply for the MU incentives (Diana, Kazley, Ford, & Menachemi, 2012). Intent to
apply for the MU incentives was examined through the 2009 AHA Annual Survey Information
Technology Supplement, in which hospitals were asked if they are pursuing the incentive
program and examined the reasons for not pursing them (Diana et al., 2012). The study found that
more than half of the U.S. hospitals intended to apply for MU incentives in 2011, while almost
one-fourth reported their intent to pursue the incentives in 2012 (Diana et al., 2012). The study
also found that despite the monetary incentives in achieving MU of certified EHRs, certain
hospitals such as those that already have a partial EHR system or a complete EHR system, larger
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hospitals and urban hospitals were more likely to plan to seek incentives, while for-profit
hospitals and system members were less likely to do so (Diana et al., 2012). This finding that
those hospitals without an EHR were less likely to apply for MU objectives raised a question of
whether the HITECH Act was just impacting the EHR users to achieve MU, instead of impacting
the non-adopters of EHRs to adopt them and then achieve MU (Diana et al., 2012). Similarly,
EHR adopters continued to be more likely to receive the MU incentives, as compared to nonadopters (Diana et al., 2014). The authors thus contend that the EHR incentive payments may
have provided a disproportionate advantage to the hospitals that had already adopted an EHR
system prior to the start of the incentive program and hence may not be effective in the goal of
widespread EHR adoption and its meaningful use (Diana et al., 2014). Further, about 30% of the
hospitals that had the infrastructure in place to achieve the MU objectives failed to report their
eligibility to receive the MU incentives (Diana et al., 2014). The reason for this has been
attributed to the inability to meet the MU objective measure for CPOE (Diana et al., 2014).

Adoption of MMTs
Zhang et al. (2013) examined the differences between the U.S. acute care hospitals that
adopted health IT and those that did not (Zhang et al., 2013). They examined 52 technologies by
clustering them into clinical IT, administrative IT and strategic decision making IT and found that
the most important factors that are significantly associated with the adoption of IT are large size,
urban location of the hospital and HMO penetration (Zhang et al., 2013). This study was
conducted using data from the year 2006 i.e., before the enactment of the HITECH Act. Thus, the
study recommended examining the impact of the EHR Incentive program in 2011 on the adoption
of IT by U.S. acute care hospitals (Zhang et al., 2013).
Uy et al. (2015) examined the trends in the adoption of bar-code, RFID, biometric and
pharmacy automation technologies in US hospitals using the HIMSS Analytics Database (Uy et
al., 2015). The study found that the medication administration department had the highest growth
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rate for bar-code and RFID technologies (Uy et al., 2015). Further in 2012, bar-coding had a high
adoption rate (73.9%) in the pharmacy department (Uy et al., 2015). High adoption rates were
also observed for the pharmacy automation technologies such as ADM (81%), with steady
growths in the adoption of carousels and robot-filling for prescriptions (Uy et al., 2015).
A study by Furukawa et al. (2008) examined the adoption of eight MMTs and is one of
the few studies that attempts to examine technologies specifically used for automation of the
medication management process (EMR, CDSS, CPOE, bar-coding at medication dispensing,
robot for medication dispensing, ADM, eMAR and bar-coding at medication administration) and
the factors associated with their adoption (Furukawa et al., 2008). This cross-sectional study used
the HIMSS Analytics Database and limited the sample to acute care hospitals in the U.S.
(Furukawa et al., 2008). The measure of health IT adoption was a binary variable of adoption of
technology (1 if adopted, 0 otherwise) and a count variable for the number of health IT
applications that were adopted (Furukawa et al., 2008). The results revealed the highest adoption
rate for ADMs at 62%, followed by CDSS (46%), EMR (37%), bar-coding at medication
dispensing (27.1%), eMAR (26%), CPOE (14%), robot (7%) and bar-coding at medication
administration (5%) (Furukawa et al., 2008). The study also found that hospitals with certain
characteristics had a higher likelihood of adoption of health IT such as larger hospitals, teaching
hospitals and hospitals with system membership and JCAHO accreditation (Furukawa et al.,
2008). Also, rural hospitals, investor-owned and state/local government hospitals and hospitals
with a higher share of Medicare discharges and higher share of Medicaid discharges were less
likely to adopt health IT systems, although the probability of adoption varied by the type of
technology (Furukawa et al., 2008). The study also established evidence for an important aspect
that could influence health IT adoption, which were the safety initiatives in the state such as
patient safety coalitions, adverse-event reporting systems and patient safety centers (Furukawa et
al., 2008).
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Cutler et al. (2005) examined the reasons for low adoption of CPOE from the point of
view of financial and ownership status theories. They found that government hospitals and
teaching hospitals are more likely to invest into the implementation of CPOE at that time (Cutler,
Feldman, & Horwitz, 2005). Appari et al. (2012) examined the adoption of two technologies for
medication safety- CPOE and eMAR and found that adoption of eMAR alone as well as in
combination with CPOE improved adherence to medication guidelines in the hospitals (Appari et
al., 2012).

Summary of Gaps in the Literature
The current empirical literature has examined the factors associated with EHRs and
achievement of MU objectives widely. A few studies have also focused on the adoption of
different MMTs. However, there is a paucity of empirical organizational studies that examines
MMTs in context of their functions in the steps of the medication management process.
Additionally, there has not been a study that examines the factors associated with adoption of
CLMM. Further, the impact of the implementation of the HITECH Act on adoption of MMTs is
still unknown. Since adoption of MMT is the first step towards their implementation leading to
reduction in medication errors and improvement of patient safety, there is a need to examine the
changes in the adoption of MMTs after the implementation of the HITECH Act.

Summary of the Chapter
This chapter presented an overview of medication safety in U.S. hospitals with a
discussion of the steps of the medication management process and the technologies that are used
to automate the medication management process. The regulatory environment in which the U.S.
hospitals function with regards to adoption of health IT with a focus on the HITECH Act and the
MU objectives is discussed. Finally, the empirical literature available on the adoption of MMTs
by U.S. hospitals is presented. A review of this literature indicated the important implications of
the HITECH Act in the adoption of MMTs. It also indicated a dearth of empirical organizational
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studies that examine the adoption of MMTs in the context of the different steps of the medication
management process.
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CHAPTER THREE: THEORETICAL BACKGROUND
This chapter consists of two sections. The first section explores the competing
perspectives that have been used in the literature to examine organizational strategic behavior,
specifically focusing on the organization’s decision to adopt innovations. The second section of
this chapter discusses the theoretical framework for this study and the development of the
conceptual model, key constructs and research hypotheses that were empirically tested in this
study. The theoretical framework presented in this chapter attempts to answer the two research
questions of this study as described below:
1) How did the implementation of the HITECH Act affect the adoption of MMTs in U.S. acute
care hospitals?
2) What are the organizational and environmental factors that are associated with the adoption
of MMTs in U.S. acute care hospitals?
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Section One: Competing Perspectives for Organizational Strategic Behavior
Organizational Strategic Behavior
Until the late 1950s, a closed systems perspective was dominant and organizational
behavior was considered to be through the actions occurring due to solely the internal operations
and events of that organization (Hatch, 1997). However, open systems theorists established that
organizations are influenced by their environment and introduced the idea of a relationship
between organizations and their environment (Scott & Davis, 2003). Organizational environment
was commonly categorized as the inter-organizational network, the general environment and the
international/global environment (Hatch, 1997). Each organization interacts with the members in
its environment and develops an inter-organizational network (Hatch & Cunliffe, 2013). The
general environment refers to the “more general forces” that have an impact throughout the
network, while the international/global environment consists of the forces that are not limited to
the national boundaries and act on a global-level (Hatch, 1997). Analyzing the general
environmental conditions is more useful in examining the relationship between the organization
and its environment (Hatch, 1997). Hence, in the late 1950s and early 1960s, the framework of
the relationship between organizations and their environment and the importance of this concept
was developed and in the period from late 1970s continuing till today, the environment has been
considered to have an important influence on the organization (Hatch, 1997). Organization
theories during this time were developed to understand the way in which this influence works
(Hatch, 1997). In this period, the three most influential theories surrounding the organizationenvironment relationship were developed and have been widely used since. These theories are the
resource dependence theory (RDT), population ecology theory and institutional theory (Hatch,
1997).
RDT establishes that an organization is dependent on its environment for resources and
the need for resources such as raw materials, labor, capital, equipment, knowledge and outlets for
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its products and services renders the organization vulnerable and provides the environment with
control over the organization (Hatch & Cunliffe, 2013). This theory provides a framework to
understand the dependencies of the organization on its environment and strategies for managing
these dependency relationships (Pfeffer & Salancik, 1978). The dependence between the
organization and its environment is a complex one, in the sense that is “neither singular nor
undifferentiated” (Hatch & Cunliffe, 2013). Assessing resource criticality as well as scarcity in
order to prioritize the management of dependencies is an essential component of the resource
dependence perspective (Hatch & Cunliffe, 2013).
Population ecology theory is similar to RDT in the assumption of organizational
dependence on the environment for resources, but they differ in their points of view, as the
population ecology theory looks at organizations from the perspective of the environment
(Hannan & Freeman, 1977). This theory posits that the environment has control over selecting
those organizations to survive which best fit the needs of the environment (Hatch, 1997).
Population ecologists are interested in understanding the successes and failures of organizations
competing for the same pool of resources (Hatch & Cunliffe, 2013). Researchers find that the
application of the population ecology theory to organizational management is difficult owing to
the unit of analysis being outside the boundary of the organization and thereby outside
organizational control (Hatch & Cunliffe, 2013). Additionally, this theory is applicable to highly
competitive populations and may not be justifiable in all contexts (Hatch & Cunliffe, 2013).
Both the resource dependence and population ecology theories emphasize the necessity
of resources for the organization’s survival, while the institutional theory recognizes sociocultural
demands that the organization must conform to in order to ensure its survival (Hatch, 1997).
These are referred to as institutional pressures and are the norms, values and expectations that
lead to the social legitimacy of the organization in the environment, which may be as important
for the organization’s survival as any other resource (DiMaggio & Powell, 1983). Institutional
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theorists believe that in addition to technical, economic and physical demands, environments also
place social, cultural, legal, or political demands that require organizations to engage in certain
behaviors for the sake of acceptance in the society (Hatch & Cunliffe, 2013).
These three theories provide three unique perspectives, but they are unified by the
common idea of the impact of the environment on the organization (Hatch, 1997). These theories
emphasize the concept of “strategic fit” of the organization referring to the actions taken by the
organization to comply with the demands of the environment and ensure its survival (Hatch,
1997). A strategist is concerned with interpreting these theories into strategies that can help the
organization to take actions that provide them with a competitive advantage to ensure their
survival (Hatch, 1997). The view point of the RDT aligns with that of the strategist, which is
centered on the organization rather than the environment and the framework of the theory can be
converted into opportunities to strategize and achieve fit (Hatch, 1997). The strategist interprets
institutional theory as managing the aspects of the organizations that would lead to the
organization being legitimate and thereby, attract resources from the environment (Hatch, 1997).
This could be done by imitating the successful organizations, by conforming rules, regulations or
sanctions, or by following behaviors of peer organizations (Scott & Davis, 2003). This imitation
could also be a strategy to ensure selection and retention by the environment, through the
population ecology perspective (Scott & Davis, 2003).
For the purpose of this study, the adaptive perspective of the RDT was considered to be a
better fit than institutional theory. This is because the adoption of MMTs is likely to be not
random and is a conscious strategic behavior of the hospital owing to the extent of the resource
input that is needed. MMTs are expensive and their use also requires the need to train staff.
Hence, for a strategic decision such as adoption of MMTs, hospital leadership needs to account
for the availability of resources in order to make this investment. The HITECH Act added a
regulatory pressure on the hospitals, however the resources needed to adopt MMTs go much
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beyond the incentives offered by the HITECH Act, especially for those hospitals that do not
already have the infrastructure of EHR in place (Diana et al., 2014). Hence, the decision to adopt
MMTs in context of the HITECH Act is more likely to be based on the availability of resources
rather than to gain legitimacy. Thus, this study utilized the adaptive perspective offered by RDT
in order to develop the framework to examine the organizational strategic behavior of adoption of
MMTs. As described above, RDT assumes that organizations engage in strategies to improve
their chances of survival in an uncertain environment. Previous literature supports the adoption of
this perspective when examining strategic choices by organizations, as evidence suggests that the
leadership of the organization make strategic choices for environmental adaptation (Alexander &
Morrisey, 1989; Augier & Teece, 2009; Floyd & Wooldridge, 1997). Further, RDT has been
applied widely to study the adoption of technologies by hospitals in the health services research
literature (Kazley & Ozcan, 2007; Menachemi, Shin, Ford, & Yu, 2011; Menachemi, Mazurenko,
Kazley, Diana, & Ford, 2012).

Organizational Innovation
In a dynamic environment, innovation has been considered as a means of competitive
advantage for the organizations. In fact, innovation is considered to be the most valuable aspect
of a firm’s performance. Crossan & Apaydin (2010) established a comprehensive definition of
innovation as:
“Production or adoption, assimilation and exploitation of a value-added novelty in
economic and social spheres; renewal and enlargement of products, services and markets;
development of new methods of production; and establishment of new management
systems. It is both a process and an outcome (Crossan & Apaydin, 2010).”
The core intention of adopting innovations is to enhance the performance of the
organization and it can be done either as a reactive strategy to tackle the changes in the
environment or as a proactive strategy to bring about a change in the environment (Damanpour,
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1991). As organizations adopt innovations continually to keep up with the dynamic nature of the
environment, Damanpour (1991) contended that, “organizational innovativeness is more
accurately represented when multiple rather than single innovations are considered” (Damanpour,
1991).
Three distinctions in the type of innovations have been made in the literature as service,
administrative process and technological process innovations (Damanpour, Walker, &
Avellaneda, 2009). Service innovations refer to the introduction of new services or introducing
existing services to new clients (Damanpour et al., 2009). Administrative innovations include
those innovations that bring forth a change in the structure of an organization (Damanpour et al.,
2009). These innovations are those that impact the basic activities in the organization and are
directly linked to the management of the organization (Damanpour et al., 2009).Technological
innovations are those that lead to changes in technology in the organization (Damanpour et al.,
2009). Technology is “a tool, technique, physical equipment or system by which the employees,
the units, or the organization extend their capabilities” (Damanpour, 1987). Thus, technological
innovations can be considered to be new tools, techniques, device, or system (Damanpour, 1987).
From the perspective of organizations being open systems, it is considered that
organizations adopt innovations due to environment pressures and as a means to maintain or
improve performance. Organizations are considered as adaptive systems, which introduce change
to adapt with the changing environment and to continue to function in that environment
(Damanpour et al., 2009). Multiple factors such as individual, organizational and environmental
factors are considered to have an impact on the adoption of innovations. Among these,
organizational factors have been widely examined and have been considered as primary
determinants of organizational innovation (Damanpour, 1991). The external environment
provides opportunities and constraints on the organizational adoption of innovation (Damanpour
& Schneider, 2006). Further, organizational leaders and managers are constituted to be influential
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in innovation adoption as they control the resources and major decisions for the organization
(Damanpour & Schneider, 2006).

Adoption of Innovation
Previous studies on the adoption of innovation have majorly focused on the effect of
organizational factors on the adoption of innovation, while few have also considered the effect of
other contextual factors such as environmental effects and top managerial factors. Kimberly &
Evanisco (1981) examined the influence of individual, organizational and contextual factors on
the adoption of technological and administrative innovation by hospitals (Kimberly & Evanisko,
1981). In this study, technological innovations were those innovations that were related to the
diagnostic and treatment capabilities of the hospital and were directly related to the working of
the hospital (Kimberly & Evanisko, 1981). On the other hand, administrative innovations were
those that were not directly related to the working of the hospital and included the adoption of
electronic data processing for internal logistical activities of the hospital (Kimberly & Evanisko,
1981). The study found that the individual, organizational and contextual factors included in the
study were better in terms of predicting adoption of technological innovations rather than
administrative innovations (Kimberly & Evanisko, 1981). Also, there were differences in terms of
which factors influence the adoption of which type of innovation. The study also established that
the organizational level factors were superlative than other factors for predicting adoption of both
types of innovations (Kimberly & Evanisko, 1981).
Damanpour (1987) examined organizational factors as predictors of adoption of
technological, administrative and ancillary innovations in public libraries and established that the
organizational factors were better at predicting adoption of technological innovations, rather than
administrative or ancillary innovations (Damanpour, 1987). An important conclusion that was
established from this study is that it is essential to distinguish between types of innovation, as
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well as the stages of adoption of the innovation when studying innovation adoption (Damanpour,
1987).
Damanpour (1991) conducted a meta-analysis of the effects of organizational
determinants on innovation adoption (Damanpour, 1991). This study found that there was a
positive association between innovation adoption and specialization, functional differentiation,
professionalism, attitude of managers towards change, resources of technical knowledge,
administrative intensity, slack resources as well as external and internal communication
(Damanpour, 1991). The factors of resources of technical knowledge and slack resources closely
aligns with ‘munificence’, which is a construct of RDT (Pfeffer & Salancik, 1978). The study
also established a negative association between adoption of innovation and centralization; and no
significant association between adoption of innovation and formalization, tenure of manager and
vertical differentiation (Damanpour, 1991).
Damanpour & Gopalakrishnan (1998) examined the role of environmental change in the
theories of the relationship between organizational structure and innovation adoption (Damanpour
& Gopalakrishnan, 1998). This study established four scenarios in the environment based on the
high and low levels of stability and predictability (Damanpour & Gopalakrishnan, 1998). In a
stable and predictable environment, it was contended that the speed of innovation adoption is
slow and the rate of adoption is low (Damanpour & Gopalakrishnan, 1998). In a stable but
unpredictable environment, the rate of adoption is low though the speed is fast (Damanpour &
Gopalakrishnan, 1998). In an unstable and predictable environment, the rate of adoption is high,
while the speed is moderate (Damanpour & Gopalakrishnan, 1998). And finally, in an unstable
unpredictable environment, the rate of adoption is high and the speed is fast (Damanpour &
Gopalakrishnan, 1998). Thus, this study established the crucial role that the environmental state
plays in the adoption rate and the rate of innovation adoption.
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A study conducted by Damanpour & Schneider (2006) on the effect of environment,
organizational and top managers’ characteristics on the phases of adoption of innovation found
that organizational factors as well as the attitudes of the top managers were better predictors of
each phase of innovation as compared to environmental factors and the demographic
characteristics of the top managers (Damanpour & Schneider, 2006). The study defined the
phases of innovation as initiation, adoption decision and implementation of innovation
(Damanpour & Schneider, 2006).
These studies on adoption of innovation establish the important role that the
organizational and environmental characteristics play in the strategic decision of adoption of
innovation. Further, the importance of examining multiple innovations as well as distinguishing
between the different types of innovation and the phases of innovation have been brought forth.

Section Two: Theoretical Framework of the Study
The ensuing paragraphs describe the conceptualization process for the two research
questions of the study:
1) How did the implementation of the HITECH Act affect the adoption of MMTs in U.S. acute
care hospitals?
2) What are the organizational and environmental factors that are associated with the adoption
of MMTs in U.S. acute care hospitals?
The RDT perspective was used to derive the framework to answer these research questions.

Overview of Resource Dependence Theory
Resource dependence theory (RDT) was proposed by Pfeffer and Salancik (1978) in their
book, ‘The External Control of Organizations: A Resource Dependence Perspective’. RDT posits
that organizational survival is derived from its ability to manage environmental demands and
acquire resources from the environment that are critical for its survival (Pfeffer & Salancik,
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1978). This macro-organizational theory is based on an open systems perspective and provides a
rational approach to understand the control that the environment has over the organizations
(Pfeffer & Salancik, 2003). The open systems perspective proposes that no organization is fully
self-sufficient in terms of the resources necessary for its survival and must engage in exchange
relationships with its environment in order to secure these resources (Scott & Davis, 2003).
The RDT provides a framework to understand the dependence of the organization on its
environment in order to acquire resources, since all necessary resources cannot be obtained from
within the organization itself (Scott & Davis, 2003). Hence, organizations may alter their
structure or certain behaviors in order to acquire and maintain its resources (Scott & Davis,
2003). Organizations strategize to gain critical scarce resources in order to deal with uncertainty
and scarcity in the environment and reduce their dependency on others (Jaana, Ward, Pare, &
Sicotte, 2006; Verbruggen, Christiaens, & Milis, 2011). Thus, many of the observed actions of an
organization may reflect the organization’s intention to secure resources from the environment
(Banaszak-Holl, Zinn, & Mor, 1996). Given the scarcity of resources in the environment, RDT
posits that organizational operate rationally in such an environment by maintaining their
dependencies on external entities, but not losing complete autonomy (Scott & Davis, 2003).
Thus, the core tenet of RDT is that organizations strategize to acquire critical resources
from the environment in order to ensure survival in times of uncertainty, while maintaining
interdependent relationships with external organizations. RDT has been widely used in health
services research to examine and explain various strategic behavior of health care organizations
such as provision of various innovative services (Banaszak-Holl et al., 1996), staffing changes
(Nayar, 2008), adoption of technology (Kazley & Ozcan, 2007), alliances (Zinn, Proenca, &
Rosko, 1997), strategic responses to improve efficiency (Apenteng, Nayar, Yu, Adams, & Opoku,
2015), quality improvement and management initiatives (Zinn, Weech, & Brannon, 1998) and
contractual strategies (Alexander & Morrisey, 1989; Apenteng, Nayar, Yu, Adams, & Opoku,
2015; Kazley & Ozcan, 2007; Nayar, 2008)
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The three key constructs specified by RDT include uncertainty, munificence and
interdependence (Scott & Davis, 2003). Uncertainty refers to the unstable nature of the
environment that plays a role in the availability of resources (Pfeffer & Salancik, 1978). RDT
posits that organizations depend on the environment for scarce resources and when faced with
uncertainty in the environment, they are more likely to adopt strategic behaviors that could help
them secure a stable flow of resources (Pfeffer & Salancik, 1978). This behavior would thereby
minimize the uncertainty in the environment and improve the chances of organizational survival
(Hatch & Cunliffe, 2013). Uncertainty usually arises due to competition in the market when more
organizations must share the same resources, or under regulatory changes. Thus, in highly
competitive markets, organizations would be more likely to try to innovate in order to
differentiate themselves from other organizations. Additionally, regulatory pressures from
government agencies such as policy enactment that affects access to financial resources for an
organization creates an uncertainty in the flow of resources for the organization. Thus, in order to
maintain the flow of these financial resources into the organization and maintain stability in an
uncertain environment, organizations could engage in strategies that facilitate this. If this involves
complying with the objectives of the policy, organizations would be more likely to try to align
with the regulations of the policy to ensure survival.
Munificence represents availability and accessibility of resources in the environment
(Pfeffer & Salancik, 1978). RDT posits that organizations that have access to critical resources
will be more likely to have the capacity to adopt innovations (Damanpour et al., 2009). In the
health care industry, munificence is represented by abundance of resources in the market, as well
as the size of the organization (Alexander & Morrisey, 1989; Apenteng et al., 2015; Kazley &
Ozcan, 2007; Nayar, 2008).
Interdependence refers to the degree to which organizations are dependent on other
organizations for resources (Pfeffer & Salancik, 1978). Organizations with interdependent
relationships are more likely to have availability of resources to adopt innovations (Damanpour,
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1991). Further, those organizations that are dependent on external entities for resources are more
likely to comply with the demands of these external entities (Pfeffer & Salancik, 1978). In the
health care industry, interdependent relationships arise through dependence on external entities,
for example Medicare, for resources such as patients or funding (Kazley & Ozcan, 2007; Nayar,
2008), or through dependence on shareholders for for-profit hospitals (Apenteng et al., 2015;
Kazley & Ozcan, 2007).

Development of the Conceptual Model
When utilizing the RDT framework to examine the strategic behavior of an organization,
the unit of analysis is the organization. In this study, ‘organization’ is defined as the individual
acute care hospital. RDT emphasizes an adaptive perspective by the adoption of strategic
behavior to maintain critical or scare resources that are essential to the organization’s survival
(Scott & Davis, 2003). For an acute care hospital, these critical resources include patients,
clinicians, other health care professionals, financial capital, payers and complying with
regulations. The adoption of MMTs can be viewed as a strategic behavior to stabilize these
resources and minimize the organization’s dependencies, while ensuring the survival of the
organization in an uncertain environment.
The conceptual model of the study shown in Figure 2 provides an illustration of how the
strategic behavior of adoption of MMTs by the focal organization i.e., the individual acute care
hospital, is influenced by various environmental and organizational factors. These factors were
derived from the key constructs of RDT- uncertainty, munificence and interdependence.
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Resource Dependence
Uncertainty

Implementation of the HITECH
Act
Competition
Munificence
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Geographical Location

Private Payer Mix
Ownership Control

Teaching Status

Figure 2: Conceptual Model of the Study
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Key Constructs
The conceptual model, as shown in Figure 2, elucidates the theoretical framework and the
key constructs of RDT that were used to derive the research hypotheses. The key behavioral
construct of the study was the adoption of organizational innovation. This construct was
operationalized as the adoption of MMTs by the acute care hospitals. The key causal constructs in
this study were derived from the three constructs of RDT, which include uncertainty, munificence
and interdependence.
Uncertainty was operationalized as the implementation of the HITECH Act and the
degree of market competition. Munificence was operationalized as community wealth in the
hospital market, organizational size, system membership and the availability of financial
resources. Interdependence was operationalized as private payer mix and ownership control of the
hospital.

Research Hypotheses
Based on the key constructs of RDT, the main empirical hypotheses proposed in this
study were: 1) After the implementation of the HITECH Act, U.S. acute care hospitals will be
more likely to adopt MMTs; and 2) organizational factors (organizational size, system
membership, financial resources, private payer mix and ownership control) and environmental
factors (market competition and community wealth in the hospital market) will be associated with
the adoption of MMTs by the U.S. acute care hospitals. The specific research hypotheses that
were empirically tested in this study are described in the ensuing paragraphs.
Uncertainty. As previously mentioned, RDT posits that organizations are dependent on
the external environment to gain critical resources necessary for its survival (Pfeffer & Salancik,
1978). As the environment is dynamic, it may create uncertainties in the availability of these
resources. Thus, organizations that are faced by a high degree of uncertainty in the environment
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respond with strategic behaviors that will ensure the availability of resources and thereby,
minimize the level of uncertainty in the environment ensuring the organization’s chances of
survival (Proenca, Rosko, & Zinn, 2000). Higher uncertainty in the environment leads to
increased competition for the acquiring critical resources and thus organizations may adopt
strategies to protect themselves from the external uncertainties and secure critical resources
(Apenteng et al., 2015; Kazley & Ozcan, 2007). In the past, uncertainty in environment has been
operationalized as competition in the market (Menachemi et al., 2012) and as regulatory pressures
(Nayar, 2008). In this study, uncertainty was operationalized as the policy effect of the
implementation of the HITECH Act as well as the degree of competition in the hospital market.
The implementation of the HITECH Act was a policy change in the environment, which
affected all acute care hospitals in the U.S. As described previously in Chapter 2, the Act
established monetary incentives to promote the adoption and ‘meaningful use’ of health IT, while
penalizing those hospitals that did not comply with the objectives of the Act. The HITECH Act
established its’ objectives of meaningful use through three stages and the payment of the
incentives for complying with Stage 1 began in 2011. The extent of the financial incentives,
which started in 2011, included a $2 million base amount while the penalties, which began in
2015 started with a 1% penalty on Medicare reimbursement amounts, which then increases to 2%
in 2016 and 3% in 2017 (Centers for Medicare and Medicaid Services, 2014c). Thus, this policy
could have impacted the availability of resources, financial resources in this case, through the
incentives and penalties, creating an uncertain environment for the hospital. If assumed to behave
as rational, adaptive organizations, it is expected that the hospitals would react actively to this
policy enactment. Hospitals, thus, may have adopted MMTs to gain the financial resources
through the incentives and establish stability for their survival. Hospitals may also have acted as
adaptive organizations and prepared to adopt all MMTs with the broader goal of improving
patient safety.
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H1: Hospitals will be more likely to adopt MMTs in the period after the implementation of
the HITECH Act, all things being equal.
Organizations operating in a market with high degree of competition share the same
limited resource pool (Pfeffer & Salancik, 1978). Hence, organizational survival depends on the
allocation of these resources (Banaszak-Holl et al., 1996). In areas of high competition, health
care providers need to distinguish themselves from the other providers to acquire critical
resources. Thus, hospitals in highly competitive markets will attempt to differentiate themselves
from others by adopting new technologies (Kazley & Ozcan, 2007). Further, in such areas of
high competition, the patients may have a choice between multiple providers and would want to
choose a provider based on the services as well as the quality of services provided. To attract such
patients, a hospital may adopt new technologies known to improve the quality of services to
attract patients. Thus, hospitals in areas of high competition will engage in strategic behaviors
such as adoption of MMTs since these technologies can reduce medication errors and lead to
increased patient safety, to maintain or increase their market share and improve their chances of
survival. However, hospitals operating in areas that has less market competition may not be
concerned about availability of resources and market share as they do not share their pool of
resources with other hospitals in the market and patients do not have multiple choices.
H2: Hospitals located in markets with higher competition will be more likely to adopt
MMTs, all things being equal.
Munificence. Munificence refers to the availability of resources for the hospital and
impacts the organization’s dependencies as well as strategic behaviors. It represents the
abundance of resources external or internal to the hospital that are critical for its survival. An
organization operating in an environment with abundant resources can acquire those resources
needed for adoption of innovation with relative ease. Health services researchers have
operationalized munificence as community wealth (Apenteng et al., 2015; Kazley & Ozcan,
2007; Nayar, 2008; Yeager et al., 2014), organizational size (Apenteng et al., 2015; Banaszak-
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Holl et al., 1996; Kazley & Ozcan, 2007; Nayar, 2008; Zinn, Proenca, & Rosko, 1997),
availability of financial resources (Kazley & Ozcan, 2007) and system membership (Alexander &
Morrisey, 1989; Kazley & Ozcan, 2007).
In health services research, community wealth has been used to represent the availability
of these external resources (Apenteng et al., 2015; Kazley & Ozcan, 2007; Nayar, 2008; Yeager
et al., 2014). Hospitals operating in markets with higher community wealth have a larger patient
base of privately insured people. These privately insured patients are sources of revenue to the
hospitals. MMTs can be expensive and require an investment of financial capital from the
hospital to purchase them (Classen & Brown, 2013). Hence, hospitals located in areas with higher
income can generate revenue from their privately insured patient base. Such hospitals will hence
have higher availability of financial resources to invest into MMTs. Further, since such patients
can afford to be selective in their choice of hospitals, it is important for the hospitals to
distinguish themselves from others in the market by providing higher quality of care. As
described in Chapter 2, MMTs can improve the medication management process and through
automation of the process and reduction of medication errors. Given that medication errors are
the most common cause of medical errors (Leape et al., 1991) and the high prevalence of injuries
arising out of medication errors and ADEs (Institute of Medicine, 2006), reducing medication
errors can significantly improve patient safety and lead to higher quality of care.
H3: Hospitals located in markets with higher community wealth will be more likely to adopt
MMTs, all things being equal.
Organizational size could be indicative of the availability of internal resources
(Banaszak-Holl et al., 1996). Due to the availability of resources, larger organizations can remain
autonomous and may also control the environmental resources. Larger hospitals have the
financial capital as well as the organizational capability to invest in expensive technologies
(Kazley & Ozcan, 2007). Previous research on adoption of innovations by hospitals has
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established that larger hospitals were more likely to adopt innovations (Banaszak-Holl et al.,
1996; Kazley & Ozcan, 2007; Zinn, Weech, & Brannon, 1998).
H4: Larger hospitals will be more likely to adopt MMTs, all things being equal.
Hospitals with a system membership are those belonging to a multi-hospital system
comprising of a central headquarter hospital along with two or more affiliated hospitals
(Alexander, Morrisey, & Shortell, 1986) and thus have access to a larger pool of resources
through its member hospitals. System membership acts as a buffer to protect the member
hospitals from uncertainties in the environment and reduces its dependencies on other external
entities. Further, this affiliation also leads to sharing of knowledge as well as critical resources
among the members of the system, thus making those members ‘munificent’ in terms of resources
and giving them the ability to invest in and adopt technologies (Yeager et al., 2014).
H5: Hospitals that are part of a multi-hospital system will be more likely to adopt MMTs,
all things being equal.
MMTs can be expensive and hence availability of financial resources is a major barrier in
their adoption by the hospitals (Classen & Brown, 2013). Further, some complex new
technologies may also require additional staff to operate them initially, or the financial resources
to train the existing hospital staff (Menachemi & Brooks, 2006). The hospital may factor in this
additional investment in the cost of the technology. Thus, a hospital with adequate financial
resources can invest and purchase technologies. Those hospitals that do not have the financial
means may not be able to adopt new technologies due to lack of internal resources.
H6: Hospitals with greater financial resources will be more likely to adopt MMTs, all things
being equal.
Interdependence. Interdependence, as a construct of RDT, represents the dependencies
of the organization on other external entities for resources which may be crucial for its survival
(Pfeffer & Salancik, 1978). It is possible that organizations are more likely to comply with the
demands of the external entities on which they are dependent. In the extant health services
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literature, these interdependent relationships are represented by private payer mix (Yeager et al.,
2014) and the ownership status of the hospitals (Apenteng et al., 2015; Banaszak-Holl et al.,
1996; Kazley & Ozcan, 2007).
The private insurance agencies are one of the major payers for the hospitals.
Additionally, patients with private insurance are the affluent patients. Hence, hospitals that serve
higher proportions of patients with private insurance may be motivated to invest in innovations to
provide better quality of care in order to maintain the flow of affluent resources and maintain the
interdependence
H7: Hospitals with a higher proportion of private payer mix will be more likely to adopt
MMTs, all things being equal.
The mission of the hospital defines its various strategic behaviors. For-profit hospitals
operate with a profit maximization outlook and are dependent on their shareholders. Shareholders
expect the hospitals to manage their investments and generate profits. Thus, for-profit hospitals
may engage in innovations that would improve their efficiency and lower their costs and thereby,
maximize their profits. For-profit hospitals also have the initial financial capital to make such
investments (Clement & Grazier, 2001) and they may do so with the intention of maximizing
profit in the long run. MMTs can effectively improve the efficiency of the medication
management process and reduce costs arising out of medication errors. Thus, for-profit hospitals
may see this as a good investment, aligning with their mission and with the demands on their
shareholders.
H8: For-profit hospitals will be more likely to adopt MMTs as compared to public hospitals,
all things being equal.
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Summary of the Chapter
This chapter provided an overview of the competing theoretical perspectives on
organizational strategic behavior, presenting both the adaptive and selective perspectives and then
described the concept of innovation and adoption of innovations. Further, the second section of
the chapter outlined the theoretical framework of this study. The basic tenets of RDT were
discussed in detail and the conceptual model was developed based on the three key constructs of
RDT. Additionally, the research hypotheses that were empirically tested in this study were
described.
The ensuing Chapter 4 presents the study design, study sample and universe,
measurement of the variables, their data sources as well as the analytical methods to answer the
research question of this study.
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CHAPTER FOUR: METHODOLOGY
This chapter focuses on the research methodology, including the research design, sources
of data, study population and sample and the key measures for the dependent, independent and
control variables included in this study. Further, the analytical strategy used to answer the
research questions of this study is described. The chapter concludes by reviewing the
methodological limitations as well as the ethical considerations of this study.

Research Design
The aim of this study was to examine the impact of the implementation of the HITECH
Act on the adoption of MMTs by U.S acute care hospitals and the organizational and
environmental correlates of the adoption of MMTs by U.S. acute care hospitals. The unit of
analysis for this study was the individual acute care hospital in the U.S. and the period of the
study was two years before and two years after the implementation of the HITECH Act (which
came into effect in 2011) i.e., 2009 to 2013. The research design used to answer the research
questions of this study was the interrupted time series design, which is a quasi-experimental
design with a single group. A diagrammatic representation of this design is shown in Figure 3.

O1

O2

O3X

O4

O5

Figure 3: Research Design: Interrupted Time Series
O1-O5: Observations made two years before (2009 and 2010), during (2011) and two years after
(2012 and 2013) the implementation of the HITECH Act
X: Implementation of the HITECH Act
There was only one group in this study design, which includes all the non-CAH, nonfederal, acute care hospitals operating within the 50 U.S. States and the District of Columbia. The
implementation of the HITECH Act in the year 2011 created a natural experiment, which
impacted all the hospitals in the study sample. In the research design, this is represented by the
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(X) symbol. Data from two years before the intervention (pre-HITECH Act) and two years after
the intervention (post-HITECH Act) comprise the observations (O1-O5). Since there was only one
group in this study with an intervention and multiple observations before and after the
intervention, an interrupted time series design was the most appropriate design for this study.
When an event interrupts the time series, or takes place within the time period of the
measurements, this research design is able to examine the effects that occurred due to that event
(Campbell & Stanley, 1963; Cherulnik, 2001).
A study with a quasi-experimental research design is easier to implement in natural
settings and can be conducted using secondary databases (Cherulnik, 2001). This eliminates the
artifacts that arise out of direct interaction between the researcher and the study participant that
are common in experimental research (Cherulnik, 2001). Since this study examined pre-existing
administrative databases of hospitals and not human participants, there was no interaction
between the researchers and the study participants. Thereby, there were no threats to the study
design due to reactive arrangements, pre-test sensitization, or linguistic/cultural bias.
The availability of multiple measures for the outcome of interest over time rendered
strong internal validity to this study. These multiple measures revealed whether there were any
temporal trends before the event of interest and if the trend was altered after the event occurred
(Cherulnik, 2001). Hence, temporal trends did not pose a threat to the internal validity of the
study (Cherulnik, 2001). Due to the single group study design, group composition effects did not
pose a threat to internal validity. Thereby, the interaction between temporal effects and group
composition effects could also be ruled out as a threat to internal validity. Extreme high or low
baseline scores have the tendency to regress towards the mean and this may lead to the conclusion
that the change in observation was due to the event but it was in fact due to regression toward the
mean (Cherulnik, 2001). In an interrupted time series design, multiple measures enable the
detection of these effects of regression towards the mean, separately from the effect of the event
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(Cherulnik, 2001). Thus, there were no threats to this study design due to statistical regression
effects. Further, this study was a retrospective study using secondary data sources over multiple
years which contained all the non-CAH, non-federal, acute care hospitals in the U.S. and hence
there were no threats due to selective sample attrition in this study. However, this research design
was not able to control for the extraneous events that may be a threat to the internal validity of the
study (Cherulnik, 2001). It is possible that some other extraneous event may have occurred at the
same time as the implementation of the HITECH Act that could have impacted the outcome of
interest and thereby overestimated or underestimated the effect of the Act.
The study universe was all non-CAH, non-federal, acute care hospitals operating within
the 50 U.S. States and the District of Columbia. The study population consisted of all non-federal,
non-CAH acute care hospitals operating within the 50 U.S. States and the District of Columbia
and reporting to the HIMSS Analytics Database. The study sample was derived from the
Healthcare Information and Management Systems Society (HIMSS) Analytics Database and
consisted of all non-CAH, non-federal, acute care hospitals of the study population that merged
across all three secondary data sources used in this study, had no missing values for the
dependent and independent variables of interest and were observed for all five years of the study
duration. In order to ensure representativeness of the research sample, statistical tests were used
to compare the characteristics of the study sample with the study population. As described in
detail in Chapter 5, no significant differences were observed between the study sample and study
population. Hence, there were no threats due to non-representative research sample. The study
examined the effects of an enactment of a policy in the real-world, eliminating the threats to
external validity due to non-representative research context.
This study used panel data with lagged data for the independent variables. Panel data
consists of information on the same units followed over a given time period (Wooldridge, 2015).
The data for the dependent variable were examined from 2009 to 2013, while the data for the
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independent variables of organizational and environmental factors as well as the control variables
were examined from 2008 to 2012, representing a one-year lag. Panel data provides various
advantages over cross-sectional data or even pooled cross-sectional data (Wooldridge, 2015).
Panel data allows for assessing variations between units as well as within units over time
(Wooldridge, 2015). Availability of multiple measures on the same units over time allows
controlling for unobserved characteristics, thereby producing consistent estimates while
controlling for omitted variable bias (Wooldridge, 2015). Further, the lagging of the independent
variables addresses the issue of potential endogeneity of the variables.

Data Sources
The independent, dependent and control variables were derived from the following
secondary databases:
1. Healthcare Information and Management Systems (HIMSS) Analytics Database: The HIMSS
Analytics Database, formerly known as Dorenfest Data, contains data from over 5,300
hospitals in the U.S. Data were available from the Dorenfest Institute for H.I.T. Research and
Education, HIMSS Foundation at Chicago, Illinois (The Dorenfest Institute for H.I.T.
Research and Education, HIMSS Foundation, 2010). The data includes the Dorenfest 3000+
Databases™, the Dorenfest Integrated Healthcare Delivery System Databases™ and previous
editions of the HIMSS Analytics® Database (The Dorenfest Institute for H.I.T. Research and
Education, HIMSS Foundation, 2010). This dataset includes information on hospital
characteristics such as patient revenue, ownership control, hospital location, etc. as well as
software, hardware and infrastructure installed in the facilities and future software and
hardware purchase plans for the facilities (The Dorenfest Institute for H.I.T. Research and
Education, HIMSS Foundation, 2010). The HIMSS Analytics databases for the years 2008 to
2013, available from the Dorenfest Institute, were used in this study. Independent variables of
size, teaching status and system membership were identified from the database for the years
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2008 to 2012, while the dependent variable of adoption of MMTs were identified from the
database for the years 2009 to 2013.
2. Healthcare Cost Report Information System (HCRIS): The HCRIS is maintained by the CMS
and includes information on facility characteristics, utilization data, costs and charges,
Medicare settlement data and financial statement data (Centers for Medicare and Medicaid
Services, 2016c). The HCRIS dataset was merged with the HIMSS Analytics Database using
the Medicare Provider Number. Certain facility characteristics such as inpatient days,
operating margin and ownership control were obtained from this dataset for the years 2008 to
2012.
3. Area Health Resource File (AHRF): The AHRF contains county-level data and has current as
well as historic data for more than 6,000 variables for each county in the nation (Health
Resources and Services Administration, 2016). The AHRF provides information on “health
facilities, health professions, measures of resource scarcity, health status, economic activity,
health training programs and socioeconomic and environmental characteristics” (Health
Resources and Services Administration, 2016). For the purposes of this study, the market area
of the hospital was defined as the county within which the hospital is located (Garnick, Luft,
Robinson, & Tetreault, 1987). The county location of the hospital was used to merge the
HIMSS Analytics Database with the AHRF database in order to examine the environmental
factors in which the hospital is functioning. In this study, the county where the hospital is
located was used to calculate the measure of market competition as well as identify the
rurality of the geographical location of the hospital

Study Universe, Population and Sample
The unit of analysis for this study was the individual acute care hospital in the U.S. The
universe for this study included all the non-CAH, non-federal, acute care hospitals operating
within the 50 U.S. States and the District of Columbia. This universe excluded the hospitals with
specialized functions such as orthopedic, psychiatric or children’s hospitals. The universe also
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excluded federally-owned hospitals such as the Veteran’s Affairs Hospitals, Military Hospitals
and Public Health Indian Service Hospitals as the operation of these hospitals differs from nonfederal hospitals in terms of their financing and management structure, as well as their policies
and patient populations. This study universe also excludes CAHs as they are certified under a
different set of conditions than acute care hospitals (Scalise, 2004). Further, this population also
excluded the hospitals located in the U.S. territories (American Samoa, Guam, Northern Mariana
Islands, Puerto Rico and U.S. Virgin Islands).
The study population consisted of all the non-CAH, non-federal, acute care hospitals
operating within the 50 U.S. States and the District of Columbia that reported data to the HIMSS
Analytics Database. The HIMSS Analytics Database contains data on all non-federal hospitals in
the U.S. (Swanson, 2006). The study population consisted of 3,452 non-CAH, non-federal, acute
care hospitals in 2009, 3,435 in 2010, 3,409 in 2011, 3,407 in 2012 and 3,396 in 2013 obtained
from the HIMSS Analytics Database. This data from each year was merged with the HIMSS
Analytics database from the respective previous year using a unique identification number in the
HIMSS Analytics Database, which remained the same for each unique hospital over the years.
After this merging, 76 observations were dropped off from the dataset of year 2009, 32 from
2010, 27 from 2011, 38 from 2012 and 20 from 2013. This dataset was merged with the HCRIS
data of the previous year using the Medicare Provider Number. In the HCRIS data, only those
hospitals that reported data covering 270 fiscal days or more were retained. After this merging,
363 observations were dropped off from the dataset of year 2009, 342 from 2010, 332 from 2011,
285 from 2012 and 312 from 2013. This dataset was then merged with the AHRF data of the
previous year by matching the county of the hospital location obtained from the HCRIS data to
the county name variable in the AHRF data. This merging with the AHRF data did not drop any
observations. Further, hospitals with missing data for any of the study variables were excluded.
This led to observations on 48 hospitals being dropped from the dataset of the year 2009, 50 from
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2010, 43 from 2011, 43 from 2012 and 40 from 2013. Further, only those hospitals that were
observed for all years of the study period were retained in the final empirical sample. Thus, the
final empirical sample consisted of 13,690 observations from 2,738 unique hospitals. The dataset
was a balanced panel i.e., all the hospitals were observed for the entire study period of five years.
In order to ensure that the study sample was representative of the study population, differences in
the independent and dependent variable measures between the study population and sample were
examined.

Key Measures
This section provides the description and measures of the variables in this study, derived
from the constructs of resource dependence theory (RDT), as presented in the conceptual model.
For the purpose of this study, the market area of the hospital was defined as the county within
which the hospital was located. This definition for the hospital market has been used extensively
in previous research (Alexander & Morrisey, 1989; Apenteng et al., 2015; Rosko, Chilingerian,
Zinn, & Aaronson, 1995; Zinn et al., 1997; Zinn et al., 1998). Further, Garnick et al. noted that
for the purpose of measuring competition, the definition of the market as a county or as a 15-mile
radius area of the hospitals did not make a significant difference (Garnick et al., 1987). Table 1
provides a summary of constructs, variables and their measures and data sources.
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Table 1: Constructs, Variables and Measurements and Data Sources
Construct

Variable

Behavioral Construct

Dependent Variable

Organizational
Innovation

Adoption of MMTs

Causal Construct

Independent
Variables

Uncertainty

Policy Enactment

Measure

Description of Measure

Data Source

Global measure of adoption
MMTs (GLOBAL_ADOPT)

GLOBAL_ADOPT=total number of
MMTs adopted

2009-2013
HIMSS

Adoption of MU MMTs
(MU_MMT)

MU_MMT=1, if adopted CPOE, CDSS
and eMAR together; 0 otherwise

2009-2013
HIMSS

Adoption of CLMM
(CLOSEDLOOP)

CLOSEDLOOP=1, if adopted; 0
otherwise

2009-2013
HIMSS

Adoption of ordering
technology (ORDER)

0= low adoption; 1= medium adoption;
2=high adoption

2009-2013
HIMSS

Adoption of transcribing
technology (TRANSCRIBE)

0= low adoption; 1= medium adoption;
2=high adoption

2009-2013
HIMSS

Adoption of dispensing
technology (DISPENSE)

0= low adoption; 1= medium adoption;
2=high adoption

2009-2013
HIMSS

Adoption of administration
technology (ADMINISTER)

0= low adoption; 1= medium adoption;
2=high adoption

2009-2013
HIMSS

Implementation of the
HITECH Act
(PRE_HITECH and
POST_HITECH)

PRE_HITECH=1, if the time period of
data was 2009 or 2010; 0 otherwise
POST_HITECH=1, if the time period of
data was 2012 or 2013; 0 otherwise

CMS
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Munificence

Interdependence

Competition

Herfindahl-Hirschman Index
(HHI)

HHI= sum of squares of the total
inpatient days in the hospital annually/
total inpatient days in all hospitals in that
county
INCOME=Average household income in
the county

2008-2012
HCRIS and
2008-2012
AHRF
2008-2012
AHRF

Community Wealth

Household Income
(INCOME)

Size

Organizational Size (SIZE)

SIZE=Total number of Beds set up and
staffed

2008-2012
HIMSS

System Member

System Membership
(SYSTEM)

SYSTEM=1, if the hospital is a member
of a system; 0 otherwise

2008-2012
HIMSS

Financial Resources

Operating Margin
(OPERATING_MARGIN)

2008-2012
HCRIS

Private Payer Mix

Private Payer Mix
(PRIVATE_PAYER)

Ownership Control

For-profit ownership
(FOR_PROFIT)

OPERATING_MARGIN= (Operating
Revenue-Operating Expenses)/Operating
Revenue
PRIVATE_PAYER= Number of private
insurance inpatient days/Total number of
inpatient days
FOR_PROFIT=1, if for-profit hospital; 0
otherwise

Non-Profit ownership
(NON_PROFIT)

NON_PROFIT=1, if non-profit hospital;
0 otherwise

2008-2012
HCRIS

Geographical Location
(METRO_ADJ, RURAL)

METRO_ADJ=1, if hospital located in a
county with RUCC Codes 04, 06
(Metropolitan adjacent counties); 0
otherwise
RURAL=1, if hospital located in a
county with RUCC Codes 05, 07, 08, 09
(Rural counties); 0 otherwise

2008-2012
AHRF

2008-2012
HCRIS
2008-2012
HCRIS

Control Variables
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Member of Council of
Teaching Hospital of the
Association of American
Medical College (TEACH)

TEACH=1, if a member; 0 otherwise

2008-2012
HIMSSAnalytics
Database
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Dependent Variables
The behavioral construct of adoption of innovation was operationalized as the adoption of
MMTs. Adoption of MMTs was specifically measured as: (1) the global adoption of all MMTs,
(2) adoption of MU MMTs (CDSS, CPOE and eMAR), (3) adoption of CLMM and as the
adoption of technology for each of the steps of the medication management process viz., (4)
ordering technology, (5) transcribing technology, (6) dispensing technology and (7)
administration technology. Data on the adoption of 12 MMTs were available from the HIMSS
Analytics Database for the years 2009 to 2013. These 13 technologies are: Computerized
Physician Order Entry (CPOE), Clinical Decision System Software (CDSS), in-house
transcription software, bar-coding at dispensing, Radio Frequency Identification (RFID) at
dispensing, robot-filling for prescriptions, Automated Dispensing Machine (ADM), pharmacy
management system, bar-coding at medication administration, RFID at medication
administration, Electronic Medication Administration Record (eMAR), smart pumps and CLMM.
The descriptions and functions of each of these technologies were provided in detail in Chapter 2.
As described earlier in Chapter 2, these different technologies are used for automation of
the four steps of the medication management process (ordering, transcribing, dispensing and
administration). CPOE and CDSS are used at the ordering step; in-house transcription software
and eMAR are used at the transcribing step; bar-coding at dispensing, RFID at dispensing, robotfilling for prescriptions, ADMs and pharmacy management system are used at the dispensing
step; and bar-coding at medication administration, RFID at medication administration, eMAR and
smart pumps are used at the administration step. The definition of adoption is described in the
ensuing paragraph.

90
To measure the dependent variable of adoption of MMTs, the adoption status of each
technology needed to be defined. In the HIMSS dataset, the adoption status of five technologies
(CPOE, CDSS, in-house transcription software, pharmacy management system and eMAR) was
categorized as ‘Contracted/Not Yet Installed’, ‘Installation in Process’, ‘Live and Operational’,
‘Not Automated’, ‘Not Reported’, ‘Not Yet Contracted’, ‘Service Not Provided’ and ‘To be
Replaced’. This study defined adoption as the hospitals’ reporting their status as ‘Live and
Operational’. This conservative measure of adoption has been used in previous studies using the
HIMSS Analytics Database (Furukawa et al., 2008; Kazley & Ozcan, 2007). Data on the adoption
of the remaining seven technologies was categorized in the dataset as whether or not the facility
uses the technology. Hence, adoption of these technologies was defined as the response of ‘yes’
to the question of their use in that facility.
Further, data on the adoption of CLMM were also available in the dataset. The CLMM
system is an inter-connected environment that integrates each of the four steps of the medication
management process (Healthcare Information and Management Systems Society, 2010). This
system is not a separate technology used at a specific step of the medication management process
but it is a process in the hospital that integrates the different steps of medication management. In
the HIMSS Analytics Database, adoption of closed-loop medication administration at point of
CLMM was a dichotomous variable and was measured as through the responses of ‘yes’ or ‘no’
to depict whether or not it was adopted. Table 2 provides a summary of the categorization of the
technologies for the different steps of the medication management process and the measurement
of their adoption.
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Table 2: MMTs used in the Medication Management Process and their Adoption
Definitions
Step of
Medication
Management
Ordering

Transcribing

Dispensing

Administration

All steps

Technology

1. Computerized Physician Order
Entry (CPOE)
2. Clinical Decision Support System
(CDSS)
3. In-house Transcription software
4. Electronic Medication
Administration Record (eMAR)
5. Bar-coding at Dispensing
6. RFID at Dispensing
7. Robots
8. Automated Dispensing Machines
(ADMs)
9. Pharmacy Management System
10. Bar-coding at Administration
11. RFID at Administration
12. Electronic Medication
Administration Record (eMAR)
13. Smart Pumps
14. CLMM

Adoption
defined as
‘live and
operational’
x

Adoption
defined as ‘yes’
response to use
of technology

x
x
x
x
x
x
x
x
x
x
x
x
x

Measurement of Dependent Variables
After the adoption status of each technology was defined, the next step was to use this
adoption status to define the measurement of the dependent variable of adoption of MMTs. The
dependent variable was measured in seven ways:
1) Global adoption of MMTs (GLOBAL_ADOPT): a count of the total number of MMTs that
were adopted by the hospital.
2) Adoption of MU MMT (MU_MMT): dichotomous variable representing whether or not the
hospital adopted all three MU MMTs (CPOE, CDSS, eMAR).
3) Adoption of CLMM (CLOSEDLOOP): dichotomous variable representing whether the
hospital adopted closed-loop medication administration at point of care or not.
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4) Adoption of ordering technology (ORDER): a categorical variable representing the level of
adoption of ordering technologies defined as low adoption (adoption of no technology),
medium adoption (adoption of one technology) and high adoption (adoption of both
technologies).
5) Adoption of transcribing technology (TRANSCRIBE): a categorical variable representing the
level of adoption of transcribing technologies defined as low adoption (adoption of no
technology), medium adoption (adoption of one technology) and high adoption (adoption of
both technologies).
6) Adoption of dispensing technology (DISPENSE): a categorical variable representing the level
of adoption of dispensing technologies defined as low adoption (adoption of less than three
technologies), medium adoption (adoption of three technologies) and high adoption (adoption
of more than three technologies).
7) Adoption of administration technology (ADMINISTER): a categorical variable representing
the level of adoption of administration technologies defined as low adoption (adoption of less
than two technologies), medium adoption (adoption of two technologies) and high adoption
(adoption of more than two technologies).

Independent Variables
The causal constructs of the study were the key constructs of resource dependence theory
and were represented as uncertainty, munificence and interdependence. The operationalization
and measurement of these constructs are discussed below.
Operationalizing Uncertainty. Uncertainty refers to the instability in the environment
that impacts the availability of resources for the organizations (Pfeffer & Salancik, 1978). This
construct of uncertainty was operationalized as the implementation of the HITECH Act and the
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degree of market competition. A change in policy creates an uncertainty for the organization to
access resources (Nayar, 2008). The HITECH Act was enacted to encourage the adoption and use
of technology for improved outcomes. The Act established incentives that were implemented in
the year 2011, as well as and penalties for the hospitals. It thus represents an uncertainty in the
hospital environment with respect to availability of financial resources through the incentives and
penalty. Further, competition in the hospital market represents uncertainty for the hospital to
acquire the resources shared by the same pool of competing hospitals (Kazley & Ozcan, 2007;
Yeager et al., 2014). The measurements of these variables are described below.
1) Implementation of the HITECH Act (PRE_HITECH and POST_HITECH): The variable was
measured using dummy variables for the time period of data with respect to the year 2011, in
which the HITECH Act first went into effect. These dummy variables will be represented as
PRE_HITECH (1 if year was 2009 or 2010, 0 otherwise) and POST_HITECH (1 if year was
2012 or 2013, 0 otherwise), with period of 2011 being the reference group.
2) Competition (HHI): The Herfindahl-Hirschman Index (HHI) represents competition in the
hospital environment and was computed as the sum of squares of the total inpatient days in
the hospital annually divided by the total inpatient days in all hospitals in that county. HHI
ranges from a scale of 0 to 1, with 0 capturing perfect competition and 1 capturing perfect
monopoly. Hence, lower HHI implied higher competition. Data on inpatient days were
obtained from the HCRIS database for the years 2008 to 2012.
Operationalizing Munificence. Munificence refers to the abundance of resources
available to the organization (Pfeffer & Salancik, 1978). In accordance with the literature,
munificence was operationalized as community wealth, organizational size, system membership
and financial resources (Kazley & Ozcan, 2007; Yeager et al., 2014). The measurements of these
variables are described below.
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1) Community Wealth (INCOME): Community wealth was measured by the average household
income of the county in which the hospital is located in. Data on the household income in the
county were obtained from the AHRF database for the years 2008 to 2012.
2) Size (SIZE): Hospital size was measured by the number of beds set up and staffed. Data were
obtained from the HIMSS Analytics Database for the years 2008 to 2012.
3) System Membership (SYSTEM): System membership was measured by whether or not the
hospital is a participant of a multi-hospital system. Data for this variable were obtained from
the HIMSS Analytics Database for the years 2008 to 2012.
4) Financial Resources (OPERATING_MARGIN): Financial resources of the hospital were
measured by operating margin, which was computed by dividing the net operating income
(operating revenue-operating expenses) by the operating revenue. Data for this variable were
obtained from the HCRIS database for the years 2008 to 2012.
Operationalizing Interdependence. Interdependence is represented by the dependency
of the organization on external entities for acquiring resources. In consistence with previous
literature, interdependence was operationalized as the private payer mix (Yeager et al., 2014) and
the ownership control of the hospital (Apenteng et al., 2015; Nayar, 2008; Yeager et al., 2014).
The measurements of these variables are described below.
1) Private Payer Mix (PRIVATE_PAYER): Private payer mix was measured as the proportion
of the inpatient days covered by private insurance as compared to the total number of
inpatient days for the hospital. This variable was obtained from the HCRIS database for the
years 2008 to 2012.
2) Ownership Control (FOR_PROFIT, NON_PROFIT): For-profit ownership control of the
hospital was measured as a dummy variable which indicated whether the hospital was a forprofit hospital or otherwise. Non-profit ownership control of the hospital was measured as a
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dummy variable which indicated whether the hospital was a non-profit hospital or otherwise.
In this case, the reference group for ownership control was public ownership. This
information was obtained from the HCRIS database for the years 2008 to 2012.

Control Variables
Other organizational and environmental characteristics of the hospital that may have had
an impact on the adoption of MMTs were controlled for in this study. These factors were
represented by geographical location and the teaching status of the hospital. The measurements of
these variables are described below.
1) Geographical Location (METRO_ADJ and RURAL): Rural-Urban Continuum Codes
(RUCC) were used to identify the geographic location of the county in which the hospital was
located in. RUCC codes can be categorized as metropolitan (RUCC Codes 01, 02, 03),
metropolitan adjacent counties (RUCC Codes 04, 06) and rural counties (RUCC Codes 05,
07, 08, 09). This study adjusted for the rural/urban location of the hospital, which was
measured through a dummy variable for metropolitan adjacent counties (METRO_ADJ) and
a dummy variable for rural counties (RURAL), with the metropolitan counties being the
reference group. This information was obtained from the AHRF for the years 2008 to 2012.
2) Teaching Status (TEACH): Teaching status of the hospital was represented by the hospital’s
membership in Council of Teaching Hospital (COTH) of the Association of American
Medical Colleges (White, Cochran, & Patel, 2002). This variable was measured by a dummy
variable which indicated if the hospital was a member of COTH or otherwise. Data for this
variable were obtained from the HIMSS Analytics Database for the years 2008 to 2012.
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Data Analysis Approach
The empirical model for the study is specified as follows:
𝐴𝑑𝑜𝑝𝑡𝑖𝑜𝑛𝑖𝑡 = 𝛽0 + 𝛽1 𝑃𝑅𝐸_𝐻𝐼𝑇𝐸𝐶𝐻𝑡 + 𝛽2 𝑃𝑂𝑆𝑇_𝐻𝐼𝑇𝐸𝐶𝐻𝑡 + 𝛽3 𝐸𝑛𝑣𝑖𝑡 + 𝛽4 𝑂𝑟𝑔𝑖𝑡 +
𝛽5 𝛾𝑡 + +𝛼𝑖 + 𝜀𝑖𝑡 (Model 1)
In this model,
i represents the hospital and t represent time
𝐴𝑑𝑜𝑝𝑡𝑖𝑜𝑛𝑖𝑡 refers to the adoption status of technology in hospital i at time t
𝑃𝑅𝐸_𝐻𝐼𝑇𝐸𝐶𝐻𝑡 is a dummy variable for time before the implementation of the HITECH Act
(PRE_HITECH=1 for the years 2009 and 2010, 0 otherwise)
𝑃𝑂𝑆𝑇_𝐻𝐼𝑇𝐸𝐶𝐻𝑡 is a dummy variable for time after the implementation of the HITECH Act
(POST_HITECH=1 for the years 2012 and 2013, 0 otherwise)
𝐸𝑛𝑣𝑖𝑡 represents the vector of environmental variables for hospital i at time t
𝑂𝑟𝑔𝑖𝑡 represents the vector of organizational variables for hospital i at time t
𝛾𝑡 refers to the year dummies that account for the secular trends, irrespective of the change in
policy
𝛼𝑖 refers to the unobserved hospital-specific effects
𝜀𝑖𝑡 is the error term
Data analyses were conducted using SAS 9.4 and Stata 14 software (SAS Institute Inc.,
Cary, North Carolina; StataCorp LP., College Station, TX). Statistical significance was assessed
at a two-sided p-value of <0.05. A p-value of <0.10 was considered to be marginally significant.
Descriptive analyses and multivariate analyses were conducted as described below.
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Descriptive Analyses
Descriptive statistics such as frequencies and cross-tabulations for categorical variables
and means, standard deviations, minimum and maximum for continuous variables were used to
describe the characteristics of the hospitals in the study sample and the population. The variables
were also checked for missing data, outliers, skewness and kurtosis and were appropriately
transformed. T-tests were used to compare the characteristics of the study sample with the study
population. Pearson’s correlation coefficients were used to test the correlations between all the
independent variables in the study and to detect any issue of multicollinearity.

Multivariate Analyses
Since panel data consists of observations from the same set of units over multiple years,
there is correlation between these observations (Wooldridge, 2015). Thus, it is important to
account for the correlation structure when conducting any analysis. Analytical methods that can
handle correlated data include fixed effects, random effects and mixed effects/multi-level models.
A description of each of these methods is provided below:
1) Fixed effects model: A fixed effects model can control for the time-invariant variables in the
model and can assess the group and time effects (Wooldridge, 2015). Thus, fixed effects
models should when researcher is interested in analyzing the impact of variables that are
changing over time and should not be used when the key independent variables that specific
to the hospital are time-invariant. A fixed effects model is represented as:
𝑌𝑖𝑡 = 𝛽0 + 𝛽0 𝑋𝑖𝑡 + 𝛼𝑖 + 𝜀𝑖𝑡
Here,
𝑌𝑖𝑡 is the dependent variable
𝑋𝑖𝑡 is the independent variable
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𝛼𝑖 represents the un-observed hospital specific characteristics
𝜀𝑖𝑡 is the idiosyncratic error term
The un-observed hospital specific characteristics (𝛼𝑖 ) are the fixed effects
components that captures the unobserved heterogeneity across hospitals that are fixed over
time. When using fixed effects model, it is assumed that 𝛼𝑖 impacts the dependent and
independent variables, which is why they should be controlled (Wooldridge, 2015). A fixed
effects model allows for correlation between the hospital-specific error term 𝛼𝑖 and the
independent variables.
𝐶𝑜𝑣(𝑋𝑖𝑡 , 𝛼𝑖 ) ≠ 0
Hence, the time-invariant explanatory variables are swept away in a fixed effects
estimation. Another assumption is that the idiosyncratic error-term 𝜀𝑖𝑡 is uncorrelated with
the independent variables across all time periods (Wooldridge, 2015). There are three
approaches to fixed effects estimation: (a) within transformation, (b) least squares dummy
variable estimator and (c) between estimator (Wooldridge, 2015).
In the within transformation approach, time-demeaned data for the independent and
dependent variables are used, which eliminates the unobserved effect 𝛼𝑖 (Wooldridge, 2015).
In the least squares dummy variable estimation, dummy variable for each cross-sectional
observation is included in the model along with the independent variables (Wooldridge,
2015). Thus, for N repeated observations, N-1 dummy variables will be included in the
model. These dummy variables account for the un-observed time-invariant hospital-specific
characteristics that may impact the outcome of interest. If the panel data has large N and
small T, which is the case in this study, the number of explanatory variables would make it
challenging to carry out the regression (Wooldridge, 2015). In the between estimator, time
averages for the independent and the dependent variables are used and thereby limiting the
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analysis to a cross-sectional regression (Wooldridge, 2015). The between estimator thus uses
N observations, instead of the N*T observations that are used in the first two approaches.
This estimator thereby ignores the trend in variables over time.
Since the dataset used in this study has large N and small T, the least squares dummy
variable estimator was not suitable. Further, trends over time could not be ignored in this
study and hence, the between estimator was not appropriate. Thereby, the within
transformation approach was used to assess the fixed effects model in this study.
2) Random effects model: The random effects model is used when the un-observed effect 𝛼𝑖 is
uncorrelated with each explanatory variable in all time periods (Wooldridge, 2015).
𝐶𝑜𝑣(𝑋𝑖𝑡 , 𝛼𝑖 ) = 0
In such a case, inefficient estimators will be produced if transformation is used to
eliminate 𝛼𝑖 . All the assumptions of the fixed effects model apply to the random effects
model, with the exception that 𝛼𝑖 should be independent of all explanatory variables in all
time periods (Wooldridge, 2015). Since 𝛼𝑖 is uncorrelated with all explanatory variables, it is
possible that the coefficients could be estimated consistently with pooled ordinary least
square (OLS) regression with time dummies. However, the pooled OLS estimator ignores the
serial correlations in the error terms across time and hence produces incorrect standard errors
and test statistics (Wooldridge, 2015). The random effects estimator, on the other hand, uses
the generalized least squares (GLS) method to account for the serial correlation (Wooldridge,
2015). Wooldridge (2013) suggests when applying fixed effects and random effects models,
it may be also beneficial to compute the pooled OLS estimates for comparison (Wooldridge,
2015). This comparison can help examine the biases that are caused when 𝛼𝑖 is left entirely in
the error term (pooled OLS) or partially in the error term (random effects model).
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3) Specification Tests: The Hausman test is used to choose the appropriate model between the
random effects and fixed effects model (Wooldridge, 2015). The null hypothesis of the
Hausman test is that 𝛼𝑖 is uncorrelated with the explanatory variables (Wooldridge, 2015).
Thus, the random effects model was used if the null hypothesis was not rejected and the fixed
effects model was used if the null hypothesis was rejected (Wooldridge, 2015). If the
Hausman test rejected the fixed effects model and a random effects model is considered
appropriate, the Breusch-Pagan Lagrange multiplier test was used to evaluate whether the
random effects model or the pooled OLS model yielded consistent estimates and one of the
models were chosen based on the results of the test (Wooldridge, 2015). However, if the
Hausman test did not reject the null hypothesis and a fixed effects model was deemed
appropriate, a mixed effects model was considered. The rationale behind choosing a mixed
effects model over a fixed effects model is described below.
4) Mixed effects model: In the fixed-effects model, all the time-invariant variables would be
excluded from the model (Wooldridge, 2015). Some of the key independent variables in this
study were not expected to vary over time, such as ownership control, system membership,
etc. A mixed effects model allows a researcher to assess both fixed and random effects,
thereby allowing the inclusion of the time-invariant effects as well as the random effects
(Rabe-Hesketh & Skrondal, 2012). This model allows the researcher to account for
hierarchies or multi-levels in the dataset (Rabe-Hesketh & Skrondal, 2012). The hierarchical
data structure is true for this study, as both the organizational-level factors as well as countylevel factors were examined. Hence, between a fixed effects model and a mixed effects
model, the latter was appropriate for this study in order to be able to examine the timeinvariant variables and also account for the hierarchical data structure. Different mixed
effects models were examined such as models with hospital random intercept only, hospital

101
and county-level random intercepts, hospital and state-level random intercepts and hospital,
county and state-level random intercepts. The models with the lowest Akaike Information
Criterion (AIC) values were chosen for each measure of the dependent variable (Akaike,
1974).
There were seven measures of the adoption of MMTs in this study: GLOBAL_ADOPT,
CLOSEDLOOP, MU_MMT, ORDER, TRANSCRIBE, DISPENSE and ADMINISTER. Of
these, one outcome of interest (GLOBAL_ADOPT) was a count variable and hence a Poisson
regression model was appropriate. Two measures of adoption of MMTs (CLOSEDLOOP and
MU_MMT) were dichotomous variables and hence, logistic regression models were appropriate.
For Poisson and logistic regression models, specification of fixed effects, random effects and
mixed effects is possible. The remaining four outcomes of interest (ORDER, TRANSCRIBE,
DISPENSE and ADMINISTER) were categorical variables with three levels. Hence, multinomial
logistic regression models were appropriate. For the multinomial logistic regression models, fixed
effects specification alone was not possible as its use is limited in practice due to unfeasible
computations (Pforr, 2011). Further, the analytical dataset was multi-level in nature i.e., the
dataset consisted of hospitals nested within counties, which were further nested within states and
both organizational and count-level factors were used in the regression analyses. Hence given this
multi-level nature of the dataset, a mixed effects model for the multinomial logistic regression
was used.

Methodological Limitations
There were certain methodological limitations in this study that must be considered. The
absence of the control group in the study design is an important limitation of this study. With no
comparison group, it is not possible to control for other extraneous events that may be related to
the adoption of MMTs. Further, due to the absence of a control group, the policy effects could not
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be separated from the effects of secular trends. Also, this study may have missed on certain
explanatory variables such as hospital leadership characteristics that may influence the adoption
of MMTs due to unavailability of data.

Ethical Considerations
Since this study used secondary data sources at the organizational-level and did not
include human participants or patient-level data, a review by the Institutional Review Board was
not required.

Summary of the Chapter
This chapter described the research design, data sources, study population and the study
sample, as well as the key measures for the dependent, independent and control variables used in
this study. The use of a quasi-experimental interrupted time series design is a strength of this
study. Further, two data sources were merged to obtain the variables of the study. Analytical
strategies for panel data such as fixed effects, random effects and mixed effects models were
discussed and the rationale for using the final model was discussed. Further, the methodological
limitations as well as the ethical considerations were discussed. The ensuing Chapter 5 presents
the results of the study and the findings and implications of the study are discussed in Chapter 6.
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CHAPTER FIVE: RESULTS
This chapter presents the results of the empirical analyses of this study in two sections:
Descriptive Analyses Results and Multivariate Regression Analyses Results. The Descriptive
Analyses section includes the descriptive statistics of the organizational and environmental
characteristics of the study population and sample, trends in the outcomes of interest from the
pre-HITECH period to the post-HITECH period and a correlation analysis between the
independent variables used in the study. In the next part comprising of the multivariate regression
analyses, seven empirical models examining the organizational and environmental correlates of
the adoption of MMTs are presented. These models are:
1) Global Adoption of MMTs
2) Adoption of MU MMTs
3) Adoption of CLMM
4) Adoption of Ordering Technologies
5) Adoption of Transcribing Technologies
6) Adoption of Dispensing Technologies
7) Adoption of Administration Technologies
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Descriptive Analyses Results
The aim of this study was to examine the impact of the HITECH Act on the adoption of
MMTs by U.S. acute care hospitals and the organizational and environmental factors associated
with this adoption. The study population consisted of all non-CAH, non-federal, acute care
hospitals operating within the 50 U.S. States and the District of Columbia. The dependent variable
measures were obtained from 2009 to 2013 and the independent variables were measured from
2008 to 2012, representing a one-year lag for the independent variables. This study period was
chosen since the Stage 1 of the HITECH Act came into effect in 2011 i.e., the HITECH Act was
implemented in the year 2011. Hence, the study examined data from two years before and two
years after this implementation to examine the early impact of the Act on adoption etc.
The study population consisted of 3,452 non-CAH, non-federal, acute care hospitals in
2009, 3,435 in 2010, 3,409 in 2011, 3,407 in 2012 and 3,396 in 2013 obtained from the HIMSS
Analytics Database. This data from each year was merged with the HIMSS Analytics database from
the respective previous year using a unique identification number in the HIMSS Analytics
Database, which remains the same for each unique hospital over the years. After this merging, 76
observations were dropped off from the dataset of year 2009, 32 from 2010, 27 from 2011, 38 from
2012 and 20 from 2013. This dataset was merged with the HCRIS data of the previous year using
the Medicare Provider Number. In the HCRIS data, only those hospitals that reported data covering
270 fiscal days or more were retained. After this merging, 363 observations were dropped off from
the dataset of year 2009, 342 from 2010, 332 from 2011, 285 from 2012 and 312 from 2013. This
dataset was then merged with the AHRF data of the previous year by matching the county of the
hospital location obtained from the HCRIS data to the county name variable in the AHRF data.
This merging with the AHRF data did not drop any observation. Further, hospitals with missing
data for any of the study variables were excluded. This led to observations on 48 hospitals being
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dropped from the dataset of the year 2009, 50 from 2010, 43 from 2011, 43 from 2012 and 40 from
2013. Further, only those hospitals that were observed for all years of the study period were retained
in the final empirical sample. Thus, the final empirical sample consisted of 13,690 observations
from 2,738 unique hospitals. Table 3 summarizes the steps of the creation of the analytical study
sample and the number of hospitals in the population and the sample for all the years.
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Table 3: Creation of Study Sample
Sample Creation Step
Total Number of non-federal Hospitals in the
HIMSS Analytics Database
Total Number of Acute Care Hospitals
Hospitals Excluded:
Critical Access Hospitals
Hospitals in U.S. territories (American Samoa,
Guam, Northern Mariana Islands, Puerto Rico,
U.S. Virgin Islands)
Study Population of non-CAH, non-federal, acute
care hospitals
Merging with HIMSS Analytics data from the
previous year
Merging with HCRIS data from the previous year
Merging with AHRF data from previous year
Keeping only non-missing observations for all
study variables
Keeping only those hospitals that were observed
across all 5 years of the study

2009
5,237

2010
5,283

2011
5,339

2012
5,467

2013
5,467

Total
26,793

4,743

4,737

4,739

4,754

4,741

23,714

-1,291

-1,302

-1,330

-1,342

-1,340

-6,605
-10

0

0

0

-5

-5

3,452

3,435

3,409

3,407

3,396

17,099

3,376

3,403

3,382

3,369

3,376

16,906

3,013
3,013
2,965

3,061
3,061
3,011

3,050
3,050
3,007

3,084
3,084
3,041

3,064
3,064
3,024

15,272
15,272
15,048

2,738

2,738

2,738

2,738

2,738

13,690
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Comparison of Study Population and Sample
The results of the comparison between the study population and the study sample are
presented in Table 4. A pooled cross-sectional database of the dependent variable measures was
constructed from 2009 to 2013 and a pooled cross-sectional database of the independent variables
was constructed from 2008 to 2012 to compare the characteristics of the study population with
the study sample. The observations for all variables were then averaged across the observed years
for each unique hospital. For the dependent and the independent variables obtained from the
HIMSS Analytics database, comparisons were made between the study sample and all non-CAH,
non-federal, acute care hospitals in the study population in the HIMSS Analytics Database.
Similarly, for the independent variables obtained from the HCRIS database, comparisons were
made between the study sample and all the non-CAH, non-federal, acute care hospitals in the
study population in the HCRIS database. T-tests and chi-square tests were used to compare the
continuous and categorical variables respectively. The null hypothesis tested in this comparison
was that the sample means or proportions represented by the study sample were equal to the true
means or proportions of the study population. For all the dependent and independent variables,
there were no statistically significant differences between the study population and study sample
at p<0.05 level. Hence, the study sample was representative of the study population.
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Table 4: Comparison of Non-CAH, Non-federal, Acute Care Hospitals in Study Population
and Sample
Variables from HIMSS Analytics Database
Variable
Population
Sample
t-statistic
P(N=3,563)
(N=2,738)
value
Mean (SD)
Mean (SD)
Dependent Variables: 2009 to 2013
GLOBAL_ADOPT
6.423 (1.836)
6.487 (2.029)
1.650
0.099
MU_MMT
0.386 (0.361)
0.395 (0.489)
0.963
0.336
CLOSEDLOOP
0.366 (0.380)
0.382 (0.486)
1.723
0.085
ORDER
1.312 (0.522)
1.327 (0.640)
1.226
0.220
TRANSCRIBE
1.408 (0.568)
1.427 (0.663)
1.499
0.134
DISPENSE
0.813 (0.620)
0.827 (0.622)
1.177
0.239
ADMINISTER
0.811 (0.625)
0.834 (0.745)
1.615
0.106
Independent Variables: 2008 to 2012
SIZE
211.1 (169.3)
213.7 (177.8)
0.765
0.444
SYSTEM
0.628 (0.457)
0.613 (0.487)
-1.612
0.107
TEACH
0.073 (0.241)
0.081 (0.273)
1.533
0.125
Variables from HCRIS Database
Variable
Population
Sample
t-statistic
P(N=3,512)
(N=2,738)
value
Mean (SD)
Mean (SD)
Independent Variables: 2008 to 2012
HHI
0.553 (0.353)
0.559 (0.357)
0.879
0.379
INCOME
49380.8(12894.2)
49516.9 (13297.5)
0.536
0.592
OPERATING_MARGIN
-0.019 (0.219)
-0.014 (0.146)
-1.792
0.073
PRIVATE_PAYER
0.447 (0.148)
0.443 (0.136)
-1.539
0.124
FOR_PROFIT
0.209 (0.425)
0.200 (0.400)
-1.777
0.239
NON_PROFIT
0.615 (0.482)
0.628 (0.483)
1.411
0.158
METRO_ADJ
0.152 (0.359)
0.160 (0.367)
1.14
0.254
RURAL
0.105 (0.307)
0.107 (0.310)
0.338
0.736
Sample Descriptive Characteristics
The descriptive statistics of the study sample, including the means and standard
deviations or frequencies and proportions for the dependent and independent variables, are
presented in Table 5. The distributions of all the variables were examined for skewness and
kurtosis and log transformation was performed where appropriate. Two independent variableshospital size (SIZE) and median household income (INCOME) were log transformed since the
data distributions were skewed. The operating margin variable (OPERATING_MARGIN)
showed extreme outliers. Hence, this variable was winsorized at the 1 st and 99th percentile.
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Winsorization is a well-accepted method to control for extreme outliers in financial data without
completely removing the outlier from the analysis (Black, Jang, & Kim, 2006; Durnev & Kim,
2005). The winsorized operating margin variable was then used in further analyses. Means and
standard deviations were examined for the continuous variables and frequencies and proportions
were examined for the categorical variables for the pooled study sample (2009 to 2013 for the
dependent variable and 2008 to 2012 for the independent variables).
As previously defined in Chapter 4, the variable of adoption of MMTs was measured
through seven outcome measures:
1) Global adoption of MMTs (GLOBAL_ADOPT): a count of the total number of MMTs that
were adopted by the hospital.
2) Adoption of MU MMT (MU_MMT): dichotomous variable representing whether or not the
hospital adopted all three MU MMTs (CPOE, CDSS, eMAR).
3) Adoption of CLMM (CLOSEDLOOP): dichotomous variable representing whether the
hospital adopted closed-loop medication administration at point of care or not.
4) Adoption of ordering technology (ORDER): a categorical variable representing the level of
adoption of ordering technologies defined as low adoption (adoption of no technology),
medium adoption (adoption of one technology) and high adoption (adoption of both
technologies).
5) Adoption of transcribing technology (TRANSCRIBE): a categorical variable representing the
level of adoption of transcribing technologies defined as low adoption (adoption of no
technology), medium adoption (adoption of one technology) and high adoption (adoption of
both technologies).
6) Adoption of dispensing technology (DISPENSE): a categorical variable representing the level
of adoption of dispensing technologies defined as low adoption (adoption of less than three
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technologies), medium adoption (adoption of three technologies) and high adoption (adoption
of more than three technologies).
7) Adoption of administration technology (ADMINISTER): a categorical variable representing
the level of adoption of administration technologies defined as low adoption (adoption of less
than two technologies), medium adoption (adoption of two technologies) and high adoption
(adoption of more than two technologies).
In the pooled five-year sample of hospitals, the mean number of MMTs adopted were
6.5. Further, 39.5% of the hospitals adopted all three MU MMTs and 38.2% of the hospitals
adopted CLMM. For ordering technologies, 9.4% of the hospitals had low adoption, 48.4% had
medium adoption and 42.2% had high adoption levels. For transcribing technologies, 9.7% of the
hospitals had low adoption, 37.9% had medium adoption and 52.4% had high adoption levels. For
dispensing technologies, 31.2% of the hospitals had low adoption, 58.3% had medium adoption
and 12.2.6% had high adoption levels. For administration technologies, 37.5% of the hospitals
had low adoption, 41.67% had medium adoption and 20.9% had high adoption levels. The mean
value of HHI was 0.6. The mean value of INCOME was 49,516.8 and the mean value of log
(INCOME) was 10.77. Further, 16.0% of the hospitals were located in metropolitan adjacent
areas, 10.7% were located in rural areas and the remaining in metropolitan areas. The mean value
of SIZE was 213.7 and the mean value of log (SIZE) was 5.0. The mean value of the operating
margin was -0.01, while the average private payer mix was 44.3%. System members accounted
for 61.3% and teaching hospitals accounted for 8.1% of the hospitals. Only 20.0% of the hospitals
were for-profit, while 62.8% of the hospitals were non-profit hospitals and the remainder were
public hospitals.
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Table 5: Descriptive Statistics for Study Variables for all Years (n=13,690)
Variable
Definition
Frequency (%)
Dependent Variables: 2009 to 2013
GLOBAL_ADOPT
Total number of MMTs adopted
MU_MMT
1=adopt all three MU MMTs;
0=8,285 (60.52)
0=otherwise
1=5,405 (39.48)
CLOSEDLOOP
1= adopted CLMM; 0 = otherwise
0=8,460 (61.80)
1=5,230 (38.20)

Mean (SD)

Min

Max

6.487 (2.029)
-

0.000
-

12.000
-

-

-

-

0=1,292 (9.44)
1=6,623 (48.38)
2=5,775 (42.18)
0= low adoption; 1= medium
0=1,330 (9.72)
adoption; 2=high adoption
1=5,182 (37.85)
2=7,178 (52.43)
0= low adoption; 1= medium
0=4,042 (31.23)
adoption; 2=high adoption
1=7,976 (58.26)
2=1,672 (12.21)
0= low adoption; 1= medium
0=5,129 (37.47)
adoption; 2=high adoption
1=5,705 (41.67)
2=2,856 (20.86)
Independent Variables: 2008 to 2012

-

-

-

-

-

-

-

-

-

-

-

-

Environmental Factors
PRE_HITECH

1=Year 2009 or 2010; 0=Otherwise

-

-

-

POST_HITECH

1=Year 2012 or 2013; 0=Otherwise

0=8,214 (60.00)
1=5,476 (40.00)
0=8,214 (60.00)
1=5,476 (40.00)

-

-

-

HHI

Sum of Squared Market Shares of
Inpatient Days
Median Household Income of the
County
Ln(Median Household Income of the
County)
1=Metropolitan Adjacent County;
0=Otherwise

-

0.559 (0.357)

0.020

1.000

-

49516.860
(13297.520)
10.777 (0.252)

20486.000

119525.000

9.927

11.691

-

-

-

ORDER

TRANSCRIBE

DISPENSE

ADMINISTER

INCOME
LOG_INCOME
METRO_ADJ

0= low adoption; 1= medium
adoption; 2=high adoption

0=11,498 (83.99)
1=2,192 (16.01)

112
RURAL
Organizational Factors
SIZE
LOG_SIZE
SYSTEM

1=Rural County; 0=Otherwise

Total Number of Beds Set Up and
Staffed
log (Total Number of Beds Set Up
and Staffed)
1=System Member; 0=Otherwise

0=12,220 (89.26)
1=1,470 (10.74)

-

-

-

-

213.729
(177.778)
5.0337 (0.849)

4.000

1558.000

1.386

7.351

0=5,298 (38.70)
1=8,392 (61.30)
-

-

-

-

-0.014 (0.146)

-0.748

0.307

-

0.443 (0.136)

0.002

0.991

0=10,947 (79.96)
1=2,743 (20.04)

-

-

-

OPERATING_MARGIN

(Operating Revenue-Operating
Expenses)/Operating Revenue

PRIVATE_PAYER
FOR_PROFIT

Private Insurance Inpatient
Days/Total Inpatient Days
1=For-Profit; 0=Otherwise

NON_PROFIT

1=Non-Profit; 0=Otherwise

0=5,097(37.23)
1=8,593 (62.77)

-

-

-

TEACH

1=Teaching Hospital; 0=Otherwise

0=12,583 (91.91)
1=1,107 (8.09)

-

-

-
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Changes in the Dependent Variable Measures from the Pre-HITECH period to the PostHITECH Period
The changes in the means and proportions for the dependent variable between the periods
before the implementation of the HITECH Act (PRE_HITECH), during the HITECH Act
implementation year and after the implementation of the HITECH Act (POST_HITECH) was
examined. The PRE_HITECH value was obtained by averaging the observations for the year
2009 and 2010. The HITECH value was obtained from the observations of the year 2011. The
POST_HITECH value was obtained by averaging the observations for the year 2012 and 2011.
The percentage change was computed as [(POST_HITECH value-PRE_HITECH
value)/(PRE_HITECH value)]*100. Between the pre-HITECH period and the post-HITECH
period, the mean number of MMTs adopted increased significantly from 5.91 to 7.08 (p<0.001).
The proportion of hospitals that adopted all three MU MMTs increased from 21.2% to 36.4%
(p<0.001) and the proportion of hospitals that adopted CLMM increased from 22.7% to 34.1%
(p<0.001). Also, the mean adoption level of ordering technologies increased from 1.09 to 1.25
(p<0.001), the mean adoption level of transcribing technologies increased from 1.32 to 1.40
(p<0.001), the mean adoption level of dispensing technologies increased from 0.73 to 0.89
(p<0.001) and the mean adoption level of administration technologies increased from 0.86 to 1.17
(p<0.001). A summary of the changes in the dependent variable measures between the preHITECH period and the post-HITECH period is presented in Table 6. Further, a graphical
representation is presented in Figure 4. The graphical representation shows a steeper increase in
all the measures of the dependent variable between the HITECH period and the post-HITECH
period as compared to the increase from the pre-HITECH period to the HITECH period.
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Table 6: Changes in the Dependent Variable Measures from the pre-HITECH period to the
post-HITECH period
Dependent Variable
PRE_
HITECH
POST_
%Change
P-value
Measures
HITECH
period
HITECH
[(B-A)/A]
period (A)
period (B)
*100
GLOBAL_ADOPT
5.9129
6.4408
7.0849
19.8211
0.000***
MU_MMT
0.2160
0.3762
0.5829
169.8611
0.000***
CLOSEDLOOP
0.2274
0.3532
0.5511
142.3483
0.000***
ORDER
1.1041
1.3104
1.5594
41.2372
0.000***
TRANSCRIBE
1.3382
1.4229
1.5183
13.4584
0.000***
DISPENSE
0.7482
0.8119
0.9131
22.0396
0.000***
ADMINISTER
0.6563
0.8126
1.0222
55.7519
0.000***
*p<0.05; **p<0.01; ***p<0.001

7.50

GLOBAL_ADOPT
7.08

7.00
6.50
6.00

6.44
5.91

5.50

0.70

MU_MMT
0.58

0.50

POST_HITECH

CLOSEDLOOP
0.55

0.50
0.40

0.40

0.38

0.30

1.60

0.22

0.20
HITECH

ORDER

POST_HITECH

1.31

1.30
1.20
1.10

1.00
PRE_HITECH

0.95

HITECH

0.85
0.81

0.80
0.75

0.70
PRE_HITECH

HITECH

POST_HITECH

POST_HITECH

TRANSCRIBE
1.52

1.45
1.42

1.40
1.35

1.34

1.30
PRE_HITECH

1.05
0.91

HITECH

1.50

POST_HITECH

DISPENSE

0.90

0.75

1.55

Mean Number of
Technologies Adopted

1.40

0.23
PRE_HITECH

1.56

1.50

1.10

0.35

0.30

PRE_HITECH

Mean Number of
Technologies Adopted

0.60

0.60

0.20

Mean Number of
Technologies Adopted

HITECH

Mean Number of
Technologies Adopted

Proportion of Hospitals
that Adopted

PRE_HITECH

Proportion of Hospitals
that Adopted

Mean Number of
Technologies Adopted
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HITECH

POST_HITECH

ADMINISTER
1.02

0.95
0.85
0.81
0.75
0.65

0.66
PRE_HITECH

HITECH

POST_HITECH

Figure 4: Changes in Dependent Variable Measures from Pre-HITECH period to PostHITECH period.
PRE_HITECH: Average value of the observations for the year 2009 and 2010
HITECH: Value of the observations for the year 2011
POST_HITECH: Average value of the observations for the year 2012 and 2013
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Correlation Analysis
In addition to the above descriptive analysis, a correlation analysis of the pooled five-year
data was conducted to detect any multicollinearity between the independent variables and to
evaluate which independent variables could be used in the multivariate models. Table 7
summarizes the results of the correlation analysis. The standard cut-off point (r = 0.70) was used.
The correlation co-efficient of all paired variables was lower than 0.70, indicating the lack of
multicollinearity in the data. Thus, all the independent variables were included in the multivariate
regression models.
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Table 7: Correlation Analysis for Pooled Analytic Sample (n=13,690)
1
2
3
4
5
6
7
1. PRE_HITECH
1.000
2. POST_HITECH -0.667 1.000
3. HHI
-0.003 0.003 1.000
4. LOG_INCOME
0.020 0.007 -0.401 1.000
5. METRO_ADJ
0.001 0.000 0.429 -0.335 1.000
6. RURAL
0.000 0.000 0.361 -0.315 -0.151 1.000
7. LOG_SIZE
0.003 -0.003 -0.495 0.244 -0.351 -0.286 1.000
8. SYSTEM
-0.026 0.026 -0.250 0.112 -0.148 -0.157 0.185
9. OPERATING_
MARGIN
0.016 -0.033 0.017 0.061 -0.053 -0.044 0.071
10. PRIVATE_
PAYER
-0.067 0.081 -0.384 0.380 -0.272 -0.273 0.335
11. FOR_PROFIT
-0.017 0.017 -0.037 -0.100 0.009 -0.013 -0.109
12. NON_PROFIT
0.010 -0.008 -0.105 0.207 -0.094 -0.090 0.196
13. TEACH
0.041 -0.030 -0.248 0.106 -0.128 -0.099 0.374

8

9

10

11

12

13

1.000
-0.650
-0.121

1.000
0.044

1.000

1.000
0.243

1.000

0.202 0.104 1.000
0.285 0.204 -0.062
0.026 0.056 0.145
0.032 -0.103 0.202
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Multivariate Regression Analyses Results
Multivariate regression analyses were conducted using Stata/SE 14.2 and SAS 9.4
software (SAS Institute Inc., Cary, North Carolina; StataCorp LP., College Station, TX). The
sample size was 13,690 hospital years, representing 2,738 unique hospitals over five years. The
dataset was balanced panel i.e., all the hospitals were observed for the entire study period of five
years. The panel data were then analyzed using panel data analytical models such as fixed effects,
random effects and multi-level or mixed effects models. One outcome of interest
(GLOBAL_ADOPT) was a count variable and hence a Poisson regression model was
appropriate. Two measures of adoption of MMTs (CLOSEDLOOP and MU_MMT) were
dichotomous variables and hence, logistic regression models were appropriate. For Poisson and
logistic regression models, specification of fixed effects, random effects and mixed effects is
possible. The remaining four outcomes of interest (ORDER, TRANSCRIBE, DISPENSE and
ADMINISTER) were categorical variables with three levels. Hence, multinomial logistic
regression models were appropriate. For the multinomial logistic regression models, fixed effects
specification alone was not possible as its use is limited in practice due to unfeasible
computations (Pforr, 2011). Further, the analytical dataset was multi-level in nature i.e., the
dataset consisted of hospitals nested within counties, which were further nested within states and
both organizational and count-level factors were used in the regression analyses. Hence given this
multi-level nature of the dataset, a mixed effects model for the multinomial logistic regression
was used.

Specification Tests of Consistency
Since for GLOBAL_ADOPT, CLOSEDLOOP and MU_MMT, fixed effects as well as
random effects specification was possible; the Hausman specification test was used to decide
between the fixed effects model and the random effects model. In all three cases, the Hausman
specification test rejected the null hypothesis of no systematic differences between the fixed
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effects and random effects co-efficient estimates (Table 8). Therefore, the Hausman Specification
Test favored the fixed effects model. However, the fixed effects model drops all the timeinvariant variables from the model. Since, some of the key independent variables in this study
(for e.g. system membership, ownership status, etc.) were not expected to vary over time for a
specific hospital, a fixed-effects model may not be appropriate to test the hypotheses for this
study. Hence, multi-level or mixed-effects regression models would be more appropriate for these
three outcomes of interest. This mixed effects approach allows modeling both the fixed effects as
well as the random effects. Further, it is also appropriate for the multi-level nature of this dataset
(i.e., facility and county-level factors). Also, a mixed-effects model was chosen for the remaining
four outcomes of interest (ORDER, TRANSCRIBE, DISPENSE and ADMINISTER). Thus, a
mixed-effects model was appropriate for all the seven dependent variables.
Different mixed effects models were examined such as models with hospital random
intercept only, hospital and county-level random intercepts, hospital and state-level random
intercepts and hospital, county and state-level random intercepts. The models with the lowest
Akaike Information Criterion (AIC) values were chosen for each measure of the dependent
variable and are presented in this section. Statistical significance was assessed at p<0.05 and
p<0.10 was considered as marginally significant.
Table 8: Hausman Specification Test
Dependent Variable
𝝌𝟐
GLOBAL_ADOPT
106.21
MU_MMT
88.58
CLOSEDLOOP
91.17

P-value
<0.001
<0.001
<0.001

Model 1: Global Adoption of MMTs
Model 1 examined the impact of the HITECH Act on the adoption of the number of
MMTs by U.S. acute care hospitals and the organizational and environmental correlates of this
adoption using a Poisson regression model. For this variable, the model with the best AIC was the
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mixed-effects model with random hospital, county and state-level intercepts. The key policy
variables of PRE_HITECH and POST_HITECH were statistically significant (p<0.001). In line
with what was predicted, hospitals adopted 11% more MMTs in the post-HITECH period
(p<0.001) and 8% less MMTs in the pre-HITECH period (p<0.001) as compared to the HITECH
period. Contrary to expectation, hospitals with one unit higher HHI (i.e., lower competition) had
adopted 1.04 more number of MMTs (p<0.05). Contrary to expectation, community wealth was
not statistically significant in this model. As expected, larger hospitals adopted a higher number
of MMTs (p<0.001). Contrary to what was expected, system membership was not statistically
significant. As expected, hospitals with one unit higher operating margin adopted 1.13 more
number of MMTs (p<0.001) and hospitals with one unit higher private payer mix adopted 1.35
more number of MMTs. Contrary to what was expected, for-profit hospitals adopted 11% lower
MMTs as compared to public hospitals (p<0.001). The results from this model are presented in
Table 9.
Table 9: Parameter Estimates: Global Adoption of MMTs
Correlate
Exp(β)
95% CI for Exp(β)
P-value
Lower
Upper
Limit
Limit
Environmental Factors
PRE_HITECH vs. HITECH
0.918
0.901
0.935
0.000***
POST_HITECH vs. HITECH
1.096
1.077
1.116
0.000***
HHI
1.044
1.003
1.087
0.035*
LOG_INCOME
1.043
0.991
1.098
0.104
METRO_ADJ vs. METROPOLITAN
1.024
0.992
1.058
0.139
RURAL vs. METROPOLITAN
1.004
0.967
1.042
0.848
Organizational Factors
LOG_SIZE
1.108
1.093
1.122
0.000***
SYSTEM
0.992
0.972
1.012
0.431
OPERATING_MARGIN
1.128
1.061
1.200
0.000***
PRIVATE_PAYER_MIX
1.353
1.245
1.470
0.000***
FOR_PROFIT vs. PUBLIC
0.888
0.859
0.917
0.000***
NON_PROFIT vs. PUBLIC
1.004
0.978
1.031
0.775
TEACH
1.027
0.994
1.061
0.111
Sample Size=13,690; Level 2 units=2,738; Level 3 units=1,447; Level 4 units=51
Exp(β): Exponentiated co-efficient; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001
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Model 2: Adoption of MU MMTs
Model 2 examined the impact of the HITECH Act on adoption of all three MU MMTs
(CPOE, CDSS and eMAR) by U.S. acute care hospitals and the organizational and environmental
correlates of this adoption using a logistic regression model. For this variable, the mixed effects
model with random hospital, county and state-level intercepts had the lowest AIC. The key policy
variables of PRE_HITECH and POST_HITECH were statistically significant (p<0.001). In line
with what was predicted, hospitals were 6.94 times more likely to adopt all three MU MMTs in
the post-HITECH period (OR: 6.939; p<0.001) and 0.16 times less likely to adopt all three MU
MMTs in the pre-HITECH period (OR:0.158; p<0.001) as compared to the HITECH Act
implementation period. Contrary to expectations, HHI (competition) was not statistically
significant in this model. As expected, hospitals in counties with higher community wealth were
more likely to adopt all three MU MMTs (OR: 2.680; p<0.01). As expected, larger hospitals were
more likely to adopt all three MU MMTs (OR: 1.553; p<0.001). Contrary to what was predicted,
operating margin was not statistically significant in this model. As expected, hospitals with one
unit higher private payer mix were almost 42 times more likely to adopt all three MU MMTs
(OR:42.094; p<0.001). Contrary to expectation, for-profit hospitals were less likely to adopt all
three MU MMTs as compared to public hospitals (OR: 0.128; p<0.001). Among the control
variables, teaching hospitals were almost three times more likely to adopt all three MU MMTs
(OR: 3.002; p<0.001). The results from this model are presented in Table 10.

122

Table 10: Parameter Estimates: Adoption of Meaningful Use MMTs
Correlate
OR
95% CI for OR
Lower
Upper
Limit
Limit
Environmental Factors
PRE_HITECH vs. HITECH
0.158
0.133
0.187
POST_HITECH vs. HITECH
6.939
5.898
8.165
HHI
1.262
0.711
2.240
LOG_INCOME
2.680
1.303
5.510
METRO_ADJ vs. METROPOLITAN
1.139
0.710
1.828
RURAL vs. METROPOLITAN
1.387
0.798
2.411
Organizational Factors
LOG_SIZE
1.553
1.283
1.879
SYSTEM
0.806
0.616
1.053
OPERATING_MARGIN
0.562
0.272
1.161
PRIVATE_PAYER_MIX
42.094
14.728
120.307
FOR_PROFIT vs. PUBLIC
0.128
0.081
0.202
NON_PROFIT vs. PUBLIC
1.002
0.692
1.450
TEACH
3.002
1.949
4.622
Sample Size=13,690; Level 2 units=2,738; Level 3 units=1,447; Level 4 units=51
OR: Odds Ratio; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001

P-value

0.000***
0.000***
0.427
0.007**
0.588
0.246
0.000***
0.114
0.120
0.000***
0.000***
0.992
0.000***

Model 3: Adoption of CLMM
Model 3 examined the impact of the HITECH Act on the adoption of CLMM by U.S.
acute care hospitals and the organizational and environmental correlates of this adoption using a
logistic regression model. For this variable, the mixed effects model with random hospital, county
and state-level intercepts had the lowest AIC. The key policy variables of PRE_HITECH and
POST_HITECH were statistically significant (p<0.001). In line with what was predicted,
hospitals were 12.71 times more likely to adopt CLMM in the post-HITECH period (OR: 12.714;
p<0.001) and 0.16 times less likely to adopt CLMM in the pre-HITECH period (OR: 0.157;
p<0.001) as compared to the HITECH Act implementation period. Contrary to expectations, HHI
(competition) and community wealth were not statistically significant in this model. As expected,
larger hospitals were more likely to adopt CLMM (OR: 1.924; p<0.001). Contrary to what was
predicted, system members were 0.55 times less likely to adopt CLMM (OR: 0.553; p<0.05) as
compared to non-system members. Hospitals with one unit higher operating margin were almost
five times more likely to adopt CLMM (OR: 5.071; p<0.01) and hospitals with one unit higher

123

private payer mix were almost 20 times more likely to adopt CLMM (OR:20.003; p<0.001).
Contrary to what was expected, for-profit hospital ownership was not statistically significant in
this model. The results from this model are presented in Table 11.
Table 11: Parameter Estimates: Adoption of CLMM
Correlate
OR

95% CI for OR
Lower
Upper
Limit
Limit

Environmental Factors
PRE_HITECH vs. HITECH
0.157
0.129
0.191
POST_HITECH vs. HITECH
12.714
10.339
15.634
HHI
0.764
0.318
1.837
LOG_INCOME
1.583
0.567
4.424
METRO_ADJ vs. METROPOLITAN
1.564
0.768
3.183
RURAL vs. METROPOLITAN
1.080
0.467
2.496
Organizational Factors
LOG_SIZE
1.924
1.452
2.550
SYSTEM
0.553
0.381
0.804
OPERATING_MARGIN
5.071
1.959
13.122
PRIVATE_PAYER_MIX
20.003
4.761
84.051
FOR_PROFIT vs. PUBLIC
0.700
0.368
1.330
NON_PROFIT vs. PUBLIC
1.156
0.675
1.979
TEACH
0.658
0.339
1.277
Sample Size=13,690; Level 2 units=2,738; Level 3 units=1,447; Level 4 units=51
OR: Odds Ratio; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001

P-value

0.000***
0.000***
0.548
0.381
0.218
0.857
0.000***
0.002**
0.001**
0.000***
0.276
0.598
0.216

Model 4: Adoption of Ordering Technologies
Model 4 examined the impact of the HITECH Act on the adoption levels of ordering
technologies by U.S. acute care hospitals and the organizational and environmental correlates of
this adoption using a multinomial logistic regression model. For this variable, the model with the
best AIC was the mixed-effects model with random hospital-level intercepts. The key policy
variables of PRE_HITECH and POST_HITECH were statistically significant (p<0.001). In line
with what was predicted, hospitals had 5.91 times higher odds to be medium adopters and 13.91
times higher odds to be high adopters in post-HITECH period (p<0.001) as compared to the
HITECH period and 0.25 times lower odds of medium adoption level and 0.12 times lower odds
of high adoption level in the pre-HITECH period (p<0.001) as compared to the HITECH period.
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Contrary to expectations, hospitals with one unit higher HHI (i.e., lower competition) were
significantly more likely to be medium-level adopters and high-level adopters (p<0.01). As
expected, higher community wealth was significantly associated with increased likelihood of
having medium adoption (p<0.05) and high adoption (p<0.01).
As predicted, larger hospital size was positively associated with the likelihood of medium
adoption and high adoption (p<0.001) and system members were 1.60 times more likely to be
medium adopters (p<0.05) as compared to non-system members, though system membership was
not significantly associated with odds of high adoption. Contrary to expectation, higher operating
margin was only marginally significantly associate (p<0.10) with medium-level and high-level
adoption. Hospitals with one unit higher private payer mix had significantly higher odds of being
medium-level adopters (p<0.01) as well as high-level adopters (p<0.001). Contrary to what was
expected, for-profit hospitals was only marginally associated with the likelihood of high adoption
and not significantly associated with the likelihood of medium adoption. Among the control
variables, teaching hospitals were 3.22 times more likely to be high adopters (OR: 3.221;
p<0.001). The results from the model are presented in Table 12.
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Table 12: Parameter Estimates: Adoption of Ordering Technologies
Correlate
ORDER
OR
95% CI for OR
Lower
Upper
Limit
Limit
Ref=Low
Environmental Factors
PRE_HITECH vs. HITECH
Medium
0.250
0.185
0.340
High
0.117
0.086
0.159
POST_HITECH vs. HITECH
Medium
5.907
4.025
8.669
High
13.908
9.471
20.425
HHI
Medium
3.540
1.604
7.811
High
3.541
1.596
7.855
LOG_INCOME
Medium
3.349
1.236
9.072
High
4.474
1.643
12.188
METRO_ADJ vs.
Medium
1.571
0.751
3.289
METROPOLITAN
High
1.570
0.746
3.305
RURAL vs.
Medium
1.074
0.455
2.536
METROPOLITAN
High
1.127
0.474
2.678
Organizational Factors
LOG_SIZE
Medium
4.811
3.421
6.765
High
5.440
3.862
7.663
SYSTEM
Medium
1.595
1.012
2.515
High
1.370
0.867
2.166
OPERATING_MARGIN
Medium
3.097
0.929
10.322
High
3.050
0.906
10.267
PRIVATE_PAYER
Medium
11.663
2.262
60.123
High
49.962
9.586
260.391
FOR_PROFIT vs. PUBLIC
Medium
1.657
0.797
3.448
High
0.510
0.243
1.069
NON_PROFIT vs. PUBLIC
Medium
1.224
0.677
2.212
High
1.320
0.728
2.393
TEACH
Medium
1.462
0.639
3.343
High
3.221
1.408
7.365
Sample Size=13,690; Level 2 units=2,738
OR: Odds Ratio; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001

P-value

0.000***
0.000***
0.000***
0.000***
0.002**
0.002**
0.017*
0.003**
0.230
0.235
0.871
0.787
0.000***
0.000***
0.044*
0.177
0.066Ψ
0.072Ψ
0.003**
0.000***
0.176
0.074Ψ
0.504
0.361
0.369
0.006**

Model 5: Adoption of Transcribing Technologies
Model 5 examined the impact of the HITECH Act on the adoption levels of transcribing
technologies by U.S. acute care hospitals and the organizational and environmental correlates of
this adoption using a multinomial logistic regression model. For this variable, the model with the
best AIC was the mixed-effects model with random hospital-level intercepts. The key policy
variables of PRE_HITECH and POST_HITECH were statistically significant (p<0.001). In line
with what was predicted, hospitals had 1.51 times higher odds to be medium adopters and twice
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the odds to be high adopters in post-HITECH period (p<0.001) as compared to the HITECH
period and 0.71 times lower odds of high adoption level in the pre-HITECH period (p<0.01) as
compared to the HITECH period. Contrary to expectations, hospitals with one unit higher HHI
(i.e., lower competition) were significantly more likely to be medium-level adopters and highlevel adopters (p<0.001). Contrary to what was predicted, higher community wealth was not
statistically significantly associated with the likelihood of medium and high adoption.
As predicted, larger hospital size was positively associated with the likelihood of medium
adoption and high adoption (p<0.001). Contrary to expectation, system membership was not
statistically significant in this model. As expected, hospitals with one unit higher operating
margin were almost three times more likely to be high adopters ( OR: 3.274; p<0.05), although
operating margin was not significantly associated with the likelihood of medium adoption. As
expected, hospitals with one unit higher private payer mix had significantly higher odds of being
medium-level and high-level adopters (p<0.001). Contrary to what was expected, for-profit
hospitals were 0.29 times less likely to be medium adopters (OR: 0.290; p<0.001) and 0.18 times
less likely to be high adopters (OR: 1.178; p<0.001) as compared to public hospitals. Among the
control variables, hospitals located in rural areas had significantly higher odds of medium and
high adoption (p<0.01) as compared to the hospitals located in metropolitan areas. The results
from the model are presented in Table 13.
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Table 13: Parameter Estimates: Adoption of Transcribing Technologies
Correlate
TRANSCRIBE
OR
95% CI for OR
Lower
Upper
Limit
Limit
Ref=Low
Environmental Factors
PRE_HITECH vs.
Medium
0.985
0.786
1.234
HITECH
High
0.705
0.563
0.882
POST_HITECH vs.
Medium
1.506
1.185
1.913
HITECH
High
1.996
1.575
2.529
HHI
Medium
3.351
1.719
6.530
High
7.792
4.005
15.159
LOG_INCOME
Medium
0.916
0.404
2.076
High
0.929
0.411
2.102
METRO_ADJ vs.
Medium
1.614
0.855
3.049
METROPOLITAN
High
1.648
0.874
3.107
RURAL vs.
Medium
2.782
1.325
5.844
METROPOLITAN
High
2.745
1.309
5.756
Organizational Factors
LOG_SIZE
Medium
1.780
1.375
2.304
High
2.267
1.752
2.933
SYSTEM
Medium
1.139
0.789
1.644
High
1.049
0.727
1.513
OPERATING_MARGIN
Medium
1.285
0.504
3.272
High
3.274
1.281
8.364
PRIVATE_PAYER
Medium
11.997
3.341
43.071
High
37.444 10.453
134.127
FOR_PROFIT vs. PUBLIC Medium
0.290
0.161
0.520
High
0.178
0.099
0.320
NON_PROFIT vs.
Medium
1.418
0.879
2.287
PUBLIC
High
1.725
1.070
2.779
TEACH
Medium
1.328
0.712
2.477
High
1.173
0.629
2.184
Sample Size=13,690; Level 2 units=2,738
OR: Odds Ratio; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001

P-value

0.895
0.002**
0.001**
0.000***
0.000***
0.000***
0.834
0.860
0.140
0.122
0.007**
0.008**
0.000***
0.000***
0.488
0.798
0.600
0.013*
0.000***
0.000***
0.000***
0.000***
0.153
0.025*
0.373
0.616

Model 6: Adoption of Dispensing Technologies
Model 6 examined the impact of the HITECH Act on the adoption levels of dispensing
technologies by U.S. acute care hospitals and the organizational and environmental correlates of
this adoption using a multinomial logistic regression model. For this variable, the model with the
best AIC was the mixed-effects model with random hospital-level intercepts. The key policy
variables of PRE_HITECH and POST_HITECH were statistically significant (p<0.001). In line
with what was predicted, hospitals had 2.88 times higher odds to be medium adopters and 2.75
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times higher odds to be high adopters in post-HITECH period (p<0.001) as compared to the
HITECH period and 0.55 times lower odds of medium adoption level and 0.58 times lower odds
of high adoption level in the pre-HITECH period (p<0.001) as compared to the HITECH period.
Contrary to expectations, hospitals with one unit higher HHI (i.e., lower competition) were
significantly more likely to be medium-level adopters (p<0.01) and high-level adopters
(p<0.001). Contrary to what was predicted, community wealth was not statistically significantly
associated with likelihood of medium and high adoption.
As predicted, larger hospital size was positively associated with the likelihood of medium
adoption and high adoption (p<0.001). Contrary to expectations, system membership was not
statistically significantly associated with the likelihood of medium and high adoption. As
expected, hospitals with one unit higher operating margin were almost five times more likely to
be high adopters (OR:4.916; p<0.001), though operating margin was only marginally significant
with medium-level adoption. As expected, hospitals with one unit higher private payer mix had
significantly higher odds of being medium-level adopters as well as high-level adopters
(p<0.001). Contrary to what was expected, for-profit hospitals were 0.50 times less likely to be
high adopters (p<0.01) as compared to public hospitals, though for-profit status was not
significantly associated with medium-level adoption. Among the control variables, hospitals
located in metropolitan adjacent areas had significantly lower odds of high adoption (p<0.05) and
those located in rural areas had significantly lower odds of high adoption (p<0.01) as compared to
the hospitals located in metropolitan areas. The results from the model are presented in Table 14.
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Table 14: Parameter Estimates: Adoption of Dispensing Technologies
Correlate
DISPENSE
OR
95% CI for OR
Lower
Upper
Limit
Limit
Ref=Low
Environmental Factors
PRE_HITECH vs. HITECH
Medium
0.545
0.468
0.635
High
0.584
0.477
0.716
POST_HITECH vs. HITECH
Medium
2.882
2.452
3.388
High
2.745
2.225
3.387
HHI
Medium
2.386
1.419
4.013
High
4.104
2.366
7.120
LOG_INCOME
Medium
0.603
0.319
1.141
High
0.568
0.288
1.117
METRO_ADJ vs.
Medium
0.867
0.533
1.410
METROPOLITAN
High
0.510
0.294
0.885
RURAL vs. METROPOLITAN Medium
0.700
0.400
1.224
High
0.342
0.180
0.652
Organizational Factors
LOG_SIZE
Medium
3.048
2.489
3.732
High
11.955
9.546
14.973
SYSTEM
Medium
1.230
0.928
1.629
High
0.809
0.598
1.095
OPERATING_MARGIN
Medium
1.906
0.936
3.882
High
4.916
2.173
11.122
PRIVATE_PAYER
Medium
20.061
7.673
52.449
High
73.289
25.238
212.825
FOR_PROFIT vs. PUBLIC
Medium
0.875
0.555
1.379
High
0.503
0.305
0.830
NON_PROFIT vs. PUBLIC
Medium
0.953
0.656
1.385
High
0.769
0.517
1.144
TEACH
Medium
1.757
1.075
2.872
High
1.661
1.003
2.750
Sample Size=13,690; Level 2 units=2,738
OR: Odds Ratio; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001

P-value

0.000***
0.000***
0.000***
0.000***
0.001**
0.000***
0.120
0.101
0.566
0.017*
0.211
0.001**
0.000***
0.000***
0.150
0.170
0.075
0.000***
0.000***
0.000***
0.565
0.007**
0.802
0.195
0.025*
0.048*

Model 7: Adoption of Administration Technologies
Model 7 examined the impact of the HITECH Act on the adoption levels of
administration technologies by U.S. acute care hospitals and the organizational and
environmental correlates of this adoption using a multinomial logistic regression model. For this
variable, the model with the best AIC was the mixed-effects model with random hospital-level
intercepts. The key policy variables of PRE_HITECH and POST_HITECH were statistically
significant (p<0.001). In line with what was predicted, hospitals had almost four times higher
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odds to be medium adopters and five times higher odds to be high adopters in post-HITECH
period (p<0.001) as compared to the HITECH period and 0.44 times lower odds of medium
adoption level and 0.30 times lower odds of high adoption level in the pre-HITECH period
(p<0.001) as compared to the HITECH period. Contrary to expectations, hospitals with one unit
higher HHI (i.e., lower competition) were significantly more likely to be medium-level adopters
(p<0.01) and high-level adopters (p<0.05). Contrary to what was expected, higher community
wealth was not statistically significantly associated with likelihood of medium and high adoption.
As predicted, larger hospital size was positively associated with the likelihood of medium
adoption and high adoption (p<0.001). Contrary to what was predicted, system membership was
not statistically significantly associated with the likelihood of medium and high adoption. As
expected, higher operating margin was only significantly associated with the likelihood high
adoption (p<0.01), though it was not statistically significantly associated with likelihood of
medium adoption. As expected, hospitals with one unit higher private payer mix had significantly
higher odds of being medium-level adopters as well as high-level adopters (p<0.001). Contrary to
what was expected, for-profit hospitals were 0.55 times less likely to be high adopters (p<0.001)
as compared to public hospitals, though for-profit status was not significantly associated with
medium-level adoption. The results from the model are presented in Table 15.
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Table 15: Parameter Estimates: Adoption of Administration Technologies
Correlate
ADMINISTER
OR
95% CI for OR
Lower
Upper
Limit
Limit
Ref=Low
Environmental Factors
PRE_HITECH vs.
Medium
0.436
0.370
0.514
HITECH
High
0.299
0.249
0.359
POST_HITECH vs.
Medium
4.279
3.593
5.096
HITECH
High
5.284
4.381
6.374
HHI
Medium
2.585
1.311
5.097
High
2.066
1.039
4.109
LOG_INCOME
Medium
1.694
0.752
3.817
High
1.843
0.809
4.198
METRO_ADJ vs.
Medium
0.991
0.522
1.882
METROPOLITAN
High
0.981
0.512
1.881
RURAL vs.
Medium
0.781
0.377
1.618
METROPOLITAN
High
0.814
0.389
1.706
Organizational Factors
LOG_SIZE
Medium
2.598
2.003
3.371
High
3.179
2.441
4.139
SYSTEM
Medium
1.102
0.790
1.538
High
0.827
0.589
1.161
OPERATING_MARGIN
Medium
1.808
0.810
4.033
High
3.520
1.524
8.131
PRIVATE_PAYER
Medium
31.909
10.012
101.700
High
32.209
9.844
105.381
FOR_PROFIT vs. PUBLIC Medium
0.792
0.444
1.414
High
0.550
0.304
0.994
NON_PROFIT vs.
Medium
0.815
0.510
1.300
PUBLIC
High
0.930
0.578
1.495
TEACH
Medium
0.660
0.369
1.181
High
0.626
0.347
1.130
Sample Size=13,690; Level 2 units=2,738
OR: Odds Ratio; Ψp<0.10; *p<0.05; **p<0.01; ***p<0.001

P-value

0.000***
0.000***
0.000***
0.000***
0.006**
0.039*
0.204
0.146
0.978
0.954
0.506
0.586
0.000***
0.000***
0.568
0.273
0.148
0.003**
0.000***
0.000***
0.431
0.048*
0.390
0.763
0.162
0.120

Sensitivity Analysis
A sensitivity analysis using a Tobit regression model was conducted for Model 1, which
examined the GLOBAL_ADOPT variable using a mixed-effects model with Poisson distribution
and random hospital, county and state-level intercepts. Since this variable had an upper limit of
12 technologies that could be adopted by the hospital, a Tobit model would also be appropriate.
The results from the Tobit model were consistent with those obtained from Model 1.
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Summary of Chapter
This chapter presented the results of the descriptive and multivariate regression analyses.
The study sample was not significantly different from the study population. Changes in the
dependent variable measures before and after the implementation of the HITECH Act in 2011,
revealed significant increases in all the measures with a steeper increase between the postHITECH period and the HITECH period as compared to the increase between the HITECH
period and the pre-HITECH period.
The multivariate analyses found that the key policy variable of the HITECH Act period
was significantly associated with all seven dependent variables, with significantly higher adoption
of MMTs in the post-HITECH Act period and lower adoption of MMTs in the pre-HITECH Act
period, as compared to the HITECH Act period. Further, competition, hospital size, operating
margin, private payer mix and ownership control were significantly associated with the global
adoption of MMTs. Community wealth, hospital size, private payer mix, ownership control and
teaching status were significantly associated with the adoption of MU MMTs. Competition,
community wealth, geographic location, hospital size, system membership, private payer mix,
ownership control and teaching status were significantly associated with the adoption levels of
ordering technologies. Competition, geographic location hospital size, operating margin, private
payer mix and ownership control were significantly associated with the adoption levels of
transcribing technologies. Competition, geographic location, hospital size, system membership,
private payer mix, ownership control and teaching status were significantly associated with the
adoption levels of dispensing technologies. Competition, geographic location, hospital size,
system membership and ownership control were significantly associated with the adoption levels
of administration technologies.
In the final Chapter 6, a summary of the findings from the descriptive statistics and
hypotheses testing through the multivariate analyses are presented. The chapter also provides the
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interpretation of the results and a discussion of the implications of this study for future research,
policy and practice. The chapter concludes with a discussion of the limitations of this study and
opportunities for future research.
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CHAPTER SIX: DISCUSSION
Introduction
The aim of this study was to examine the impact of the implementation of the HITECH
Act on the adoption of MMTs by U.S. acute care hospitals as well as to assess the environmental
and organizational correlates of the adoption of MMTs by U.S. acute care hospitals. Two research
questions were posed in this study:
1) How did the implementation of the HITECH Act affect the adoption of MMTs in U.S. acute
care hospitals?
2) What are the organizational and environmental factors that are associated with the adoption
of MMTs in U.S. acute care hospitals?
Specifically, this study examined MMTs through their functional uses in the four steps of
the medication management process: ordering, transcribing, dispensing and administration,
adoption of CLMM; as well as through the global adoption of MMTs (total number of MMTs
adopted) and adoption of MU MMTs (CDSS, CPOE and eMAR). This study derived its
conceptual framework from the resource dependence theory (RDT) and the central empirical
hypotheses of this study were: 1) After the implementation of the HITECH Act, U.S. acute care
hospitals will be more likely to adopt MMTs; and 2) organizational factors and environmental
factors will be associated with the adoption of MMTs by U.S. acute care hospitals. The
organizational factors examined in this study were organizational size, system membership,
financial resources, private payer mix and ownership control. The environmental factors that were
examined were the degree of competition and community wealth in the hospital market. The
study also included an organizational control variable of teaching status and an environmental
control variable of the geographic location of the hospital.
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Specific hypotheses were based upon the three key tenets of the RDT- uncertainty,
munificence and interdependence. It was proposed that the implementation of the HITECH Act
would bring about adoption and meaningful use of health IT. Thus, it was hypothesized that
hospitals would be more likely to adopt MMTs in the period after the implementation of the
HITECH Act. The basic MMTs that were required to be adopted by the HITECH Act were
CPOE, CDSS and eMAR. Hence, hospitals would be more likely to adopt these three MMTs
together in the period after the implementation of the HITECH Act. This policy effect was
considered to create an uncertainty in the environment, leading to the hospitals to comply with the
objectives of the policy to ensure survival. Further, it was also proposed that market competition,
representing uncertainty; community wealth, hospital size, system membership and financial
performance, representing munificence; and dependence on private insurance payers and
shareholders, representing interdependence would be positively associated with adoption of
MMTs. More specifically, being larger in size; being a system member; having financial
resources; being a for-profit hospital; having a higher private payer mix; and operating in areas
with higher competition and higher degree of community wealth would be positively associated
with adoption of MMTs.
To test these hypotheses, data were drawn from three secondary administrative data
sources: HIMSS Analytics Database, obtained from The Dorenfest Institute for H.I.T. Research
and Education, HIMSS Foundation; HCRIS database, obtained from the CMS; and the countylevel data from AHRF. The independent variables in the study were lagged by one year i.e., they
were assessed for 2008 to 2012, while the dependent variable measures were assessed from 2009
to 2013. Only non-CAH, non-federal, acute care hospitals operating in the 50 U.S. States and the
District of Columbia reporting to the HIMSS Analytics Database were included in the study
population. After merging all three datasets, keeping only those observations with non-missing
data for all study variables and keeping only those hospitals that were observed for all five years
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of the study, the final sample size used in the empirical analyses was 13,690 for the years 2009 to
2013 consisting of balanced panel dataset of 2,738 unique hospitals. The ensuing paragraphs in
this chapter summarize the findings from the descriptive and multivariate analyses, interpret these
findings and discuss the implications of the study with respect to theory-based research,
methodology, policy and practice. The limitations and future research directions are also
described.

Summary and Interpretation of Descriptive Analyses
Descriptive analyses of the study variables were conducted using frequencies,
proportions, means and standard deviations as appropriate and a correlation analysis was
conducted. Correlation analysis revealed no issue of multicollinearity between the independent
variables in this study. A comparison of the study sample with the study population revealed no
statistically significant differences between the two groups. Hence, the study sample was
representative of the study population. Changes in the dependent variable measures before and
after the implementation of the HITECH Act were examined. As expected, statistically significant
increases were observed in all seven dependent variable measures after the implementation of the
HITECH Act (post-HITECH) as compared to before (pre-HITECH). Interestingly, a graphical
representation of the changes in the dependent variable measures with respect to HITECH Act
implementation time period revealed a steeper increase in all dependent variable mneasures
between the post-HITECH period and the HITECH period as compared to the increase from the
pre-HITECH period to the HITECH period. This suggests that the adoption rate of MMTs was
greater after the implementation of the HITECH Act, as compared to before the implementation.

Summary and Interpretation of Hypotheses Testing
The ensuing paragraphs discuss the interpretations of the hypotheses that were proposed
in Chapter 3 based on the results of the empirical analyses presented in Chapter 5. The key
outcome of interest of adoption of MMTs was operationalized through seven different measures:
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(1) the global adoption of MMTs (GLOBAL_ADOPT), (2) adoption of MU MMTs (MU_MMT),
(3) adoption of CLMM (CLOSEDLOOP), (4) adoption of ordering technologies (ORDER), (5)
adoption of transcribing technologies (TRANSCRIBE), (6) adoption of dispensing technologies
(DISPENSE) and (7) adoption of administration technologies (ADMINISTER). The following
discussion will elaborate the findings based on these seven measures of adoption of MMTs.
H1: Hospitals will be more likely to adopt MMTs in the period after the implementation of
the HITECH Act, all things being equal.
Hypothesis 1 proposed that hospitals will be more likely to adopt MMTs in the postHITECH implementation period as compared to before the implementation of the Act. The
findings of this study support this hypothesis through all the measures of the dependent variable
examined in this study (GLOBAL_ADOPT, CLOSEDLOOP, MU_MMT, ORDER,
TRANSCRIBE, DISPENSE and ADMINISTER) at the p<0.05 level. The coefficient estimates
for the post-HITECH Act implementation variable (POST_HITECH) were positive and
significant and the coefficient estimates for the pre-HITECH Act implementation variable
(PRE_HITECH) were negative and significant at the p<0.05 level for all models. In the postHITECH period, hospitals were significantly more likely to adopt MMTs and in the pre-HITECH
period, hospitals were significantly less likely to adopt MMTs. In the post-HITECH Act period,
financial incentives were offered by CMS to comply with the MU Stage 1 objectives while those
who did not comply with the objectives would be penalized (Centers for Medicare and Medicaid
Services, 2016d). The objective of the HITECH Act was to improve the quality of care through
the use of technology (Centers for Medicare and Medicaid Services, 2016a). This policy
enactment, which established financial incentives and penalties created an uncertain environment
for the hospitals. In such an uncertain environment, hospitals may strategize to gain critical
financial resources and ensure survival (Alexander & Morrisey, 1989; Apenteng et al., 2015;
Banaszak-Holl et al., 1996; Kazley & Ozcan, 2007; Nayar, 2008). Thus, hospitals may have
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adopted MMTs as a strategic decision to maintain the inflow of resources in an uncertain
environment. Table 16 summarizes the results of the hypothesis testing and direction of
coefficients for hypothesis 1.
Table 16: Confirmation of Hypothesis 1 and Direction of Coefficients
Model
Adoption
Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Positive
MMTs
Model 2: Adoption of MU
Positive
Positive
MMTs
Model 3: Adoption of CLMM
Positive
Positive
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Positive
Model 5: Adoption of
Medium
Positive
Positive
Transcribing Technologies
High
Positive
Positive
Model 6: Adoption of
Medium
Positive
Positive
Dispensing Technologies
High
Positive
Positive
Model 7: Adoption of
Medium
Positive
Positive
Administration Technologies
High
Positive
Positive

P-value

Supported
at p<0.05

<0.001

Yes

<0.001

Yes

<0.001
<0.001
<0.001
0.001
<0.001
<0.001
<0.001
<0.001
<0.001

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

H2: Hospitals located in markets with higher competition will be more likely to adopt
MMTs, all things being equal.
Hypothesis 2 proposed that competition in the hospital market would be positively
associated with the adoption of MMTs. The findings of this study do not support this hypothesis
for any of the seven outcome measures of interest. Competition was measured through HHI,
which ranges from a scale of 0 to 1, with 0 capturing perfect competition and 1 capturing perfect
monopoly. Hence, lower HHI implied higher competition. This study found a positive and
significant association between HHI and GLOBAL_ADOPT and medium- and high-level
adoption of ORDER, TRANSCRIBE, DISPENSE and ADMINISTER and no significant
association between HHI and CLOSEDLOOP and MU_MMT. The positive association indicates
that those hospitals that were located in less competitive markets were more likely to adopt
MMTs.
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This may be due to the reason that hospitals that were adopting MMTs could be doing so
based on criteria other than competition. Further, MMTs are expensive which requires higher
capital with uncertainties on the return on investments (Classen & Brown, 2013). In competitive
environments, there is a limited pool of resources that the organizations share (Scott & Davis,
2003). To secure these resources, hospitals in a market with higher competition could be
prioritizing other strategies such as advertising to attract patients, which could ensure their
survival rather than the adoption of expensive technology with uncertain immediate returns.
Although HHI was not significant with CLOSEDLOOP and MU_MMT, the direction of the
association remained the same. The non-significant results indicate that hospitals may be
prioritizing certain other strategies to ensure their survival. Table 17 summarizes the results of the
hypothesis testing and direction of coefficients for hypothesis 2.
Table 17: Confirmation of Hypothesis 2 and Direction of Coefficients
Model
Adoption Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Negative
MMTs
Model 2: Adoption of MU
Positive
Negative
MMTs
Model 3: Adoption of CLMM
Positive
Positive
Model 4: Adoption of
Medium
Positive
Negative
Ordering Technologies
High
Positive
Negative
Model 5: Adoption of
Medium
Positive
Negative
Transcribing Technologies
High
Positive
Negative
Model 6: Adoption of
Medium
Positive
Negative
Dispensing Technologies
High
Positive
Negative
Model 7: Adoption of
Medium
Positive
Negative
Administration Technologies
High
Positive
Negative

P-value

Supported
at p<0.05

0.035

No

0.427

No

0.548
0.002
0.002
<0.001
<0.001
0.001
<0.001
0.006
0.039

No
No
No
No
No
No
No
No
No

H3: Hospitals located in markets with higher community wealth will be more likely to adopt
MMTs, all things being equal.
Hypothesis 3 proposed that higher degree of community wealth would be positively
associated with the adoption of MMTs. This study found mixed evidence to support this
hypothesis. Two of the seven outcome measures of interest: MU_MMT and medium and high-
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level of ORDER supported this hypothesis. Community wealth in the hospital market was
measured through the median household income in the county that the hospital was located in
(INCOME) and the coefficient estimates for the INCOME variable were positive and significant
at the p<0.05 level for MU_MMT and medium and high-level adoption of ORDER. However,
community wealth was not significantly associated with the remaining measures of the dependent
variable at p<0.05 level.
Higher income in the county signifies a higher-paying patient base for the hospital and
thus, the hospitals located in areas with higher income have access to affluent patient resources.
These hospitals are assured of having access to these affluent resources in the long term. MU
MMTs included CPOE, CDSS and eMAR, while ordering technologies included CPOE and
CDSS. CPOE, CDSS and eMAR are technologies that are difficult to implement and require a
longer implementation time. Hence, these hospitals that are assured of resources through their
affluent environment may risk adopting these longer term implementation projects and hence
could be more likely to adopt these technologies.
Table 18: Confirmation of Hypothesis 3 and Direction of Coefficients
Model
Adoption
Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Positive
MMTs
Model 2: Adoption of MU
Positive
Positive
MMTs
Model 3: Adoption of CLMM
Positive
Positive
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Positive
Model 5: Adoption of
Medium
Positive
Negative
Transcribing Technologies
High
Positive
Negative
Model 6: Adoption of
Medium
Positive
Negative
Dispensing Technologies
High
Positive
Negative
Model 7: Adoption of
Medium
Positive
Positive
Administration Technologies
High
Positive
Positive

P-value

Supported
at p<0.05

0.104

No

0.007

Yes

0.381
0.017
0.003
0.834
0.860
0.120
0.101
0.204
0.146

No
Yes
Yes
No
No
No
No
No
No
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H4: Larger hospitals will be more likely to adopt MMTs, all things being equal.
Hypothesis 4 proposed that organizational size was positively associated with the
adoption of MMTs. This study found evidence to support this hypothesis through all the seven
dependent variables. Larger hospital size was positively and significantly associated with all
seven models at the p<0.05 level. Larger hospitals have access to more internal resources and can
also control vital resources in the environment, thereby providing them with more resources to
invest into new technologies (Kazley & Ozcan, 2007). The finding of this study resonates with
previous organizational literature that also showed that larger organizations were more likely to
adopt new technologies (Kazley & Ozcan, 2007; Kimberly & Evanisko, 1981). Table 19
summarizes the results of the hypothesis testing and direction of coefficients for hypothesis 4.
Table 19: Confirmation of Hypothesis 4 and Direction of Coefficients
Model
Adoption
Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Positive
MMTs
Model 2: Adoption of MU
Positive
Positive
MMTs
Model 3: Adoption of CLMM
Positive
Positive
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Positive
Model 5: Adoption of
Medium
Positive
Positive
Transcribing Technologies
High
Positive
Positive
Model 6: Adoption of
Medium
Positive
Positive
Dispensing Technologies
High
Positive
Positive
Model 7: Adoption of
Medium
Positive
Positive
Administration Technologies
High
Positive
Positive

P-value

Supported
at p<0.05

<0.001

Yes

<0.001

Yes

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

H5: Hospitals that are part of a multi-hospital system will be more likely to adopt MMTs,
all things being equal.
Hypothesis 5 proposed that system membership was positively associated with the
adoption of MMTs. It was proposed that since system members have access to a larger pool of
resources they would have the ability to adopt new technologies. The association between system
membership and the dependent variable varied for the seven outcomes of interest. System
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membership was negatively and significantly associated with CLOSEDLOOP, positively and
significantly associated with medium-level adoption of ORDER, DISPENSE and ADMINISTER
and not significantly associated with GLOBAL_ADOPT and TRANSCRIBE at the p<0.05 level.
System membership was negatively and marginally significantly associated with the adoption of
MU MMTs (p<0.10).
These findings indicated that system members were significantly less likely to adopt
CLMM. A possible explanation for this could be that even though system members have access
to resources through its member hospitals, they are also barriers when implementing major
changes due to the difficulties in implementing changes across an entire system. CLMM is
complex and involves high levels of coordination between different aspects of the medication
management process and the different departments of the hospital engaged in this process
(Bowles, 2012). Hence, system members may face barriers in implementing this complex system
throughout their network. The significant association between system membership and mediumlevel adoption of ORDER but no association with the high-level adoption further emphasizes on
the barriers faced by system members to achieve complete adoption owing to their complex
network structure. Table 20 summarizes the results of the hypothesis testing and direction of
coefficients for hypothesis 5.
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Table 20: Confirmation of Hypothesis 5 and Direction of Coefficients
Model
Adoption
Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Negative
MMTs
Model 2: Adoption of MU
Positive
Negative
MMTs
Model 3: Adoption of CLMM
Positive
Negative
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Positive
Model 5: Adoption of
Medium
Positive
Positive
Transcribing Technologies
High
Positive
Positive
Model 6: Adoption of
Medium
Positive
Positive
Dispensing Technologies
High
Positive
Negative
Model 7: Adoption of
Medium
Positive
Positive
Administration Technologies
High
Positive
Negative

P-value

Supported
at p<0.05

0.431

No

0.114

No

0.002
0.044
0.177
0.488
0.798
0.150
0.170
0.568
0.273

No
Yes
No
No
No
No
No
No
No

H6: Hospitals with greater financial resources will be more likely to adopt MMTs, all things
being equal.
Hypothesis 6 proposed that having higher financial resources would be positively
associated with the adoption of MMTs. This study found evidence to support this hypothesis
through five out of the seven outcomes of interest. Availability of financial resources was
measured by the operating margin of the hospital. There was positive and significant association
between operating margin and GLOBAL_ADOPT, CLOSEDLOOP and high-level adoption of
TRANSCRIBE, DISPENSE and ADMINISTER at the p<0.05 level. This indicates that hospitals
with higher operating margin have the capital to invest in expensive new technology and hence
may be more capable of adopting these MMTs.
There was no significant association between operating margin and MU_MMT, medium
and high adoption of ORDER and medium-level adoption of TRANSCRIBE, DISPENSE and
ADMINISTER. Adoption of all MMTs and adoption of CLMM is expensive and thus, higher
financial resources are needed for their adoption. It is also interesting to note that operating
margin was not significant for medium-level adoption of TRANSCRIBE, DISPENSE and
ADMINISTER and was significant for their high-level adoption. This could be due to the fact
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that MMTs are expensive (Classen & Brown, 2013) and thus, achieving a high-level adoption
requires higher investment of capital. The non-significant association between operating margin
and adoption of MU MMTs and ordering technologies resonates well with the findings of
hypothesis 3. As described earlier in context of hypothesis 3, MU MMTs (CPOE, CDSS and
eMAR) and ordering technologies (CPOE and CDSS) are difficult to implemenet and their
implementation also takes a longer time than the transcribing, dispensing and administration
technologies. Thus, hospitals that already have the financial resources may start out by adopting
the technologies that are easier to implement and undertake longer term implementation projects
later. Table 21 summarizes the results of the hypothesis testing and direction of coefficients for
hypothesis 6.
Table 21: Confirmation of Hypothesis 6 and Direction of Coefficients
Model
Adoption
Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Positive
MMTs
Model 2: Adoption of MU
Positive
Negative
MMTs
Model 3: Adoption of CLMM
Positive
Positive
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Positive
Model 5: Adoption of
Medium
Positive
Positive
Transcribing Technologies
High
Positive
Positive
Model 6: Adoption of
Medium
Positive
Positive
Dispensing Technologies
High
Positive
Positive
Model 7: Adoption of
Medium
Positive
Positive
Administration Technologies
High
Positive
Positive

P-value

Supported
at p<0.05

<0.001

Yes

0.120

No

0.001
0.066
0.077
0.600
0.013
0.075
<0.001
0.148
0.003

Yes
No
No
No
Yes
No
Yes
No
Yes

H7: Hospitals with a higher private payer mix will be more likely to adopt MMTs, all things
being equal.
Hypothesis 7 proposed that having higher proportions of patients with private insurance
was positively associated with adoption of MMTs. This study found evidence to support this
hypothesis through all the seven measures of adoption of MMTs. Private payer mix was
positively and significantly associated with GLOBAL_ADOPT, CLOSEDLOOP, MU_MMT and
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medium and high adoption levels of ORDER, TRANSCRIBE, DISPENSE and ADMINISTER at
the p<0.05 level.
This may be due to the reason that public payers such as Medicare and Medicaid
reimburse hospitals at lower prices than the cost of providing services (Zinn et al., 1997), while
the private insurance payers are more munificent payers for the hospitals. Hospitals with higher
private payer mix are more dependent on the private payers and would be more likely to adopt
new technologies that improve the quality of care provided to maintain this dependence and
continue to attract these patients with private insurance. Table 22 summarizes the results of the
hypothesis testing and direction of coefficients for hypothesis 7.
Table 22: Confirmation of Hypothesis 7 and Direction of Coefficients
Model
Adoption Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficient
Model 1: Global Adoption of
Positive
Positive
MMTs
Model 2: Adoption of MU
Positive
Positive
MMTs
Model 3: Adoption of CLMM
Positive
Positive
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Positive
Model 5: Adoption of
Medium
Positive
Positive
Transcribing Technologies
High
Positive
Positive
Model 6: Adoption of
Medium
Positive
Positive
Dispensing Technologies
High
Positive
Positive
Model 7: Adoption of
Medium
Positive
Positive
Administration Technologies
High
Positive
Positive

P-value

Supported
at p<0.05

<0.001

Yes

<0.001

Yes

<0.001
0.003
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

H8: For-profit hospitals will be more likely to adopt MMTs as compared to public hospitals,
all things being equal.
Hypothesis 8 proposed that the for-profit status of the hospital was positively associated
with the adoption of MMTs. This study did not find evidence for this hypothesis through any of
the seven outcomes of interest. In fact, for-profit hospital status was negatively and significantly
associated with GLOBAL_ADOPT, MU_MMT and high-level adoption of TRANSCRIBE,
DISPENSE and ADMINISTER at the p<0.05 level. There was no significant association between

146

for-profit status and CLOSEDLOOP medium and high level adoption of ORDER and medium
level adoption of TRANSCRIBE, DISPENSE and ADMINISTER. This indicates that for-profit
hospitals were less likely to adopt most MMTs as compared to public hospitals.
This finding is consistent with previous work on the adoption of different MMTs
(Abraham, McCullough, Parente, & Gaynor, 2011; Cutler et al., 2005; Furukawa et al., 2008).
Cutler et al. (2005) reported that for-profit hospitals were less likely to adopt EMRs (Cutler et al.,
2005) and Furukawa et al. (2008) reported a similar finding for EMR and CPOE (Furukawa et al.,
2008). These findings were also consistent with the work done by Abraham et al. (2011), which
reported that for-profit hospitals were less likely to adopt clinical IT such as EMR, CPOE, picture
archiving communications systems (PACS), eMAR and nurse charts (Abraham et al., 2011).
This negative association may be due to the resistance for for-profit hospitals to invest into
expensive technologies (Abraham et al., 2011). Additionally, public hospitals could have more to
gain from the benefits of MMTs as they have sicker patients and could benefit from the
improvement in the outcomes through improvement in patient safety (Cutler et al., 2005).
Moreover, with the political interest in patient safety and adoption of MMTs, leaders of public
hospitals could be more willing to invest into them as compared to for-profit hospitals (Cutler et
al., 2005). Although the association between for-profit status and adoption of CLMM was not
significant at the p<0.05 level, the direction of the coefficient was consistent with the other
models and was also marginally significant. Table 23 summarizes the results of the hypothesis
testing and direction of coefficients for hypothesis 8.
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Table 23: Confirmation of Hypothesis 8 and Direction of Coefficients
Model
Adoption
Expected
Observed
Level
Sign of
Sign of
Coefficient Coefficien
t
Model 1: Global Adoption of
Positive
Negative
MMTs
Model 2: Adoption of MU
Positive
Negative
MMTs
Model 3: Adoption of CLMM
Positive
Negative
Model 4: Adoption of
Medium
Positive
Positive
Ordering Technologies
High
Positive
Negative
Model 5: Adoption of
Medium
Positive
Negative
Transcribing Technologies
High
Positive
Negative
Model 6: Adoption of
Medium
Positive
Negative
Dispensing Technologies
High
Positive
Negative
Model 7: Adoption of
Medium
Positive
Negative
Administration Technologies
High
Positive
Negative

P-value

Supported
at p<0.05

<0.001

No

<0.001

No

0.276
0.176
0.074
<0.001
<0.001
0.565
0.007
0.431
0.048

No
No
No
No
No
No
No
No
No

Implications for Theory-based Research
This study adds to the growing body of literature using organizational theory to explain
the behavior of health care organizations. This is the only study of its kind to be using an
organizational theory like RDT to explain the adoption of technologies specifically used for the
automation of the medication management process while examining technologies for their
specific functionality in the medication management process. This study provides empirical
support for RDT in explaining the organizational and environmental correlates of innovation
adoption.
With respect to the global adoption of MMTs and adoption of CLMM, it was found that
the policy effect of the implementation of the HITECH Act, which represents uncertainty and the
organizational characteristics of size and operating margin, which represent munificence and the
organizational characteristic of private payer mix, which represents interdependence were
important predictors. With respect to the adoption of MU MMTs and ordering technology, it was
found that the policy effect of the implementation of the HITECH Act, which represents
uncertainty and the environmental characteristic of community wealth and the organizational
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characteristic of size, which represent munificence and the organizational characteristic of private
payer mix, which represent interdependence were important predictors. With respect to high-level
adoption of transcribing, dispensing and administration technology, it was found that the policy
effect of the implementation of the HITECH Act, which represents uncertainty, the organizational
characteristic of size, which represents munificence and the organizational characteristic of
private payer mix, which represents interdependence were important predictors.
Thus, the factors associated with the adoption of MMTs depended on the type of
technology considered. Hospitals do not adopt all MMTs, but are strategically choosing which
type of MMT to be adopted depending on its organizational and environmental characteristics.
This provided further evidence to the use of a resource dependence perspective as adoption of
types of MMTs were strategic decisions of the hospitals.

Implications for Methodology
This study also makes a significant contribution to the literature by improving the
methodology used in previous studies that examined the adoption of technologies by U.S. acute
care hospitals. Most of the previous studies have used cross-sectional analyses when examining
the factors related to the adoption of technology. The use of panel data and the panel data
analyses methods in this study provide an improvement over the previously used methodologies.
Especially, the use of a mixed-effects model allows for both fixed effects and random effects
specification. Further, this model is also appropriate for the multi-level nature of the dataset.

Implications for Policy and Practice
Given the public health burden of medication errors and ADEs as described in Chapter 2,
an increased emphasis has been put on the use of technologies by organizations such as Leapfrog,
the IOM, the AHRQ, as well as through the HITECH Act to reduce these errors and improve the
quality of care. This forms the core of the policy recommendations that have been put forth in the
HITECH Act. The results of this study are likely to be of interest to policymakers, especially with
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the uncertainties around the impact of the HITECH Act. The finding that hospitals were more
likely to adopt MMTs in the post-HITECH Act period provides positive evidence for the
expected implications of the Act.
Also, certain inherent characteristics of the hospital such as size, which represents the
internal resources of the hospital act as an enabler in the adoption of MMTs and those hospitals
that are short of these resources may be facing barriers to adopting MMTs. Especially, small
hospitals are less likely to adopt MMTs despite the incentives of the HITECH Act. Therefore,
policymakers interested in expanding the impact of the HITECH Act should pay attention to this
finding and take the necessary steps to encourage adoption of MMTs among smaller hospitals.
Certain unexpected findings of this study such as competition and for-profit status of hospitals
being negatively associated with the adoption of MMTs also calls for the attention of
policymakers and legislators. This study found that in markets with higher competition, hospitals
did not prioritize adoption of MMTs. Further, another interesting finding is that contrary to
expectations, for-profit hospitals were less likely to adopt MMTs. This reveals that for-profit
hospitals may be experiencing certain barriers in the adoption of MMTs and that using MMTs to
improve the quality of care was not a strategic priority for for-profit hospitals. This calls for the
attention of policymakers towards taking steps to understand the strategic priorities of hospitals in
highly competitive markets as well as among the for-profit hospitals.

Limitations of the Study
Despite the contributions of this study towards theory-driven research, methodology,
policy and practice, it is important to acknowledge certain limitations that must be considered
when interpreting the findings of this study.
1) The absence of a control group is a major limitation of this study. Due to this, it was not
possible to control for the extraneous events that may have impacted the adoption of MMTs
by U.S. acute care hospitals.
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2) Another limitation of the study that arises of out of the single group study design is the
inability to separate the effect of the secular trends on the adoption of MMTs from the policy
implementation measure. Since the policy implementation measure is derived from the time
period of implementation and there is no control group in the design, there was a collinearity
between the policy implementation variable and the yearly dummy variables. Due to this
collinearity, the yearly dummy variables could not be included in the models. Hence, when
interpreting the results of the HITECH Act implementation, it is important to consider that
the policy effect that is seen is a combination of the implementation of the Act as well as
secular trends over time.
3) This study is restricted to non-CAH, non-federal, acute care hospitals located in the 50 U.S.
states and the District of Columbia. Therefore, the findings of this study may not be
generalizable to all hospitals in the U.S., including specialty hospitals, federal hospitals,
CAHs, hospitals located in U.S. territories or other types of health care organizations.

Suggestions for Future Research
Future research could improve and expand upon the premise of this study by exploring
the impact of the adoption of MMTs on outcome measures such as medication errors and adverse
drug events. Although this has been examined previously, the findings from those studies are not
generalizable as they focus either on one hospital or health care system or hospitals in one state.
This may be due to the inability to measure medication errors on a national level. However, future
research could examine the impact of adoption MMTs on broader outcomes such as financial
performance, quality measures and operational efficiency of the hospitals. This will provide
additional evidence for the importance of MMTs in improving the quality of health care in the
country. It would also be interesting to extend this research by examining the impact of the
HITECH Act on certain indirect outcomes of the Act such as improvement in the quality of care,
health care costs, etc. Further, analyses similar to this study could be done to examine adoption of
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MMTs in other health care organizations such as long term care facilities or specialty care
hospitals.

Conclusions
The evidence from this study provides strong support for the implementation of the
HITECH Act on having achieved its intended objective of promoting adoption of technologies to
improve the quality of care in U.S. hospitals. With several uncertainties surrounding the benefits
of the HITECH Act, this study provides an important contribution to the body of knowledge on
the policy implications of the Act in this new era of health services research. This study also
found that the environmental characteristic of community wealth and the organizational
characteristics of size and operating margin were significantly associated with increased adoption
of MMTs. Further, the environmental characteristic of competition and the organizational
characteristic of for-profit status were found be significantly associated with decreased adoption
of MMTs. Further, factors associated with the adoption of MMTs depended on the type of
technology considered. Hospitals do not adopt all MMTs, but are strategically choosing which
type of MMT to be adopted depending on its organizational and environmental characteristics.
These results provide empirical support for using the resource dependence theory in examining
organizational response to policy implementation and strategic behavior of innovation adoption.
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